FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Lloyd Old

Research Profile

Chemicals & Drugs

Living Beings

Disorders

Anatomy

Co-author Network

Publications

TOP 3
Michiko Hirayama; Sahoko Hori; Shinichi Kageyama; Takuma Kato; Yasuhiro Nagata; Hiroyoshi Nishikawa; Lloyd J Old; Gerd Ritter; Shimon Sakaguchi; Daisuke Sugiyama; Takemasa Tsuji; Shugo Ueda; Sacha Gnjatic; Hiroshi Shiku
Overcoming regulatory T-cell suppression by a lyophilized preparation of Streptococcus pyogenes.
Patrick A Ott; Linda Pan; Neeta Pandit-Taskar; Anna Pavlick; Ralph Venhaus; John S Bomalaski; Richard D Carvajal; Eric W Hoffman; Achim A Jungbluth; Lloyd J Old; Bor-Wen Wu; Jedd D Wolchok
Phase I/II study of pegylated arginine deiminase (ADI-PEG 20) in patients with advanced melanoma.
ROBERT G MAKI; Lloyd J Old; Erika Ritter; Rita Chiu; David R D'Adamo; Sacha Gnjatic; Achim A Jungbluth; Jennifer Kachel; Mary-Louise Keohan; Israel Lowy; Kelly Scheu; Gary K Schwartz; Michael J Wagner; Gerd Ritter
A Pilot Study of Anti-CTLA4 Antibody Ipilimumab in Patients with Synovial Sarcoma.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Lloyd Old (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Michiko Hirayama; Sahoko Hori; Shinichi Kageyama; Takuma Kato; Yasuhiro Nagata; Hiroyoshi Nishikawa; Lloyd J Old; Gerd Ritter; Shimon Sakaguchi; Daisuke Sugiyama; Takemasa Tsuji; Shugo Ueda; Sacha Gnjatic; Hiroshi Shiku
Overcoming regulatory T-cell suppression by a lyophilized preparation of Streptococcus pyogenes.
European journal of immunology 2013;43(4):989-1000.
2013: Patrick A Ott; Linda Pan; Neeta Pandit-Taskar; Anna Pavlick; Ralph Venhaus; John S Bomalaski; Richard D Carvajal; Eric W Hoffman; Achim A Jungbluth; Lloyd J Old; Bor-Wen Wu; Jedd D Wolchok
Phase I/II study of pegylated arginine deiminase (ADI-PEG 20) in patients with advanced melanoma.
Investigational new drugs 2013;31(2):425-34.
2013: ROBERT G MAKI; Lloyd J Old; Erika Ritter; Rita Chiu; David R D'Adamo; Sacha Gnjatic; Achim A Jungbluth; Jennifer Kachel; Mary-Louise Keohan; Israel Lowy; Kelly Scheu; Gary K Schwartz; Michael J Wagner; Gerd Ritter
A Pilot Study of Anti-CTLA4 Antibody Ipilimumab in Patients with Synovial Sarcoma.
Sarcoma 2013;2013():168145.
2012: Paul Sabbatini; Andres M Salazar; Christine Sedrak; David Spriggs; William P Tew; Takemasa Tsuji; Kevin Tuballes; Ralph Venhaus; Martee Hensley; Eric W Hoffman; Achim A Jungbluth; Jason Konner; Lloyd J Old; Linda Pan; Erika Ritter; Gerd Ritter; Carol Aghajanian; Katherine Bell-McGuinn; Catherine Magid Diefenbach; Luis Ferran; Sacha Gnjatic
Phase I trial of overlapping long peptides from a tumor self-antigen and poly-ICLC shows rapid induction of integrated immune response in ovarian cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(23):6497-508.
2012: Julia Karbach; Markus Maeurer; Antje Neumann; Lloyd J Old; Erika Ritter; Gerd Ritter; Ekkehard Siegel; Takamasa Tsuji; Claudia Wahle; Kathrin Brand; Sacha Gnjatic; Elke Jäger
Phase I clinical trial of mixed bacterial vaccine (Coley's toxins) in patients with NY-ESO-1 expressing cancers: immunological effects and clinical activity.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(19):5449-59.
2012: Yoshihiro Ohue; Mikio Oka; Nami Okazaki; Lloyd J Old; Akiko Uenaka; Shingo Eikawa; Minoru Fukuda; Midori Isobe; Yu Mizote; Eiichi Nakayama
Spontaneous antibody, and CD4 and CD8 T-cell responses against XAGE-1b (GAGED2a) in non-small cell lung cancer patients.
International journal of cancer. Journal international du cancer 2012;131(5):E649-58.
2012: Takemasa Tsuji; Otavia L Caballero; Achim A Jungbluth; Junko Matsuzaki; Kunle Odunsi; Lloyd J Old; Gerd Ritter; Sacha Gnjatic
Heat shock protein 90-mediated peptide-selective presentation of cytosolic tumor antigen for direct recognition of tumors by CD4(+) T cells.
Journal of immunology (Baltimore, Md. : 1950) 2012;188(8):3851-8.
2012: Kunle Odunsi; Lloyd J Old; Gerd Ritter; Protul A Shrikant; Amy Beck; Nefertiti duPont; Robert Edwards; Sacha Gnjatic; Heidi Godoy; Julia Karbach; Shashikant Lele; Junko Matsuzaki; Paulette Mhawech-Fauceglia; Austin Miller; Carl D Morrison; Antje Neumann; Elke Jäger
Efficacy of vaccination with recombinant vaccinia and fowlpox vectors expressing NY-ESO-1 antigen in ovarian cancer and melanoma patients.
Proceedings of the National Academy of Sciences of the United States of America 2012;109(15):5797-802.
2012: Andrew M Scott; Jedd D Wolchok; Lloyd J Old
Antibody therapy of cancer.
Nature reviews. Cancer 2012;12(4):278-87.
2012: Takuro Noguchi; Lloyd J Old; Gerd Ritter; Shimon Sakaguchi; Eiichi Sato; Hiroshi Shiku; Linan Wang; Sacha Gnjatic; Hiroaki Ikeda; Takuma Kato; Alexander Knuth; Yuka Maeda; Hiroyoshi Nishikawa
Intracellular tumor-associated antigens represent effective targets for passive immunotherapy.
Cancer research 2012;72(7):1672-82.
2012: Hiroyoshi Nishikawa; Lloyd J Old; Yasuo Fukumori; Sacha Gnjatic; Hiroshi Inagaki; Takashi Ishida; Asahi Ito; Yuka Maeda; Fumiko Mori; Eiichi Sato; Daisuke Sugiyama; Ryuzo Ueda; Atae Utsunomiya; Shimon Sakaguchi
Cancer/testis antigens are novel targets of immunotherapy for adult T-cell leukemia/lymphoma.
Blood 2012;119(13):3097-104.
2012: Hirokazu Matsushita; Lloyd J Old; Charles G Rickert; Lauren K Shea; Mark J Smyth; Ravindra Uppaluri; Matthew D Vesely; Michael Wendl; J Michael White; Todd Wylie; James P Allison; Cora D Arthur; Yee-Shiuan Chen; Ryan Demeter; Jasreet Hundal; Daniel C Koboldt; vincent magrini; Elaine R Mardis; Robert D Schreiber
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting.
Nature 2012;482(7385):400-4.
2012: Junji Kawada; Hiroshi Miyata; Naoaki Mizuno; Roger Murphy; Yurika Nakamura; Yuichiro Doki; Shinichi Fujiwara; Sacha Gnjatic; Midori Isobe; Achim A Jungbluth; Hiroyoshi Nishikawa; Nami Okazaki; Lloyd J Old; Linda Pan; Erika Ritter; Gerd Ritter; Takashi Saika; Akiko Uenaka; Ralph Venhaus; Hisashi Wada; Makoto Yamasaki; Eiichi Nakayama
Heteroclitic serological response in esophageal and prostate cancer patients after NY-ESO-1 protein vaccination.
International journal of cancer. Journal international du cancer 2012;130(3):584-92.
2012: H M C Shantha Kumara; Aqeel Ahmed; Otavia L Caballero; Vesna Cekic; Carlos Cordon-Cardo; Sacha Gnjatic; Michael J Grieco; Lloyd J Old; Erika Ritter; Andrew J Simpson; Tao Su; Richard L Whelan
MAGE-A3 is highly expressed in a subset of colorectal cancer patients.
Cancer immunity 2012;12():16.
2012: Jorge E S de Souza; Julia Pinheiro Chagas da Cunha; Renan Valieris Bueno de Almeida; Pedro A F Galante; Daniel Takatori Ohara; Lucila Ohno-Machado; Lloyd J Old; Sandro J de Souza
SurfaceomeDB: a cancer-orientated database for genes encoding cell surface proteins.
Cancer immunity 2012;12():15.
2011: Kazuhiro Kakimi; Katsuyuki Kiura; Jun Nakajima; Yuichiro Doki; Eric W Hoffman; Midori Isobe; Keiji Iwatsuki; Yoshio Naomoto; Mikio Oka; Lloyd J Old; Linda Pan; Eiichi Sato; Yasuyuki Seto; Kenshiro Shiraishi; Nagio Takigawa; Kazuhide Tsuji; Akiko Uenaka; Hisashi Wada; Tomoki Yamatsuji; Eiichi Nakayama
A phase I study of vaccination with NY-ESO-1f peptide mixed with Picibanil OK-432 and Montanide ISA-51 in patients with cancers expressing the NY-ESO-1 antigen.
International journal of cancer. Journal international du cancer 2011;129(12):2836-46.
2011: Caroline Junqueira; Lloyd J Old; Gerd Ritter; Flávia G Rodrigues; Luara I Santos; Santuza M R Teixeira; Egler Chiari; Wanderson D DaRocha; Bruno Galvão-Filho; Sacha Gnjatic; Achim A Jungbluth; Ricardo T Gazzinelli
Trypanosoma cruzi as an effective cancer antigen delivery vector.
Proceedings of the National Academy of Sciences of the United States of America 2011;108(49):19695-700.
2011: Joseph A O'Donoghue; Lloyd J Old; Neeta Pandit-Taskar; Daniel A Pryma; Shutian Ruan; Peter Smith-Jones; Vivian E Strong; Jorge Carrasquillo; Chaitanya R Divgi; Yuman Fong; John L Humm; Achim A Jungbluth; Nancy E Kemeny; Steven M Larson
124I-huA33 antibody uptake is driven by A33 antigen concentration in tissues from colorectal cancer patients imaged by immuno-PET.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2011;52(12):1878-85.
2011: Yao-Tseng Chen; Rita Chiu; Boquan Jin; Peishan Lee; Debra Beneck; Lloyd J Old
Chromosome X-encoded cancer/testis antigens show distinctive expression patterns in developing gonads and in testicular seminoma.
Human reproduction (Oxford, England) 2011;26(12):3232-43.
2011: Theo Nicholaou; Lloyd J Old; Linda Pan; Ralph Venhaus; David Williams; Catherine Barrow; Judy Browning; Weisan Chen; Ian D Davis; Nektaria Dimopoulos; Eric W Hoffman; Wendie Hopkins; Heather M Jackson; Duncan MacGregor; Eugene Maraskovsky; Jonathan Cebon
Immunoediting and persistence of antigen-specific immunity in patients who have previously been vaccinated with NY-ESO-1 protein formulated in ISCOMATRIX™.
Cancer immunology, immunotherapy : CII 2011;60(11):1625-37.
2011: Jianda Yuan; Matthew Adamow; James P Allison; Humilidad F Gallardo; Brian A Ginsberg; Ruth Halaban; Achim A Jungbluth; Deborah Kuk; Lloyd J Old; Katherine S Panageas; Evelina Pogoriler; Teresa S Rasalan; Erika Ritter; Gerd Ritter; Mario Sznol; Stephanie L Terzulli; Jedd D Wolchok; Yinyan Xu; Sacha Gnjatic
Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab.
Proceedings of the National Academy of Sciences of the United States of America 2011;108(40):16723-8.
2011: Jorge A Carrasquillo; Chaitanya R Divgi; Yuman Fong; Mithat Gonen; John L Humm; Jaspreet S Jaggi; Achim A Jungbluth; Nancy E Kemeny; Joseph A O'Donoghue; Lloyd J Old; Katherine S Panageas; Neeta Pandit-Taskar; Daniel A Pryma; Gerd Ritter; Shutian Ruan; David A Scheinberg; Peter Smith-Jones; Douglas Wong; Pat Zanzonico; Steven M Larson
(124)I-huA33 antibody PET of colorectal cancer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2011;52(8):1173-80.
2011: Jianda Yuan; Yinyan Xu; Sylvia Adams; James P Allison; Nina Bhardwaj; Klaus Busam; Humilidad F Gallardo; Brian Ginsberg; Achim Jungbluth; Yanyun Li; Lloyd J Old; David Page; Teresa Rasalan; Jedd D Wolchok
CTLA-4 blockade increases antigen-specific CD8(+) T cells in prevaccinated patients with melanoma: three cases.
Cancer immunology, immunotherapy : CII 2011;60(8):1137-46.
2011: Tricia Nardiello; Ruben Niesvizky; Lloyd J Old; Roger Pearse; Rebecca Wasserstrum; Valéria C C Andrade; Nina Bhardwaj; Selina Chen-Kiang; Morton Coleman; Ania Dabrowski; Maurizio Diliberto; Scott Ely; Xiangao Huang; David S Jayabalan; Achim A Jungbluth; Anna Mei; Hearn Jay Cho
MAGE-A inhibits apoptosis in proliferating myeloma cells through repression of Bax and maintenance of survivin.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(13):4309-19.
2011: Daniel A Pryma; Joseph A O'Donoghue; John L Humm; Achim A Jungbluth; Lloyd J Old; Steven M Larson; Chaitanya R Divgi
Correlation of in vivo and in vitro measures of carbonic anhydrase IX antigen expression in renal masses using antibody 124I-cG250.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2011;52(4):535-40.
2011: Chung-Jr Huang; Leonardo M Damasceno; Kyle A Anderson; Sheng Zhang; Lloyd J Old; Carl A Batt
A proteomic analysis of the Pichia pastoris secretome in methanol-induced cultures.
Applied microbiology and biotechnology 2011;90(1):235-47.
2011: Robert D Schreiber; Lloyd J Old; Mark J Smyth
Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion.
Science (New York, N.Y.) 2011;331(6024):1565-70.
2011: Adam J Lowe; Cameron L Bardliving; Chung-Jr Huang; Leonardo M Teixeira; Leonardo M Damasceno; Kyle A Anderson; Gerd Ritter; Lloyd J Old; Carl A Batt
Expression and purification of cGMP grade NY-ESO-1 for clinical trials.
Biotechnology progress 2011;27(2):435-41.
2011: Julia Karbach; Antje Neumann; Akin Atmaca; Claudia Wahle; Kathrin Brand; Lotta von Boehmer; Alexander Knuth; Armin Bender; Gerd Ritter; Lloyd J Old; Elke Jäger
Efficient in vivo priming by vaccination with recombinant NY-ESO-1 protein and CpG in antigen naive prostate cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(4):861-70.
2011: Takemasa Tsuji; Junko Matsuzaki; Marcus P Kelly; Venky Ramakrishna; Laura Vitale; Li-Zhen He; Tibor Keler; Kunle Odunsi; Lloyd J Old; Gerd Ritter; Sacha Gnjatic
Antibody-targeted NY-ESO-1 to mannose receptor or DEC-205 in vitro elicits dual human CD8+ and CD4+ T cell responses with broad antigen specificity.
Journal of immunology (Baltimore, Md. : 1950) 2011;186(2):1218-27.
2011: Takemasa Tsuji; Junko Matsuzaki; Anthony Miliotto; Kunle Odunsi; Lloyd J Old; Erika Ritter; Gerd Ritter; Sacha Gnjatic
Split T cell tolerance against a self/tumor antigen: spontaneous CD4+ but not CD8+ T cell responses against p53 in cancer patients and healthy donors.
PloS one 2011;6(8):e23651.
2011: Yao-Tseng Chen; Dara S Ross; Rita Chiu; Xi K Zhou; Yunn-Yi Chen; Peishan Lee; Syed A Hoda; Andrew J Simpson; Lloyd J Old; Otavia Caballero; A Munro Neville
Multiple cancer/testis antigens are preferentially expressed in hormone-receptor negative and high-grade breast cancers.
PloS one 2011;6(3):e17876.
2011: Jeannette C Oosterwijk-Wakka; Gürsah Kats-Ugurlu; William P J Leenders; Lambertus A L M Kiemeney; Lloyd J Old; Peter F A Mulders; Egbert Oosterwijk
Effect of tyrosine kinase inhibitor treatment of renal cell carcinoma on the accumulation of carbonic anhydrase IX-specific chimeric monoclonal antibody cG250.
BJU international 2011;107(1):118-25.
2010: Tanja Burckhart; Markus Thiel; Hiroyoshi Nishikawa; Thomas Wüest; Dafne Müller; Alfred Zippelius; Gerd Ritter; Lloyd J Old; Hiroshi Shiku; Christoph Renner
Tumor-specific crosslinking of GITR as costimulation for immunotherapy.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2010;33(9):925-34.
2010: Jason Konner; Katherine Marie Bell-McGuinn; Paul Sabbatini; Martee Hensley; William P Tew; Neeta Pandit-Taskar; Nicholas Vander Els; Martin D Phillips; Charles Schweizer; Susan C Weil; Steven M Larson; Lloyd J Old
Farletuzumab, a humanized monoclonal antibody against folate receptor alpha, in epithelial ovarian cancer: a phase I study.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(21):5288-95.
2010: Ramziya Kiyamova; Olga Kostianets; Sergey Malyuchik; Valeriy Filonenko; Vasiliy Usenko; Vadym Gurtovyy; Yuliya Khozayenko; Stepan Antonuk; Lloyd J Old; Ivan T Gout
Identification of tumor-associated antigens from medullary breast carcinoma by a modified SEREX approach.
Molecular biotechnology 2010;46(2):105-12.
2010: Axel Hoos; Alexander M M Eggermont; Sylvia Janetzki; F Stephen Hodi; Ramy Ibrahim; Aparna Anderson; Rachel Humphrey; Brent Blumenstein; Lloyd J Old; Jedd D Wolchok
Improved endpoints for cancer immunotherapy trials.
Journal of the National Cancer Institute 2010;102(18):1388-97.
2010: Daisuke Muraoka; Takuma Kato; Linan Wang; Yuka Maeda; Takuro Noguchi; Naozumi Harada; Kazuyoshi Takeda; Hideo Yagita; Philippe Guillaume; Immanuel Luescher; Lloyd J Old; Hiroshi Shiku; Hiroyoshi Nishikawa
Peptide vaccine induces enhanced tumor growth associated with apoptosis induction in CD8+ T cells.
Journal of immunology (Baltimore, Md. : 1950) 2010;185(6):3768-76.
2010: Maha Ayyoub; Pascale Pignon; Danijel Dojcinovic; Isabelle Raimbaud; Lloyd J Old; Immanuel Luescher; Danila Valmori
Assessment of vaccine-induced CD4 T cell responses to the 119-143 immunodominant region of the tumor-specific antigen NY-ESO-1 using DRB1*0101 tetramers.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(18):4607-15.
2010: Sacha Gnjatic; Yanran Cao; Uta Reichelt; Emre F Yekebas; Christina Nölker; Andreas H Marx; Andreas Erbersdobler; Hiroyoshi Nishikawa; York Hildebrandt; Katrin Bartels; Christiane Horn; Tanja Stahl; Ivan Gout; Valeriy Filonenko; Khoon-Lin Ling; Vincenzo Cerundolo; Tim Luetkens; Gerd Ritter; Kay Friedrichs; Rudolf Leuwer; Susanna Hegewisch-Becker; Jakob R Izbicki; Carsten Bokemeyer; Lloyd J Old; Djordje Atanackovic
NY-CO-58/KIF2C is overexpressed in a variety of solid tumors and induces frequent T cell responses in patients with colorectal cancer.
International journal of cancer. Journal international du cancer 2010;127(2):381-93.
2010: Fook T Lee; Graeme J O'Keefe; Hui K Gan; Angela J Mountain; Gareth R Jones; Timothy H Saunder; Jessica Sagona; Angela Rigopoulos; Fiona E Smyth; Terrance G Johns; Serengulam V Govindan; David M Goldenberg; Lloyd J Old; Andrew M Scott
Immuno-PET quantitation of de2-7 epidermal growth factor receptor expression in glioma using 124I-IMP-R4-labeled antibody ch806.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2010;51(6):967-72.
2010: Jun Mitsui; Hiroyoshi Nishikawa; Daisuke Muraoka; Linan Wang; Takuro Noguchi; Eiichi Sato; Satoshi Kondo; James P Allison; Shimon Sakaguchi; Lloyd J Old; Takuma Kato; Hiroshi Shiku
Two distinct mechanisms of augmented antitumor activity by modulation of immunostimulatory/inhibitory signals.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(10):2781-91.
2010: Junko Matsuzaki; Sacha Gnjatic; Paulette Mhawech-Fauceglia; Amy Beck; Austin Miller; Takemasa Tsuji; Cheryl Eppolito; Feng Qian; Shashikant Lele; Protul A Shrikant; Lloyd J Old; Kunle Odunsi
Tumor-infiltrating NY-ESO-1-specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer.
Proceedings of the National Academy of Sciences of the United States of America 2010;107(17):7875-80.
2010: Sacha Gnjatic; Erika Ritter; Markus W Büchler; Nathalia A Giese; Benedikt Brors; Claudia Frei; Anne Murray; Niels Halama; Inka Zörnig; Yao-Tseng Chen; Christopher Andrews; Gerd Ritter; Lloyd J Old; Kunle Odunsi; Dirk Jäger
Seromic profiling of ovarian and pancreatic cancer.
Proceedings of the National Academy of Sciences of the United States of America 2010;107(11):5088-93.
2010: Chung-Jr Huang; Kyle A Anderson; Leonardo M Damasceno; Gerd Ritter; Lloyd J Old; Carl A Batt
Improved secretion of the cancer-testis antigen SSX2 in Pichia pastoris by deletion of its nuclear localization signal.
Applied microbiology and biotechnology 2010;86(1):243-53.
2010: Yao-Tseng Chen; Amy Chadburn; Peishan Lee; Melinda Hsu; Erika Ritter; April Chiu; Sacha Gnjatic; Michael Pfreundschuh; Daniel M Knowles; Lloyd J Old
Expression of cancer testis antigen CT45 in classical Hodgkin lymphoma and other B-cell lymphomas.
Proceedings of the National Academy of Sciences of the United States of America 2010;107(7):3093-8.
2010: Julia Karbach; Sacha Gnjatic; Armin Bender; Antje Neumann; Eckhart Weidmann; Jianda Yuan; Cathy A Ferrara; Eric Hoffmann; Lloyd J Old; Nasser K Altorki; Elke Jäger
Tumor-reactive CD8+ T-cell responses after vaccination with NY-ESO-1 peptide, CpG 7909 and Montanide ISA-51: association with survival.
International journal of cancer. Journal international du cancer 2010;126(4):909-18.
2010: Otavia L Caballero; Qi Zhao; Donata Rimoldi; Brian J Stevenson; Suzanne Svobodová; Sylvie Devalle; Ute F Röhrig; Anna Pagotto; Olivier Michielin; Daniel Speiser; Jedd D Wolchok; Cailian Liu; tanja pejovic; Kunle Odunsi; Francis Brasseur; Benoit J Van den Eynde; Lloyd J Old; Xin Lu; Jonathan Cebon; Robert L Strausberg; Andrew J Simpson
Frequent MAGE mutations in human melanoma.
PloS one 2010;5(9):.
2010: Nikoletta Lendvai; Sacha Gnjatic; Erika Ritter; Michael Mangone; Wayne Austin; Karina Reyner; David Jayabalan; Ruben Niesvizky; Sundar Jagannath; Nina Bhardwaj; Selina Chen-Kiang; Lloyd J Old; Hearn Jay Cho
Cellular immune responses against CT7 (MAGE-C1) and humoral responses against other cancer-testis antigens in multiple myeloma patients.
Cancer immunity 2010;10():4.
2010: Jianda Yuan; David B Page; Geoffrey Y Ku; Yanyun Li; Zhenyu Mu; Charlotte Eielson Ariyan; Humilidad F Gallardo; Ruth-Ann Roman; Agnes I Heine; Stephanie L Terzulli; Erika Ritter; Sacha Gnjatic; Gerd Ritter; Achim A Jungbluth; James P Allison; Lloyd J Old; Jedd D Wolchok
Correlation of clinical and immunological data in a metastatic melanoma patient with heterogeneous tumor responses to ipilimumab therapy.
Cancer immunity 2010;10():1.
2009: Sylvia Janetzki; Cedrik Michael Britten; Michael Kalos; Hyam I Levitsky; Holden T Maecker; Cornelius J M Melief; Lloyd J Old; Pedro Romero; Axel Hoos; Mark M Davis
"MIATA"-minimal information about T cell assays.
Immunity 2009;31(4):527-8.
2009: Takemasa Tsuji; Nasser K Altorki; Gerd Ritter; Lloyd J Old; Sacha Gnjatic
Characterization of preexisting MAGE-A3-specific CD4+ T cells in cancer patients and healthy individuals and their activation by protein vaccination.
Journal of immunology (Baltimore, Md. : 1950) 2009;183(7):4800-8.
2009: Cedrik Michael Britten; Sylvia Janetzki; Leah Ben-Porat; Timothy M Clay; Michael Kalos; Holden T Maecker; Kunle Odunsi; Michael William Pride; Lloyd J Old; Axel Hoos; Pedro Romero
Harmonization guidelines for HLA-peptide multimer assays derived from results of a large scale international proficiency panel of the Cancer Vaccine Consortium.
Cancer immunology, immunotherapy : CII 2009;58(10):1701-13.
2009: J P C da Cunha; Pedro A F Galante; Jorge E S de Souza; R F de Souza; P M Carvalho; D T Ohara; Ricardo Moura; S M Oba-Shinja; Suely K N Marie; Wilson Araújo Silva Jr; R O Perez; B Stransky; M Pieprzyk; J Moore; Otavia L Caballero; J Gama-Rodrigues; A Habr-Gama; W P Kuo; Andrew J G Simpson; Anamaria A Camargo; Lloyd J Old; Sandro J de Souza
Bioinformatics construction of the human cell surfaceome.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(39):16752-7.
2009: Anita Grigoriadis; Otavia L Caballero; Keith Hoek; Leonard da Silva; Yao-Tseng Chen; Sandra J Shin; Achim A Jungbluth; Lance D Miller; David Clouston; Jonathan Cebon; Lloyd J Old; Sunil R Lakhani; Andrew J G Simpson; A Munro Neville
CT-X antigen expression in human breast cancer.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(32):13493-8.
2009: Gilles Bioley; Christelle Dousset; Alice Yeh; Bo Dupont; Nina Bhardwaj; Gregory Mears; Lloyd J Old; Maha Ayyoub; Danila Valmori
Vaccination with recombinant NY-ESO-1 protein elicits immunodominant HLA-DR52b-restricted CD4+ T cell responses with a conserved T cell receptor repertoire.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(13):4467-74.
2009: Feng Qian; Jeannine Villella; Paul K Wallace; Paulette Mhawech-Fauceglia; Joseph D Tario; Christopher Andrews; Junko Matsuzaki; Danila Valmori; Maha Ayyoub; Peter J Frederick; Amy Beck; Jianqun Liao; Richard Cheney; Kirsten Moysich; Shashikant Lele; Protul Shrikant; Lloyd J Old; Kunle Odunsi
Efficacy of levo-1-methyl tryptophan and dextro-1-methyl tryptophan in reversing indoleamine-2,3-dioxygenase-mediated arrest of T-cell proliferation in human epithelial ovarian cancer.
Cancer research 2009;69(13):5498-504.
2009: Stefan Bauer; Jeannette C Oosterwijk-Wakka; Nicole Adrian; Egbert Oosterwijk; Eliane Fischer; Thomas Wüest; Frank Stenner; Angelo Perani; Leonard Cohen; Alexander Knuth; Chaitanya Divgi; Dirk Jäger; Andrew M Scott; Gerd Ritter; Lloyd J Old; Christoph Renner
Targeted therapy of renal cell carcinoma: synergistic activity of cG250-TNF and IFNg.
International journal of cancer. Journal international du cancer 2009;125(1):115-23.
2009: Yao-Tseng Chen; Melinda Hsu; Peishan Lee; Sandra J Shin; Paulette Mhawech-Fauceglia; Kunle Odunsi; Nasser K Altorki; Chao-Jun Song; Bo-Quan Jin; Andrew J Simpson; Lloyd J Old
Cancer/testis antigen CT45: analysis of mRNA and protein expression in human cancer.
International journal of cancer. Journal international du cancer 2009;124(12):2893-8.
2009: Thomas P J Garrett; Antony W Burgess; Hui K Gan; Rod B Luwor; Glenn Cartwright; Francesca Walker; Suzanne G Orchard; Andrew H A Clayton; Edouard C Nice; Julie Rothacker; Bruno Catimel; Webster K Cavenee; Lloyd J Old; Elisabeth Stockert; Gerd Ritter; Timothy E Adams; Peter A Hoyne; Dane Wittrup; Ginger Chao; Jennifer Cochran; Cindy Luo; Meizhen Lou; Trevor Huyton; Yibin Xu; W Douglas Fairlie; Shenggen Yao; Andrew M Scott; Terrance G Johns
Antibodies specifically targeting a locally misfolded region of tumor associated EGFR.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(13):5082-7.
2009: Sacha Gnjatic; Nasser K Altorki; Derek Ng Tang; Shi-Ming Tu; Vikas Kundra; Gerd Ritter; Lloyd J Old; Christopher J Logothetis; Padmanee Sharma
NY-ESO-1 DNA vaccine induces T-cell responses that are suppressed by regulatory T cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(6):2130-9.
2009: Rishard H Chen; Chung-Jr Huang; Brian S Newton; Gerd Ritter; Lloyd J Old; Carl A Batt
Factors affecting endotoxin removal from recombinant therapeutic proteins by anion exchange chromatography.
Protein expression and purification 2009;64(1):76-81.
2009: Sacha Gnjatic; Colin Wheeler; Martin Ebner; Erika Ritter; Anne Murray; Nasser K Altorki; Cathy A Ferrara; Henry Hepburne-Scott; Sarah Joyce; Jens Koopm,ann; Michael B McAndrew; Nicholas Workman; Gerd Ritter; Rachel Fallon; Lloyd J Old
Seromic analysis of antibody responses in non-small cell lung cancer patients and healthy donors using conformational protein arrays.
Journal of immunological methods 2009;341(1-2):50-8.
2009: Gilles Bioley; Philippe Guillaume; Immanuel Luescher; Nina Bhardwaj; Gregory Mears; Lloyd J Old; Danila Valmori; Maha Ayyoub
Vaccination with a recombinant protein encoding the tumor-specific antigen NY-ESO-1 elicits an A2/157-165-specific CTL repertoire structurally distinct and of reduced tumor reactivity than that elicited by spontaneous immune responses to NY-ESO-1-expressing Tumors.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2009;32(2):161-8.
2009: Lucie LEVEQUE; Florence Deknuydt; Gilles Bioley; Lloyd J Old; Junko Matsuzaki; Kunle Odunsi; Maha Ayyoub; Danila Valmori
Interleukin 2-mediated conversion of ovarian cancer-associated CD4+ regulatory T cells into proinflammatory interleukin 17-producing helper T cells.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2009;32(2):101-8.
2009: Yun Lin; Humilidad F Gallardo; Geoffrey Y Ku; Hao Li; Gregor Manukian; Teresa S Rasalan; Yinyan Xu; Stephanie L Terzulli; Lloyd J Old; James P Allison; Alan N Houghton; Jedd D Wolchok; Jianda Yuan
Optimization and validation of a robust human T-cell culture method for monitoring phenotypic and polyfunctional antigen-specific CD4 and CD8 T-cell responses.
Cytotherapy 2009;11(7):912-22.
2009: Nana E Tchabo; Paulette Mhawech-Fauceglia; Otavia L Caballero; Jeannine A Villella; Amy F Beck; Anthony J Miliotto; Jianqun Liao; Christopher Andrews; Shashikant Lele; Lloyd J Old; Kunle Odunsi
Expression and serum immunoreactivity of developmentally restricted differentiation antigens in epithelial ovarian cancer.
Cancer immunity 2009;9():6.
2009: Leonardo M Damasceno; Frank Lee; Gerd Ritter; Lloyd J Old; Carl A Batt
High-level expression of a phage display-derived scFv in Pichia pastoris.
Methods in molecular biology (Clifton, N.J.) 2009;562():225-36.
2009: Jianda Yuan; Geoffrey Y Ku; Humilidad F Gallardo; Francesca Orlandi; Gregor Manukian; Teresa S Rasalan; Yinyan Xu; Hao Li; Shachi Vyas; Zhenyu Mu; Paul B Chapman; Susan E Krown; Katherine S Panageas; Stephanie L Terzulli; Lloyd J Old; Alan N Houghton; Jedd D Wolchok
Safety and immunogenicity of a human and mouse gp100 DNA vaccine in a phase I trial of patients with melanoma.
Cancer immunity 2009;9():5.
2009: Sacha Gnjatic; Lloyd J Old; Yao-Tseng Chen
Autoantibodies against cancer antigens.
Methods in molecular biology (Clifton, N.J.) 2009;520():11-9.
2009: Stefan Bauer; Nicole Adrian; Uta Siebenborn; Natalie Fadle; Margarita Plesko; Eliane Fischer; Thomas Wüest; Frank Stenner; Joachim C Mertens; Alexander Knuth; Gerd Ritter; Lloyd J Old; Christoph Renner
Sequential cancer immunotherapy: targeted activity of dimeric TNF and IL-8.
Cancer immunity 2009;9():2.
2009: Gilles Bioley; Philippe Guillaume; Immanuel Luescher; Alice Yeh; Bo Dupont; Nina Bhardwaj; Gregory Mears; Lloyd J Old; Danila Valmori; Maha Ayyoub
HLA class I - associated immunodominance affects CTL responsiveness to an ESO recombinant protein tumor antigen vaccine.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(1):299-306.
2009: Luiz Gonzaga Paula de Almeida; Noboru J Sakabe; Alice R deOliveira; Maria Cristina C Silva; Alex S Mundstein; Tzeela Cohen; Yao-Tseng Chen; Ramon Chua; Sita Gurung; Sacha Gnjatic; Achim A Jungbluth; Otávia L Caballero; Amos Bairoch; Eva Kiesler; Sarah L White; Andrew J G Simpson; Lloyd J Old; Anamaria A Camargo; Ana Tereza R Vasconcelos
CTdatabase: a knowledge-base of high-throughput and curated data on cancer-testis antigens.
Nucleic acids research 2009;37(Database issue):D816-9.
2008: Oliver Hofmann; Otavia L Caballero; Brian J Stevenson; Yao-Tseng Chen; Tzeela Cohen; Ramon Chua; Christopher A. Maher; Sumir Panji; Ulf Schaefer; Adele Kruger; Minna Lehvaslaiho; piero carninci; Yoshihide Hayashizaki; Victor Jongeneel; Andrew J G Simpson; Lloyd J Old; Winston Hide
Genome-wide analysis of cancer/testis gene expression.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(51):20422-7.
2008: Jianda Yuan; Sacha Gnjatic; Hao Li; Sarah Powel; Humilidad F Gallardo; Erika Ritter; Geoffrey Y Ku; Achim A Jungbluth; Neil H Segal; Teresa S Rasalan; Gregor Manukian; Yinyan Xu; Ruth-Ann Roman; Stephanie L Terzulli; Melanie Heywood; Evelina Pogoriler; Gerd Ritter; Lloyd J Old; James P Allison; Jedd D Wolchok
CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(51):20410-5.
2008: Wolfgang Eck; Gary Craig; Aruna Sigdel; Gerd Ritter; Lloyd J Old; Laura H Tang; Murray F Brennan; Peter J Allen; Michael D Mason
PEGylated gold nanoparticles conjugated to monoclonal F19 antibodies as targeted labeling agents for human pancreatic carcinoma tissue.
ACS nano 2008;2(11):2263-72.
2008: Hisashi Wada; Eiichi Sato; Akiko Uenaka; Midori Isobe; Ryohei Kawabata; Yurika Nakamura; Shigemichi Iwae; Kouichiro Yonezawa; Makoto Yamasaki; Hiroshi Miyata; Yuichiro Doki; Hiroshi Shiku; Achim A Jungbluth; Gerd Ritter; Roger Murphy; Eric W Hoffman; Lloyd J Old; Morito Monden; Eiichi Nakayama
Analysis of peripheral and local anti-tumor immune response in esophageal cancer patients after NY-ESO-1 protein vaccination.
International journal of cancer. Journal international du cancer 2008;123(10):2362-9.
2008: Padmanee Sharma; Dean F Bajorin; Achim A Jungbluth; Harry W Herr; Lloyd J Old; Sacha Gnjatic
Immune responses detected in urothelial carcinoma patients after vaccination with NY-ESO-1 protein plus BCG and GM-CSF.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2008;31(9):849-57.
2008: Kazuhide Tsuji; Toshitada Hamada; Akiko Uenaka; Hisashi Wada; Eiichi Sato; Midori Isobe; Kenji Asagoe; Osamu Yamasaki; Hiroshi Shiku; Gerd Ritter; Roger Murphy; Eric W Hoffman; Lloyd J Old; Eiichi Nakayama; Keiji Iwatsuki
Induction of immune response against NY-ESO-1 by CHP-NY-ESO-1 vaccination and immune regulation in a melanoma patient.
Cancer immunology, immunotherapy : CII 2008;57(10):1429-37.
2008: Shanshan W Howland; Takemasa Tsuji; Sacha Gnjatic; Gerd Ritter; Lloyd J Old; K Dane Wittrup
Inducing efficient cross-priming using antigen-coated yeast particles.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2008;31(7):607-19.
2008: Ramziya Kiyamova; Vitalina Gryshkova; Galina Ovcharenko; Dmytro Lituyev; Sergyy Malyuchik; Vasiliy Usenko; Yuliya Khozhayenko; Vadym Gurtovyy; Beatrice Yin; Gerd Ritter; Lloyd J Old; Valeriy Filonenko; Ivan T Gout
Development of monoclonal antibodies specific for the human sodium-dependent phosphate co-transporter NaPi2b.
Hybridoma (2005) 2008;27(4):277-84.
2008: Junko Matsuzaki; Feng Qian; Immanuel Luescher; Shashikant Lele; Gerd Ritter; Protul A Shrikant; Sacha Gnjatic; Lloyd J Old; Kunle Odunsi
Recognition of naturally processed and ovarian cancer reactive CD8+ T cell epitopes within a promiscuous HLA class II T-helper region of NY-ESO-1.
Cancer immunology, immunotherapy : CII 2008;57(8):1185-95.
2008: Hiroyoshi Nishikawa; Takuma Kato; Michiko Hirayama; Yuki Orito; Eiichi Sato; Naozumi Harada; Sacha Gnjatic; Lloyd J Old; Hiroshi Shiku
Regulatory T cell-resistant CD8+ T cells induced by glucocorticoid-induced tumor necrosis factor receptor signaling.
Cancer research 2008;68(14):5948-54.
2008: Sylvia Adams; David W O'Neill; Daisuke Nonaka; Elizabeth Hardin; Luis Chiriboga; Kimberly Siu; Crystal M Cruz; Angelica Angiulli; Francesca Angiulli; Erika Ritter; Rose Marie Holman; Richard L Shapiro; Russell S Berman; Natalie Berner; Yongzhao Shao; Olivier Manches; Linda Pan; Ralph R Venhaus; Eric W Hoffman; Achim Jungbluth; Sacha Gnjatic; Lloyd J Old; Anna C Pavlick; Nina Bhardwaj
Immunization of malignant melanoma patients with full-length NY-ESO-1 protein using TLR7 agonist imiquimod as vaccine adjuvant.
Journal of immunology (Baltimore, Md. : 1950) 2008;181(1):776-84.
2008: Margaret E Ackerman; Cecile Chalouni; Michael M Schmidt; Vivek V Raman; Gerd Ritter; Lloyd J Old; Ira Mellman; K Dane Wittrup
A33 antigen displays persistent surface expression.
Cancer immunology, immunotherapy : CII 2008;57(7):1017-27.
2008: Catherine S M Diefenbach; Sacha Gnjatic; Paul Sabbatini; Carol Aghajanian; Martee Hensley; David Spriggs; Alexia Iasonos; Helen Lee; Bo Dupont; Sandra Pezzulli; Achim A Jungbluth; Lloyd J Old; Jakob Dupont
Safety and immunogenicity study of NY-ESO-1b peptide and montanide ISA-51 vaccination of patients with epithelial ovarian cancer in high-risk first remission.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(9):2740-8.
2008: Peter Smith-Jones; Neeta Pandit-Taskar; Wei Cao; Joseph A O'Donoghue; Martin D Philips; Jorge Carrasquillo; Jason Konner; Lloyd J Old; Steven M Larson
Preclinical radioimmunotargeting of folate receptor alpha using the monoclonal antibody conjugate DOTA-MORAb-003.
Nuclear medicine and biology 2008;35(3):343-51.
2008: Egbert Oosterwijk; Otto Boerman; Wim J C Oyen; Lloyd J Old; Peter F A Mulders
Antibody therapy in renal cell carcinoma.
World journal of urology 2008;26(2):141-6.
2008: Yi Shao; Zhen-Yuan Sun; Shi-Wei Sun; Yi Zhao; Wan Yee Sin; Yan-Hua Yuan; Andrew J Simpson; Lloyd J Old; Xin-ting Sang; Yi-lei Mao; Yong Xie; Jie-Fu Huang; Hai-tao Zhao
Identification and expression analysis of novel LAGE-1 alleles with single nucleotide polymorphisms in cancer patients.
Journal of cancer research and clinical oncology 2008;134(4):495-502.
2008: Valeria Tosello; Kunle Odunsi; Naira E Souleimanian; Shashikant Lele; Protul Shrikant; Lloyd J Old; Danila Valmori; Maha Ayyoub
Differential expression of CCR7 defines two distinct subsets of human memory CD4+CD25+ Tregs.
Clinical immunology (Orlando, Fla.) 2008;126(3):291-302.
2008: Shinichi Kageyama; Shigehisa Kitano; Michiko Hirayama; Yasuhiro Nagata; Hiroshi Imai; Taizo Shiraishi; Kazunari Akiyoshi; Andrew M Scott; Roger Murphy; Eric W Hoffman; Lloyd J Old; Naoyuki Katayama; Hiroshi Shiku
Humoral immune responses in patients vaccinated with 1-146 HER2 protein complexed with cholesteryl pullulan nanogel.
Cancer science 2008;99(3):601-7.
2008: Djordje Atanackovic; Nasser K Altorki; Yanran Cao; Erika Ritter; Cathy A Ferrara; Gerd Ritter; Eric W Hoffman; Carsten Bokemeyer; Lloyd J Old; Sacha Gnjatic
Booster vaccination of cancer patients with MAGE-A3 protein reveals long-term immunological memory or tolerance depending on priming.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(5):1650-5.
2008: Vivian E Strong; John L Humm; Paul Russo; Achim Jungbluth; Douglas Wong; Farhad Daghighian; Lloyd J Old; Yuman Fong; Steven M Larson
A novel method to localize antibody-targeted cancer deposits intraoperatively using handheld PET beta and gamma probes.
Surgical endoscopy 2008;22(2):386-91.
2008: Hiroyoshi Nishikawa; Takemasa Tsuji; Elke Jäger; Gabriel Briones; Gerd Ritter; Lloyd J Old; Jorge E Galán; Hiroshi Shiku; Sacha Gnjatic
Induction of regulatory T cell-resistant helper CD4+ T cells by bacterial vector.
Blood 2008;111(3):1404-12.
2008: Toshiaki Ishida; Yuichi Obata; Nobuya Ohara; Hirokazu Matsushita; Shuichiro Sato; Akiko Uenaka; Takashi Saika; Takako Miyamura; Kosuke Chayama; Yurika Nakamura; Hisashi Wada; Toshiharu Yamashita; Tsuneo Morishima; Lloyd J Old; Eiichi Nakayama
Identification of the HERV-K gag antigen in prostate cancer by SEREX using autologous patient serum and its immunogenicity.
Cancer immunity 2008;8():15.
2008: Sergei Rudchenko; Matthew Scanlan; Gavreel Kalantarov; Victoria Yavelsky; Chen Levy; Alison Estabrook; Lloyd J Old; Gerald L Chan; Leslie Lobel; Ilya Trakht
A human monoclonal autoantibody to breast cancer identifies the PDZ domain containing protein GIPC1 as a novel breast cancer-associated antigen.
BMC cancer 2008;8():248.
2008: Sueli M Oba-Shinjo; Otavia L Caballero; Achim A Jungbluth; Sérgio Rosemberg; Lloyd J Old; Andrew J G Simpson; Suely K N Marie
Cancer-testis (CT) antigen expression in medulloblastoma.
Cancer immunity 2008;8():7.
2008: Lloyd J Old
Cancer vaccines: an overview.
Cancer immunity 2008;8 Suppl 1():1.
2008: Beatrice W T Yin; Ramziya Kiyamova; Ramon Chua; Otavia L Caballero; Ivan T Gout; Vitalina Gryshkova; Nimesh Bhaskaran; Serhiy Souchelnytskyi; Ulf Hellman; Valeriy Filonenko; Achim A Jungbluth; Kunle Odunsi; Kenneth O Lloyd; Lloyd J Old; Gerd Ritter
Monoclonal antibody MX35 detects the membrane transporter NaPi2b (SLC34A2) in human carcinomas.
Cancer immunity 2008;8():3.
2007: Catherine M Koebel; William Vermi; Jeremy Swann; Nadeen Zerafa; Scott J Rodig; Lloyd J Old; Mark J Smyth; Robert D Schreiber
Adaptive immunity maintains occult cancer in an equilibrium state.
Nature 2007;450(7171):903-7.
2007: Rushika M Perera; Roberto Zoncu; Terrance G Johns; Marc Pypaert; Fook-Thean Lee; Ira Mellman; Lloyd J Old; Derek Toomre; Andrew M Scott
Internalization, intracellular trafficking, and biodistribution of monoclonal antibody 806: a novel anti-epidermal growth factor receptor antibody.
Neoplasia (New York, N.Y.) 2007;9(12):1099-110.
2007: Yukiko Kiniwa; Yoshihiro Miyahara; Helen Y Wang; Weiyi Peng; Guangyong Peng; Thomas M Wheeler; Timothy C Thompson; Lloyd J Old; Rongfu Wang
CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(23):6947-58.
2007: Chung-Jr Huang; Rishard H Chen; Todd Vannelli; Frank Lee; Erika Ritter; Gerd Ritter; Lloyd J Old; Carl A Batt
Expression and purification of the cancer antigen SSX2: a potential cancer vaccine.
Protein expression and purification 2007;56(2):212-9.
2007: Susann M Szmania; Sacha Gnjatic; Guido Tricot; Katie Stone; Fenghuang Zhan; Amberly Moreno; Brad Thuro; J Joseph Melenhorst; John Barrett; John Shaughnessy; Lloyd J Old; Bart Barlogie; Vincent G Brichard; Frits van Rhee
Immunization with a recombinant MAGE-A3 protein after high-dose therapy for myeloma.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2007;30(8):847-54.
2007: Julia Karbach; Sacha Gnjatic; Claudia Pauligk; Armin Bender; Markus J Maeurer; Joachim L Schultze; Kerstin Nadler; Claudia Wahle; Alexander Knuth; Lloyd J Old; Elke Jäger
Tumor-reactive CD8+ T-cell clones in patients after NY-ESO-1 peptide vaccination.
International journal of cancer. Journal international du cancer 2007;121(9):2042-8.
2007: Lee M Krug; Daniel T Milton; Achim A Jungbluth; Lin-Chi Chen; Emilio Quaia; Neeta Pandit-Taskar; Andrew Nagel; Jessica Jones; Mark G Kris; Ronald Finn; Peter Smith-Jones; Andrew M Scott; Lloyd J Old; Chaitanya R Divgi
Targeting Lewis Y (Le(y)) in small cell lung cancer with a humanized monoclonal antibody, hu3S193: a pilot trial testing two dose levels.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2007;2(10):947-52.
2007: Kunle Odunsi; Feng Qian; Junko Matsuzaki; Paulette Mhawech-Fauceglia; Christopher Andrews; Eric W Hoffman; Linda Pan; Gerd Ritter; Jeannine A Villella; Bridget Thomas; Kerry J Rodabaugh; Shashikant Lele; Protul A Shrikant; Lloyd J Old; Sacha Gnjatic
Vaccination with an NY-ESO-1 peptide of HLA class I/II specificities induces integrated humoral and T cell responses in ovarian cancer.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(31):12837-42.
2007: Andrew M Scott; Niall Tebbutt; Fook-Thean Lee; Tina Cavicchiolo; Zhanqi Liu; Sanjeev Gill; Aurora M T Poon; Wendie Hopkins; Fiona E Smyth; Carmel Murone; Duncan MacGregor; Anthony T Papenfuss; Bridget Chappell; Tim Saunder; Martin W Brechbiel; Ian D Davis; Roger Murphy; Geoffrey Chong; Eric W Hoffman; Lloyd J Old
A phase I biodistribution and pharmacokinetic trial of humanized monoclonal antibody Hu3s193 in patients with advanced epithelial cancers that express the Lewis-Y antigen.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(11):3286-92.
2007: Danila Valmori; Naira E Souleimanian; Valeria Tosello; Nina Bhardwaj; Sylvia Adams; David O'Neill; Anna Pavlick; Juliet B Escalon; Crystal M Cruz; Angelica Angiulli; Francesca Angiulli; Gregory Mears; Susan M Vogel; Linda Pan; Achim A Jungbluth; Eric W Hoffmann; Ralph Venhaus; Gerd Ritter; Lloyd J Old; Maha Ayyoub
Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-priming.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(21):8947-52.
2007: Ryohei Kawabata; Hisashi Wada; Midori Isobe; Takashi Saika; Shuichiro Sato; Akiko Uenaka; Hiroshi Miyata; Takushi Yasuda; Yuichiro Doki; Yuji Noguchi; Hiromi Kumon; Kazuhide Tsuji; Keiji Iwatsuki; Hiroshi Shiku; Gerd Ritter; Roger Murphy; Eric Hoffman; Lloyd J Old; Morito Monden; Eiichi Nakayama
Antibody response against NY-ESO-1 in CHP-NY-ESO-1 vaccinated patients.
International journal of cancer. Journal international du cancer 2007;120(10):2178-84.
2007: Chaitanya R Divgi; Neeta Pandit-Taskar; Achim A Jungbluth; Victor E Reuter; Mithat Gonen; Shutian Ruan; Christine Pierre; Andrew Nagel; Daniel A Pryma; John L Humm; Steven M Larson; Lloyd J Old; Paul Russo
Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 (124I-cG250) and PET in patients with renal masses: a phase I trial.
The lancet oncology 2007;8(4):304-10.
2007: Padmanee Sharma; Lloyd J Old; James P Allison
Immunotherapeutic strategies for high-risk bladder cancer.
Seminars in oncology 2007;34(2):165-72.
2007: Andrew M Scott; Fook-Thean Lee; Niall Tebbutt; Rebecca Herbertson; Sanjeev S Gill; Zhanqi Liu; Effie Skrinos; Carmel Murone; Tim Saunder; Bridget Chappell; Anthony T Papenfuss; Aurora M T Poon; Wendie Hopkins; Fiona E Smyth; Duncan MacGregor; Lawrence M Cher; Achim A Jungbluth; Gerd Ritter; Martin W Brechbiel; Roger Murphy; Antony W Burgess; Eric W Hoffman; Terrance G Johns; Lloyd J Old
A phase I clinical trial with monoclonal antibody ch806 targeting transitional state and mutant epidermal growth factor receptors.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(10):4071-6.
2007: Padmanee Sharma; Yu Shen; Sijin Wen; Sachiko Yamada; Achim A Jungbluth; Sacha Gnjatic; Dean F Bajorin; Victor E Reuter; Harry W Herr; Lloyd J Old; Eiichi Sato
CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(10):3967-72.
2007: Dirk Jäger; Valeriy Filonenko; Ivan T Gout; Denise Frosina; Susannah Eastlake-Wade; Sandra Castelli; Zsuzsanna Varga; Holger Moch; Yao-Tseng Chen; Klaus J Busam; Inka Seil; Lloyd J Old; Aviram Nissan; Claudia Frei; Ali O Gure; Alexander Knuth; Achim A Jungbluth
NY-BR-1 is a differentiation antigen of the mammary gland.
Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry 2007;15(1):77-83.
2007: Danan Li; Hongbin Ji; Sara Zaghlul; Kate McNamara; Mei-Chih Liang; Takeshi Shimamura; Shigeto Kubo; Masaya Takahashi; Lucian R Chirieac; Robert F Padera; Andrew M Scott; Achim A Jungbluth; Webster K Cavenee; Lloyd J Old; George D Demetri; Kwok-Kin Wong
Therapeutic anti-EGFR antibody 806 generates responses in murine de novo EGFR mutant-dependent lung carcinomas.
The Journal of clinical investigation 2007;117(2):346-52.
2007: Danila Valmori; Frédéric Lévy; Emmanuelle Godefroy; Luigi Scotto; Naira E Souleimanian; Julia Karbach; Valeria Tosello; Charles Hesdorffer; Lloyd J Old; Elke Jager; Maha Ayyoub
Epitope clustering in regions undergoing efficient proteasomal processing defines immunodominant CTL regions of a tumor antigen.
Clinical immunology (Orlando, Fla.) 2007;122(2):163-72.
2007: Leonardo M Damasceno; Kyle A Anderson; Gerd Ritter; James M Cregg; Lloyd J Old; Carl A Batt
Cooverexpression of chaperones for enhanced secretion of a single-chain antibody fragment in Pichia pastoris.
Applied microbiology and biotechnology 2007;74(2):381-9.
2007: Djordje Atanackovic; Julia Arfsten; Yanran Cao; Sacha Gnjatic; Frank Schnieders; Katrin Bartels; Georgia Schilling; Christiane Faltz; Christine Wolschke; Judith Dierlamm; Gerd Ritter; Thomas Eiermann; Dieter K Hossfeld; Axel R Zander; Achim A Jungbluth; Lloyd J Old; Carsten Bokemeyer; Nicolaus Kröger
Cancer-testis antigens are commonly expressed in multiple myeloma and induce systemic immunity following allogeneic stem cell transplantation.
Blood 2007;109(3):1103-12.
2007: Alfred Zippelius; Asma Gati; Tammo Bartnick; Senta Walton; Bernhard Odermatt; Elke Jaeger; Reinhold Dummer; Mirjana Urosevic-Maiwald; Valeriy Filonenko; Kazuhiro Osanai; Holger Moch; Yao-Tseng Chen; Lloyd J Old; Alexander Knuth; Dirk Jaeger
Melanocyte differentiation antigen RAB38/NY-MEL-1 induces frequent antibody responses exclusively in melanoma patients.
Cancer immunology, immunotherapy : CII 2007;56(2):249-58.
2007: Lloyd J Old
Cancer is a somatic cell pregnancy.
Cancer immunity 2007;7():19.
2007: Wilson A Silva; Sacha Gnjatic; Erika Ritter; Ramon Chua; Tzeela Cohen; Melinda Hsu; Achim A Jungbluth; Nasser K Altorki; Yao-Tseng Chen; Lloyd J Old; Andrew J G Simpson; Otavia L Caballero
PLAC1, a trophoblast-specific cell surface protein, is expressed in a range of human tumors and elicits spontaneous antibody responses.
Cancer immunity 2007;7():18.
2007: Armin Bender; Julia Karbach; Antje Neumann; Dirk Jäger; Salah-Eddin Al-Batran; Akin Atmaca; Eckhart Weidmann; Melina Biskamp; Sacha Gnjatic; Linda Pan; Eric Hoffman; Lloyd J Old; Alexander Knuth; Elke Jäger
LUD 00-009: phase 1 study of intensive course immunization with NY-ESO-1 peptides in HLA-A2 positive patients with NY-ESO-1-expressing cancer.
Cancer immunity 2007;7():16.
2007: Achim A Jungbluth; Wilson A Silva; Kristin Iversen; Denise Frosina; Bushra Zaidi; Keren Coplan; Susannah Eastlake-Wade; Sandra B Castelli; Giulio C Spagnoli; Lloyd J Old; Martin Vogel
Expression of cancer-testis (CT) antigens in placenta.
Cancer immunity 2007;7():15.
2007: Ian D Davis; Zhanqi Liu; Wayne Saunders; Fook-Thean Lee; Violeta Spirkoska; Wendie Hopkins; Fiona E Smyth; Geoffrey Chong; Anthony T Papenfuss; Bridget Chappell; Aurora Poon; Tim Saunder; Eric W Hoffman; Lloyd J Old; Andrew M Scott
A pilot study of monoclonal antibody cG250 and low dose subcutaneous IL-2 in patients with advanced renal cell carcinoma.
Cancer immunity 2007;7():14.
2007: Ian D Davis; Gregory A Wiseman; Fook-Thean Lee; Denise N Gansen; Wendie Hopkins; Anthony T Papenfuss; Zhanqi Liu; Timothy J Moynihan; Gary A Croghan; Alex A. Adjei; Eric W Hoffman; James N Ingle; Lloyd J Old; Andrew M Scott
A phase I multiple dose, dose escalation study of cG250 monoclonal antibody in patients with advanced renal cell carcinoma.
Cancer immunity 2007;7():13.
2007: Brian J Stevenson; Christian Iseli; Sumir Panji; Monique Zahn-Zabal; Winston Hide; Lloyd J Old; Andrew J G Simpson; Victor Jongeneel
Rapid evolution of cancer/testis genes on the X chromosome.
BMC genomics 2007;8():129.
2007: Akiko Uenaka; Hisashi Wada; Midori Isobe; Takashi Saika; Kazuhide Tsuji; Eiichi Sato; Shuichiro Sato; Yuji Noguchi; Ryohei Kawabata; Takushi Yasuda; Yuichiro Doki; Hiromi Kumon; Keiji Iwatsuki; Hiroshi Shiku; Morito Monden; Achim A Jungbluth; Gerd Ritter; Roger Murphy; Eric Hoffman; Lloyd J Old; Eiichi Nakayama
T cell immunomonitoring and tumor responses in patients immunized with a complex of cholesterol-bearing hydrophobized pullulan (CHP) and NY-ESO-1 protein.
Cancer immunity 2007;7():9.
2007: Wolfgang Ebel; Eric Routhier; Brian Foley; Sara Jacob; Jennifer M McDonough; Rina K Patel; Howard A Turchin; Qimin Chao; J Bradford Kline; Lloyd J Old; Martin D Phillips; Nicholas C Nicolaides; Philip M Sass; Luigi Grasso
Preclinical evaluation of MORAb-003, a humanized monoclonal antibody antagonizing folate receptor-alpha.
Cancer immunity 2007;7():6.
2007: Kunle Odunsi; Lloyd J Old
Tumor infiltrating lymphocytes: indicators of tumor-related immune responses.
Cancer immunity 2007;7():3.
2007: PETER NELSON; Paul J Zhang; Giulio C Spagnoli; John E Tomaszewski; Theresa L Pasha; Denise Frosina; Otavia L Caballero; Andrew J G Simpson; Lloyd J Old; Achim A Jungbluth
Cancer/testis (CT) antigens are expressed in fetal ovary.
Cancer immunity 2007;7():1.
2006: Shigehisa Kitano; Shinichi Kageyama; Yasuhiro Nagata; Yoshihiro Miyahara; Atsunori Hiasa; Hiroaki Naota; Satoshi Okumura; Hiroshi Imai; Taizo Shiraishi; Masahiro Masuya; Masakatsu Nishikawa; Junzo Sunamoto; Kazunari Akiyoshi; Takashi Kanematsu; Andrew M Scott; Roger Murphy; Eric W Hoffman; Lloyd J Old; Hiroshi Shiku
HER2-specific T-cell immune responses in patients vaccinated with truncated HER2 protein complexed with nanogels of cholesteryl pullulan.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(24):7397-405.
2006: Junichi Sakamoto; Noboru Oriuchi; Erito Mochiki; Takayuki Asao; Andrew M Scott; Eric W Hoffman; Achim A Jungbluth; Takanori Matsui; Fook-Thean Lee; Anthony T Papenfuss; Hiroyuki Kuwano; Toshitada Takahashi; Keigo Endo; Lloyd J Old
A phase I radioimmunolocalization trial of humanized monoclonal antibody huA33 in patients with gastric carcinoma.
Cancer science 2006;97(11):1248-54.
2006: Jonathan Tammela; Akiko Uenaka; Toshiro Ono; Yuji Noguchi; Achim A Jungbluth; Paulette Mhawech-Fauceglia; Feng Qian; Sally Schneider; Sameer Sharma; Deborah Driscoll; Shashikant Lele; Lloyd J Old; Eiichi Nakayama; Kunle Odunsi
OY-TES-1 expression and serum immunoreactivity in epithelial ovarian cancer.
International journal of oncology 2006;29(4):903-10.
2006: Emmanuelle Godefroy; Luigi Scotto; Naira E Souleimanian; Gerd Ritter; Lloyd J Old; Francine Jotereau; Danila Valmori; Maha Ayyoub
Identification of two Melan-A CD4+ T cell epitopes presented by frequently expressed MHC class II alleles.
Clinical immunology (Orlando, Fla.) 2006;121(1):54-62.
2006: Elke Jäger; Julia Karbach; Sacha Gnjatic; Antje Neumann; Armin Bender; Danila Valmori; Maha Ayyoub; Erika Ritter; Gerd Ritter; Dirk Jäger; Dennis Panicali; Eric Hoffman; Linda Pan; Herbert Oettgen; Lloyd J Old; Alexander Knuth
Recombinant vaccinia/fowlpox NY-ESO-1 vaccines induce both humoral and cellular NY-ESO-1-specific immune responses in cancer patients.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(39):14453-8.
2006: Padmanee Sharma; Yu Shen; Sijin Wen; Dean F Bajorin; Victor E Reuter; Lloyd J Old; Achim A Jungbluth
Cancer-testis antigens: expression and correlation with survival in human urothelial carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(18):5442-7.
2006: Ian D Davis; Qiyuan Chen; Leone Morris; Juliet Quirk; Maureen Stanley; Maria L Tavarnesi; Phillip Parente; Tina Cavicchiolo; Wendie Hopkins; Heather Jackson; Nektaria Dimopoulos; Tsin Yee Tai; Duncan MacGregor; Judy Browning; Suzanne Svobodova; Dania Caron; Eugene Maraskovsky; Lloyd J Old; Weisan Chen; Jonathan Cebon
Blood dendritic cells generated with Flt3 ligand and CD40 ligand prime CD8+ T cells efficiently in cancer patients.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2006;29(5):499-511.
2006: Sheng-Wei Ye; Yu Wang; Danila Valmori; Maha Ayyoub; Yan Han; Xiao-Lan Xu; Ai-Lian Zhao; Li Qu; Sacha Gnjatic; Gerd Ritter; Lloyd J Old; Jin Gu
Ex-vivo analysis of CD8+ T cells infiltrating colorectal tumors identifies a major effector-memory subset with low perforin content.
Journal of clinical immunology 2006;26(5):447-56.
2006: Stefan Bauer; Nicole Adrian; Eliane Fischer; Sascha Kleber; Frank Stenner; Andreas Wadle; Natalie Fadle; Andy Zöllner; Rita Bernhardt; Alexander Knuth; Lloyd J Old; Christoph Renner
Structure-activity profiles of Ab-derived TNF fusion proteins.
Journal of immunology (Baltimore, Md. : 1950) 2006;177(4):2423-30.
2006: Shinichiro Nakamura; Kazuhiro Nouso; Yuji Noguchi; Toshihiro Higashi; Toshiro Ono; Achim Jungbluth; Yao-Tseng Chen; Lloyd J Old; Eiichi Nakayama; Yasushi Shiratori
Expression and immunogenicity of NY-ESO-1 in hepatocellular carcinoma.
Journal of gastroenterology and hepatology 2006;21(8):1281-5.
2006: Andrea Piatesi; Shanshan W Howland; James A Rakestraw; Christoph Renner; Neil Robson; Jonathan Cebon; Eugene Maraskovsky; Gerd Ritter; Lloyd J Old; K Dane Wittrup
Directed evolution for improved secretion of cancer-testis antigen NY-ESO-1 from yeast.
Protein expression and purification 2006;48(2):232-42.
2006: Hiroyoshi Nishikawa; Eiichi Sato; Gabriel Briones; Li-Mei Chen; Mitsutoshi Matsuo; Yasuhiro Nagata; Gerd Ritter; Elke Jäger; Hideki Nomura; Shigeto Kondo; Isao Tawara; Takuma Kato; Hiroshi Shiku; Lloyd J Old; Jorge E Galán; Sacha Gnjatic
In vivo antigen delivery by a Salmonella typhimurium type III secretion system for therapeutic cancer vaccines.
The Journal of clinical investigation 2006;116(7):1946-54.
2006: Amy M Hicks; Gregory Riedlinger; Mark C Willingham; Martha Alexander-Miller; Chris Von Kap-Herr; Mark J Pettenati; Anne M Sanders; Holly M Weir; Wei Du; Joseph Kim; Andrew J G Simpson; Lloyd J Old; Zheng Cui
Transferable anticancer innate immunity in spontaneous regression/complete resistance mice.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(20):7753-8.
2006: Hiroyoshi Nishikawa; Feng Qian; Takemasa Tsuji; Gerd Ritter; Lloyd J Old; Sacha Gnjatic; Kunle Odunsi
Influence of CD4+CD25+ regulatory T cells on low/high-avidity CD4+ T cells following peptide vaccination.
Journal of immunology (Baltimore, Md. : 1950) 2006;176(10):6340-6.
2006: Heather Jackson; Nektaria Dimopoulos; Nicole Mifsud; Tsin Yee Tai; Qiyuan Chen; Suzanne Svobodova; Judy Browning; Immanuel F Luescher; Lisa Stockert; Lloyd J Old; Ian D Davis; Jonathan Cebon; Weisan Chen
Striking immunodominance hierarchy of naturally occurring CD8+ and CD4+ T cell responses to tumor antigen NY-ESO-1.
Journal of immunology (Baltimore, Md. : 1950) 2006;176(10):5908-17.
2006: Zsuzsanna Varga; Jean-Philippe Theurillat; Valeriy Filonenko; Bernd Sasse; Bernhard Odermatt; Achim A Jungbluth; Yao-Tseng Chen; Lloyd J Old; Alexander Knuth; Dirk Jäger; Holger Moch
Preferential nuclear and cytoplasmic NY-BR-1 protein expression in primary breast cancer and lymph node metastases.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(9):2745-51.
2006: Yao-Tseng Chen; Christian Iseli; Charis A Venditti; Lloyd J Old; Andrew J G Simpson; Victor Jongeneel
Identification of a new cancer/testis gene family, CT47, among expressed multicopy genes on the human X chromosome.
Genes, chromosomes & cancer 2006;45(4):392-400.
2006: Kosei Hasegawa; Yuji Noguchi; Fumihito Koizumi; Akiko Uenaka; Motoyuki Tanaka; Michihide Shimono; Hideo Nakamura; Hiroshi Shiku; Sacha Gnjatic; Roger Murphy; Yuji Hiramatsu; Lloyd J Old; Eiichi Nakayama
In vitro stimulation of CD8 and CD4 T cells by dendritic cells loaded with a complex of cholesterol-bearing hydrophobized pullulan and NY-ESO-1 protein: Identification of a new HLA-DR15-binding CD4 T-cell epitope.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(6):1921-7.
2006: Aviram Nissan; D Jager; M Roystacher; Diana Prus; Tamar Peretz; Iris Eisenberg; Herbert R Freund; M Scanlan; G Ritter; Lloyd J Old; Stella Mitrani-Rosenbaum
Multimarker RT-PCR assay for the detection of minimal residual disease in sentinel lymph nodes of breast cancer patients.
British journal of cancer 2006;94(5):681-5.
2006: Maha Ayyoub; Naira E Souleimanian; Emmanuelle Godefroy; Luigi Scotto; Charles Hesdorffer; Lloyd J Old; Danila Valmori
A phenotype based approach for the immune monitoring of NY-ESO-1-specific CD4+ T cell responses in cancer patients.
Clinical immunology (Orlando, Fla.) 2006;118(2-3):188-94.
2006: Julia Karbach; Claudia Pauligk; Armin Bender; Sacha Gnjatic; Kerstin Franzmann; Claudia Wahle; Dirk Jäger; Alexander Knuth; Lloyd J Old; Elke Jäger
Identification of new NY-ESO-1 epitopes recognized by CD4+ T cells and presented by HLA-DQ B1 03011.
International journal of cancer. Journal international du cancer 2006;118(3):668-74.
2006: Danila Valmori; Feng Qian; Maha Ayyoub; Christoph Renner; Andrea Merlo; Sacha Gnjatic; Sacha Gjnatic; Elisabeth Stockert; Deborah Driscoll; Shashikant Lele; Lloyd J Old; Kunle Odunsi
Expression of synovial sarcoma X (SSX) antigens in epithelial ovarian cancer and identification of SSX-4 epitopes recognized by CD4+ T cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(2):398-404.
2006: Hearn J Cho; Otavia L Caballero; Sacha Gnjatic; Valéria C C Andrade; Gisele W Colleoni; André L Vettore; Hasina H Outtz; Sheila Fortunato; Nasser K Altorki; Cathy A Ferrera; Ramon Chua; Achim A Jungbluth; Yao-Tseng Chen; Lloyd J Old; Andrew J G Simpson
Physical interaction of two cancer-testis antigens, MAGE-C1 (CT7) and NY-ESO-1 (CT6).
Cancer immunity 2006;6():12.
2006: Amy M Hicks; Mark C Willingham; Wei Du; Changlee S Pang; Lloyd J Old; Zheng Cui
Effector mechanisms of the anti-cancer immune responses of macrophages in SR/CR mice.
Cancer immunity 2006;6():11.
2006: Sacha Gnjatic; Hiroyoshi Nishikawa; Achim A Jungbluth; Ali O Güre; Gerd Ritter; Elke Jäger; Alexander Knuth; Yao-Tseng Chen; Lloyd J Old
NY-ESO-1: review of an immunogenic tumor antigen.
Advances in cancer research 2006;95():1-30.
2006: Ran Zhuang; Yong Zhu; Liang Fang; Xue-Song Liu; Ying Tian; Li-Hua Chen; Wei-ming Ouyang; Xiao-Guang Xu; Jin-Long Jian; Ali O Güre; Sheila Fortunato; Gerd Ritter; Lloyd J Old; Andrew J G Simpson; Yao T Chen; Boquan Jin; Achim A Jungbluth
Generation of monoclonal antibodies to cancer/testis (CT) antigen CT10/MAGE-C2.
Cancer immunity 2006;6():7.
2006: Matthew J Scanlan; Gerd Ritter; Beatrice W T Yin; Clarence Williams; Leonard S Cohen; Keren Coplan; Sheila R Fortunato; Denise Frosina; Sang-Yull Lee; Anne E Murray; Ramon Chua; Valeriy Filonenko; Eiichi Sato; Lloyd J Old; Achim A Jungbluth
Glycoprotein A34, a novel target for antibody-based cancer immunotherapy.
Cancer immunity 2006;6():2.
2006: Xiaosong Wang; Haitao Zhao; Qingwen Xu; Weibo Jin; Changning Liu; Huagang Zhang; Zhibin Huang; Xinyu Zhang; Yu Zhang; Dian-qi Xin; Andrew J G Simpson; Lloyd J Old; Yanqun Na; Yi Zhao; Weifeng Chen
HPtaa database-potential target genes for clinical diagnosis and immunotherapy of human carcinoma.
Nucleic acids research 2006;34(Database issue):D607-12.
2005: Eiichi Sato; Sara H Olson; Jiyoung Ahn; Brian N Bundy; Hiroyoshi Nishikawa; Feng Qian; Achim A Jungbluth; Denise Frosina; Sacha Gnjatic; Christine B Ambrosone; James L Kepner; Tosin Odunsi; Gerd Ritter; Shashikant Lele; Yao-Tseng Chen; Haruo Ohtani; Lloyd J Old; Kunle Odunsi
Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(51):18538-43.
2005: Ali O Gure; Ramon Chua; Barbara Williamson; Mithat Gonen; Cathy A Ferrera; Sacha Gnjatic; Gerd Ritter; Andrew J G Simpson; Yao-T Chen; Lloyd J Old; Nasser K Altorki
Cancer-testis genes are coordinately expressed and are markers of poor outcome in non-small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(22):8055-62.
2005: Danila Valmori; Naira E Souleimanian; Charles Hesdorffer; Lloyd J Old; Maha Ayyoub
Quantitative and qualitative assessment of circulating NY-ESO-1 specific CD4+ T cells in cancer-free individuals.
Clinical immunology (Orlando, Fla.) 2005;117(2):161-7.
2005: Andreas Wadle; Axel Mischo; Jochen Imig; Beate Wüllner; Dan Hensel; Kristin Wätzig; Frank Neumann; Boris Kubuschok; Werner Schmidt; Lloyd J Old; Michael Pfreundschuh; Christoph Renner
Serological identification of breast cancer-related antigens from a Saccharomyces cerevisiae surface display library.
International journal of cancer. Journal international du cancer 2005;117(1):104-13.
2005: Hiroyoshi Nishikawa; Takuma Kato; Isao Tawara; Hiroaki Ikeda; Kagemasa Kuribayashi; Paul M Allen; Robert D Schreiber; Lloyd J Old; Hiroshi Shiku
IFN-gamma controls the generation/activation of CD4+ CD25+ regulatory T cells in antitumor immune response.
Journal of immunology (Baltimore, Md. : 1950) 2005;175(7):4433-40.
2005: Sameer Sharma; Feng Qian; Bernadette Keitz; Deborah Driscoll; Matthew J Scanlan; Jonathan Skipper; Kerry J Rodabaugh; Shashikant Lele; Lloyd J Old; Kunle Odunsi
A-kinase anchoring protein 3 messenger RNA expression correlates with poor prognosis in epithelial ovarian cancer.
Gynecologic oncology 2005;99(1):183-8.
2005: Danila Valmori; Naira E Souleimanian; Charles Hesdorffer; Gerd Ritter; Lloyd J Old; Maha Ayyoub
Identification of B cell epitopes recognized by antibodies specific for the tumor antigen NY-ESO-1 in cancer patients with spontaneous immune responses.
Clinical immunology (Orlando, Fla.) 2005;117(1):24-30.
2005: Rushika M Perera; Yoshitaka Narita; Frank B Furnari; Hui K Gan; Carmel Murone; Marika Ahlkvist; Rodney B Luwor; Antony W Burgess; Elisabeth Stockert; Achim A Jungbluth; Lloyd J Old; Webster K Cavenee; Andrew M Scott; Terrance G Johns
Treatment of human tumor xenografts with monoclonal antibody 806 in combination with a prototypical epidermal growth factor receptor-specific antibody generates enhanced antitumor activity.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(17):6390-9.
2005: Andrew J G Simpson; Otavia L Caballero; Achim Jungbluth; Yao-Tseng Chen; Lloyd J Old
Cancer/testis antigens, gametogenesis and cancer.
Nature reviews. Cancer 2005;5(8):615-25.
2005: Hiroyoshi Nishikawa; Elke Jäger; Gerd Ritter; Lloyd J Old; Sacha Gnjatic
CD4+ CD25+ regulatory T cells control the induction of antigen-specific CD4+ helper T cell responses in cancer patients.
Blood 2005;106(3):1008-11.
2005: Geoffrey Chong; Fook-Thean Lee; Wendie Hopkins; Niall Tebbutt; Jonathan Cebon; Angela J Mountain; Bridget Chappell; Anthony T Papenfuss; Paul Schleyer; Paul U; Roger Murphy; Veronika Wirth; Fiona E Smyth; Nicole Potasz; Aurora Poon; Ian D Davis; Tim Saunder; Graeme J O'Keefe; Antony W Burgess; Eric W Hoffman; Lloyd J Old; Andrew M Scott
Phase I trial of 131I-huA33 in patients with advanced colorectal carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(13):4818-26.
2005: Andrew M Scott; Fook-Thean Lee; Robert Jones; Wendie Hopkins; Duncan MacGregor; Jonathan Cebon; Anthony Hannah; Geoffrey Chong; Paul U; Anthony T Papenfuss; Angela Rigopoulos; Sue Sturrock; Roger Murphy; Veronika Wirth; Carmel Murone; Fiona E Smyth; Simon Knight; Sydney Welt; Gerd Ritter; Elizabeth Richards; Edouard C Nice; Antony W Burgess; Lloyd J Old
A phase I trial of humanized monoclonal antibody A33 in patients with colorectal carcinoma: biodistribution, pharmacokinetics, and quantitative tumor uptake.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(13):4810-7.
2005: Achim A Jungbluth; Scott Ely; Maurizio DiLiberto; Ruben Niesvizky; Barbara Williamson; Denise Frosina; Yao-Tseng Chen; Nina Bhardwaj; Selina Chen-Kiang; Lloyd J Old; Hearn Jay Cho
The cancer-testis antigens CT7 (MAGE-C1) and MAGE-A3/6 are commonly expressed in multiple myeloma and correlate with plasma-cell proliferation.
Blood 2005;106(1):167-74.
2005: Hiroyoshi Nishikawa; Takuma Kato; Isao Tawara; Tetsushi Takemitsu; Kanako Saito; Linan Wang; Yoshinori Ikarashi; Hiro Wakasugi; Toshinori Nakayama; Masaru Taniguchi; Kagemasa Kuribayashi; Lloyd J Old; Hiroshi Shiku
Accelerated chemically induced tumor development mediated by CD4+CD25+ regulatory T cells in wild-type hosts.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(26):9253-7.
2005: Burcak Vural; Lin-Chi Chen; Pinar Saip; Yao-Tseng Chen; Zeki Ustuner; Mithat Gonen; Andrew J G Simpson; Lloyd J Old; Ugur Ozbek; Ali O Gure
Frequency of SOX Group B (SOX1, 2, 3) and ZIC2 antibodies in Turkish patients with small cell lung carcinoma and their correlation with clinical parameters.
Cancer 2005;103(12):2575-83.
2005: Yao-Tseng Chen; Matthew J Scanlan; Charis A Venditti; Ramon Chua; Gregory Theiler; Brian J Stevenson; Christian Iseli; Ali O Gure; thomas vasicek; Robert L Strausberg; Victor Jongeneel; Lloyd J Old; Andrew J G Simpson
Identification of cancer/testis-antigen genes by massively parallel signature sequencing.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(22):7940-5.
2005: Terrance G Johns; Ira Mellman; Glenn A Cartwright; Gerd Ritter; Lloyd J Old; Antony W Burgess; Andrew M Scott
The antitumor monoclonal antibody 806 recognizes a high-mannose form of the EGF receptor that reaches the cell surface when cells over-express the receptor.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2005;19(7):780-2.
2005: Gavin P Dunn; Kathleen C F Sheehan; Lloyd J Old; Robert D Schreiber
IFN unresponsiveness in LNCaP cells due to the lack of JAK1 gene expression.
Cancer research 2005;65(8):3447-53.
2005: Maha Ayyoub; Andrea Merlo; Charles Hesdorffer; Donata Rimoldi; Daniel Speiser; Jean-Charles Cerottini; Yao-Tseng Chen; Lloyd J Old; Stefan Stevanovic; Danila Valmori
CD4+ T cell responses to SSX-4 in melanoma patients.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(8):5092-9.
2005: C Panousis; V M Rayzman; Terrance G Johns; C Renner; Zhanqi Liu; Glenn A Cartwright; Fook-Thean Lee; D Wang; Hui K Gan; D Cao; A Kypridis; Fiona E Smyth; Martin W Brechbiel; Antony W Burgess; Lloyd J Old; Andrew M Scott
Engineering and characterisation of chimeric monoclonal antibody 806 (ch806) for targeted immunotherapy of tumours expressing de2-7 EGFR or amplified EGFR.
British journal of cancer 2005;92(6):1069-77.
2005: Hiroyoshi Nishikawa; Takuma Kato; Isao Tawara; Kanako Saito; Hiroaki Ikeda; Kagemasa Kuribayashi; Paul M Allen; Robert D Schreiber; Shimon Sakaguchi; Lloyd J Old; Hiroshi Shiku
Definition of target antigens for naturally occurring CD4(+) CD25(+) regulatory T cells.
The Journal of experimental medicine 2005;201(5):681-6.
2005: Andrew M Scott; Zhanqi Liu; Carmel Murone; Terrance G Johns; Duncan MacGregor; Fiona E Smyth; Fook-Thean Lee; Jonathan Cebon; Ian D Davis; Wendie Hopkins; Angela J Mountain; Angela Rigopoulos; Nobuo Hanai; Lloyd J Old
Immunological effects of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma.
Cancer immunity 2005;5():3.
2005: Dirk Jäger; Julia Karbach; Claudia Pauligk; Inka Seil; Claudia Frei; Yao-Tseng Chen; Lloyd J Old; Alexander Knuth; Elke Jäger
Humoral and cellular immune responses against the breast cancer antigen NY-BR-1: definition of two HLA-A2 restricted peptide epitopes.
Cancer immunity 2005;5():11.
2005: Yao-Tseng Chen; Charis A Venditti; Gregory Theiler; Brian J Stevenson; Christian Iseli; Ali O Gure; Victor Jongeneel; Lloyd J Old; Andrew J G Simpson
Identification of CT46/HORMAD1, an immunogenic cancer/testis antigen encoding a putative meiosis-related protein.
Cancer immunity 2005;5():9.
2005: Roger Murphy; Simon Green; Gerd Ritter; L Cohen; D Ryan; W Woods; M Rubira; Jonathan Cebon; Ian D Davis; A Sjolander; A Kypridis; H Kalnins; M McNamara; M B Moloney; J Ackland; Glenn A Cartwright; J Rood; G Dumsday; K Healey; D Maher; Eugene Maraskovsky; Yao-Tseng Chen; Eric W Hoffman; Lloyd J Old; Andrew M Scott
Recombinant NY-ESO-1 cancer antigen: production and purification under cGMP conditions.
Preparative biochemistry & biotechnology 2005;35(2):119-34.
2005: Maha Ayyoub; Andrea Merlo; Charles Hesdorffer; Daniel Speiser; Donata Rimoldi; Jean-Charles Cerottini; Gerd Ritter; Yao-Tseng Chen; Lloyd J Old; Stefan Stevanovic; Danila Valmori
Distinct but overlapping T helper epitopes in the 37-58 region of SSX-2.
Clinical immunology (Orlando, Fla.) 2005;114(1):70-8.
2005: Shuichiro Sato; Yuji Noguchi; Hisashi Wada; Shoichiro Fujita; Shinichiro Nakamura; Ryo Tanaka; Tetsuya Nakada; Kosei Hasegawa; Kazuhiko Nakagawa; Fumihito Koizumi; Toshiro Ono; Kazuhiro Nouso; Achim Jungbluth; Yao-Tseng Chen; Lloyd J Old; Yasushi Shiratori; Eiichi Nakayama
Quantitative real-time RT-PCR analysis of NY-ESO-1 and LAGE-1a mRNA expression in normal tissues and tumors, and correlation of the protein expression with the mRNA copy number.
International journal of oncology 2005;26(1):57-63.
2004: Eduardo Huarte; Julia Karbach; Sacha Gnjatic; Armin Bender; Dirk Jäger; Michael Arand; Djordje Atanackovic; Jonathan Skipper; Gerd Ritter; Yao-Tseng Chen; Lloyd J Old; Alexander Knuth; Elke Jäger
HLA-DP4 expression and immunity to NY-ESO-1: correlation and characterization of cytotoxic CD4+ CD25- CD8- T cell clones.
Cancer immunity 2004;4():15.
2004: Hilary A Vaughan; Suzanne Svobodova; Duncan MacGregor; Sue Sturrock; Achim A Jungbluth; Judy Browning; Ian D Davis; Phillip Parente; Yao-Tseng Chen; Elisabeth Stockert; Fiona St Clair; Lloyd J Old; Jonathan Cebon
Immunohistochemical and molecular analysis of human melanomas for expression of the human cancer-testis antigens NY-ESO-1 and LAGE-1.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(24):8396-404.
2004: Christine Campagnolo; Katherine J Meyers; Thomas Ryan; Robert C Atkinson; Yao-Tseng Chen; Matt J Scanlan; Gerd Ritter; Lloyd J Old; Carl A Batt
Real-Time, label-free monitoring of tumor antigen and serum antibody interactions.
Journal of biochemical and biophysical methods 2004;61(3):283-98.
2004: Sang-Yull Lee; Barbara Williamson; Otavia L Caballero; Yao-Tseng Chen; Matthew J Scanlan; Gerd Ritter; Victor Jongeneel; Andrew J G Simpson; Lloyd J Old
Identification of the gonad-specific anion transporter SLCO6A1 as a cancer/testis (CT) antigen expressed in human lung cancer.
Cancer immunity 2004;4():13.
2004: Feng Qian; Sacha Gnjatic; Elke Jäger; Darren Santiago; Achim Jungbluth; Cathy Grande; Sally Schneider; Bernadette Keitz; Deborah Driscoll; Gerd Ritter; Shashikant Lele; Ashwani Sood; Lloyd J Old; Kunle Odunsi
Th1/Th2 CD4+ T cell responses against NY-ESO-1 in HLA-DPB1*0401/0402 patients with epithelial ovarian cancer.
Cancer immunity 2004;4():12.
2004: Jonathan Skipper; Eric W Hoffman; Jill O'Donnell-Tormey; Lloyd J Old
Translation of cancer immunotherapies.
Nature medicine 2004;10(11):1154-5; author reply 1155.
2004: Yu Wang; Xiao-Jiang Wu; Ai-Lian Zhao; Yan-Hua Yuan; Yao-Tseng Chen; Achim A Jungbluth; Sacha Gnjatic; Darren Santiago; Gerd Ritter; Wei-Feng Chen; Lloyd J Old; Jia-Fu Ji
Cancer/testis antigen expression and autologous humoral immunity to NY-ESO-1 in gastric cancer.
Cancer immunity 2004;4():11.
2004: Jonathan Tammela; Achim A Jungbluth; Feng Qian; Darren Santiago; Matthew J Scanlan; Bernadette Keitz; Deborah Driscoll; Kerry J Rodabaugh; Shashikant Lele; Lloyd J Old; Kunle Odunsi
SCP-1 cancer/testis antigen is a prognostic indicator and a candidate target for immunotherapy in epithelial ovarian cancer.
Cancer immunity 2004;4():10.
2004: Xiao-Ying Shang; Hong-Song Chen; Hua-Gang Zhang; Xue-Wen Pang; Huan Qiao; Ji-run Peng; Liu-liang Qin; Ran Fei; Ming-hui Mei; Xi-sheng Leng; Sacha Gnjatic; Gerd Ritter; Andrew J G Simpson; Lloyd J Old; Wei-Feng Chen
The spontaneous CD8+ T-cell response to HLA-A2-restricted NY-ESO-1b peptide in hepatocellular carcinoma patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(20):6946-55.
2004: Mitsutoshi Matsuo; Yasuhiro Nagata; Eiichi Sato; Djordje Atanackovic; Danila Valmori; Yao-Tseng Chen; Gerd Ritter; Ira Mellman; Lloyd J Old; Sacha Gnjatic
IFN-gamma enables cross-presentation of exogenous protein antigen in human Langerhans cells by potentiating maturation.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(40):14467-72.
2004: Shoichiro Fujita; Hisashi Wada; Achim A Jungbluth; Shuichiro Sato; Tetsuya Nakata; Yuji Noguchi; Yuichiro Doki; Masayoshi Yasui; Yurika Sugita; Takushi Yasuda; Masahiko Yano; Toshiro Ono; Yao-Tseng Chen; Masahiko Higashiyama; Sacha Gnjatic; Lloyd J Old; Eiichi Nakayama; Morito Monden
NY-ESO-1 expression and immunogenicity in esophageal cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(19):6551-8.
2004: Gerhard Held; Mitsutoshi Matsuo; Malka Epel; Sacha Gnjatic; Gerd Ritter; Sang-Yull Lee; Tsin Yee Tai; Cyrille Cohen; Lloyd J Old; Michael Pfreundschuh; Yoram Reiter; Hennie Hoogenboom; Christoph Renner
Dissecting cytotoxic T cell responses towards the NY-ESO-1 protein by peptide/MHC-specific antibody fragments.
European journal of immunology 2004;34(10):2919-29.
2004: Leonardo M Damasceno; Itzcoatl Pla; Hyun-Joo Chang; Leonard Cohen; Gerd Ritter; Lloyd J Old; Carl A Batt
An optimized fermentation process for high-level production of a single-chain Fv antibody fragment in Pichia pastoris.
Protein expression and purification 2004;37(1):18-26.
2004: Heather M Jackson; Nektaria Dimopoulos; Qiyuan Chen; Tina Luke; Tsin Yee Tai; Eugene Maraskovsky; Lloyd J Old; Ian D Davis; Jonathan Cebon; Weisan Chen
A robust human T-cell culture method suitable for monitoring CD8+ and CD4+ T-cell responses from cancer clinical trial samples.
Journal of immunological methods 2004;291(1-2):51-62.
2004: Gavin P Dunn; Lloyd J Old; Robert D Schreiber
The immunobiology of cancer immunosurveillance and immunoediting.
Immunity 2004;21(2):137-48.
2004: Chaitanya R Divgi; Joseph A O'Donoghue; Sydney Welt; Jayne O'Neel; Ronald Finn; Robert J Motzer; Achim Jungbluth; Eric Hoffman; Gerd Ritter; Steven M Larson; Lloyd J Old
Phase I clinical trial with fractionated radioimmunotherapy using 131I-labeled chimeric G250 in metastatic renal cancer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2004;45(8):1412-21.
2004: Ian D Davis; Weisan Chen; Heather Jackson; Phillip Parente; Mark Shackleton; Wendie Hopkins; Qiyuan Chen; Nektaria Dimopoulos; Tina Luke; Roger Murphy; Andrew M Scott; Eugene Maraskovsky; Grant McArthur; Duncan MacGregor; Sue Sturrock; Tsin Yee Tai; Simon Green; Andrew Cuthbertson; Darryl Maher; Lena Miloradovic; Susan V Mitchell; Gerd Ritter; Achim A Jungbluth; Yao-Tseng Chen; Sacha Gnjatic; Eric W Hoffman; Lloyd J Old; Jonathan Cebon
Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4(+) and CD8(+) T cell responses in humans.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(29):10697-702.
2004: Hilary A Vaughan; Fiona St Clair; Matthew J Scanlan; Yao-Tsen Chen; Eugene Maraskovsky; Andrew Sizeland; Lloyd J Old; Jonathan Cebon
The humoral immune response to head and neck cancer antigens as defined by the serological analysis of tumor antigens by recombinant cDNA expression cloning.
Cancer immunity 2004;4():5.
2004: Terrance G Johns; Timothy E Adams; Jennifer Cochran; Nathan E Hall; Peter A Hoyne; Mark J Olsen; Yong-Sung Kim; Julie Rothacker; Edouard C Nice; Francesca Walker; Gerd Ritter; Achim A Jungbluth; Lloyd J Old; Colin W Ward; Antony W Burgess; K Dane Wittrup; Andrew M Scott
Identification of the epitope for the epidermal growth factor receptor-specific monoclonal antibody 806 reveals that it preferentially recognizes an untethered form of the receptor.
The Journal of biological chemistry 2004;279(29):30375-84.
2004: Qiyuan Chen; Heather Jackson; Phillip Parente; Tina Luke; Mark Rizkalla; Tsin Yee Tai; He-Cheng Zhu; Nicole Mifsud; Nektaria Dimopoulos; Kelly-Anne Masterman; Wendie Hopkins; Heather Goldie; Eugene Maraskovsky; Simon Green; Lena Miloradovic; James McCluskey; Lloyd J Old; Ian D Davis; Jonathan Cebon; Weisan Chen
Immunodominant CD4+ responses identified in a patient vaccinated with full-length NY-ESO-1 formulated with ISCOMATRIX adjuvant.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(25):9363-8.
2004: Maha Ayyoub; Charles Hesdorffer; Genevieve Metthez; Stefan Stevanovic; Gerd Ritter; Yao-Tseng Chen; Lloyd J Old; Daniel Speiser; Jean-Charles Cerottini; Danila Valmori
Identification of an SSX-2 epitope presented by dendritic cells to circulating autologous CD4+ T cells.
Journal of immunology (Baltimore, Md. : 1950) 2004;172(11):7206-11.
2004: Robert L Strausberg; Andrew J G Simpson; Lloyd J Old; Gregory J Riggins
Oncogenomics and the development of new cancer therapies.
Nature 2004;429(6990):469-74.
2004: P Markus Deckert; William G Bornmann; Gerd Ritter; Clarence Williams; Juergen Franke; Ulrich Keilholz; Eckhard Thiel; Lloyd J Old; Joseph R Bertino; Sydney Welt
Specific tumour localisation of a huA33 antibody--carboxypeptidase A conjugate and activation of methotrexate-phenylalanine.
International journal of oncology 2004;24(5):1289-95.
2004: Maha Ayyoub; Charles Hesdorffer; Monica Montes; Andrea Merlo; Daniel Speiser; Donata Rimoldi; Jean-Charles Cerottini; Gerd Ritter; Matthew Scanlan; Lloyd J Old; Danila Valmori
An immunodominant SSX-2-derived epitope recognized by CD4+ T cells in association with HLA-DR.
The Journal of clinical investigation 2004;113(8):1225-33.
2004: Yu Wang; Zhen Liang; Yan-hua Yuan; Yan Han; Yue-xiang Liu; Nian Liu; Yao-Tseng Chen; Gerd Ritter; Lloyd J Old; Li-jian Zhang
[Expression of multiple cancer-testis antigen genes in non-small cell lung cancer treated by chemotherapy prior surgery].
Zhonghua yi xue za zhi 2004;84(6):464-8.
2004: Yurika Sugita; Hisashi Wada; Shoichiro Fujita; Tetsuya Nakata; Shuichiro Sato; Yuji Noguchi; Achim A Jungbluth; Masae Yamaguchi; Yao-Tseng Chen; Elisabeth Stockert; Sacha Gnjatic; Barbara Williamson; Matthew J Scanlan; Toshiro Ono; Isao Sakita; Masayoshi Yasui; Yasuo Miyoshi; Yasuhiro Tamaki; Nariaki Matsuura; Shinzaburo Noguchi; Lloyd J Old; Eiichi Nakayama; Morito Monden
NY-ESO-1 expression and immunogenicity in malignant and benign breast tumors.
Cancer research 2004;64(6):2199-204.
2004: Djordje Atanackovic; Nasser K Altorki; Elisabeth Stockert; Barbara Williamson; Achim A Jungbluth; Erika Ritter; Darren Santiago; Cathy A Ferrara; Mitsutoshi Matsuo; Annamalai Selvakumar; Bo Dupont; Yao-Tseng Chen; Eric W Hoffman; Gerd Ritter; Lloyd J Old; Sacha Gnjatic
Vaccine-induced CD4+ T cell responses to MAGE-3 protein in lung cancer patients.
Journal of immunology (Baltimore, Md. : 1950) 2004;172(5):3289-96.
2004: Matthew J Scanlan; Andrew J G Simpson; Lloyd J Old
The cancer/testis genes: review, standardization, and commentary.
Cancer immunity 2004;4():1.
2004: Gavin P Dunn; Lloyd J Old; Robert D Schreiber
The three Es of cancer immunoediting.
Annual review of immunology 2004;22():329-60.
2003: Terrance G Johns; Rodney B Luwor; Carmel Murone; Francesca Walker; Janet Weinstock; Angela A Vitali; Rushika M Perera; Achim A Jungbluth; Elisabeth Stockert; Lloyd J Old; Edouard C Nice; Antony W Burgess; Andrew M Scott
Antitumor efficacy of cytotoxic drugs and the monoclonal antibody 806 is enhanced by the EGF receptor inhibitor AG1478.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(26):15871-6.
2003: Padmanee Sharma; Sacha Gnjatic; Achim A Jungbluth; Barbara Williamson; Harry W Herr; Elisabeth Stockert; Guido Dalbagni; S Machele Donat; Victor E Reuter; Darren Santiago; Yao-Tseng Chen; Dean F Bajorin; Lloyd J Old
Frequency of NY-ESO-1 and LAGE-1 expression in bladder cancer and evidence of a new NY-ESO-1 T-cell epitope in a patient with bladder cancer.
Cancer immunity 2003;3():19.
2003: Lloyd J Old
Cancer vaccines 2003: opening address.
Cancer immunity 2003;3 Suppl 2():1.
2003: Yao-Tseng Chen; Birgit Alpen; Toshiro Ono; Ali O Gure; Matthew A Scanlan; William H Biggs; Karen C Arden; Eiichi Nakayama; Lloyd J Old
Identification and characterization of mouse SSX genes: a multigene family on the X chromosome with restricted cancer/testis expression.
Genomics 2003;82(6):628-36.
2003: Ian F Hermans; Jonathan Silk; Uzi Gileadi; Mariolina Salio; Bini Mathew; Gerd Ritter; Richard Schmidt; Adrian L Harris; Lloyd J Old; Vincenzo Cerundolo
NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells.
Journal of immunology (Baltimore, Md. : 1950) 2003;171(10):5140-7.
2003: Monica Rodolfo; Roberto Luksch; Elisabeth Stockert; Yao-Tseng Chen; Paola Collini; Tiziana Ranzani; Claudia Lombardo; Piero Dalerba; Licia Rivoltini; Flavio Arienti; Franca Fossati-Bellani; Lloyd J Old; Giorgio Parmiani; Chiara Castelli
Antigen-specific immunity in neuroblastoma patients: antibody and T-cell recognition of NY-ESO-1 tumor antigen.
Cancer research 2003;63(20):6948-55.
2003: Maha Ayyoub; Michelle Brehm; Genevieve Metthez; Susan Talbot; Valérie Dutoit; Robert N Taub; Mary-Louise Keohan; Ali O Gure; Yao-Tseng Chen; Barbara Williamson; Achim A Jungbluth; Lloyd J Old; Charles Hesdorffer; Danila Valmori
SSX antigens as tumor vaccine targets in human sarcoma.
Cancer immunity 2003;3():13.
2003: Kouhei Tajima; Yuichi Obata; Hiromi Tamaki; Masahiro Yoshida; Yao-Tseng Chen; Matthew J Scanlan; Lloyd J Old; Hiroyuki Kuwano; Toshitada Takahashi; Toshitada Takahashi; Tetsuya Mitsudomi
Expression of cancer/testis (CT) antigens in lung cancer.
Lung cancer (Amsterdam, Netherlands) 2003;42(1):23-33.
2003: Hiroyoshi Nishikawa; Takuma Kato; Koji Tanida; Atsunori Hiasa; Isao Tawara; Hiroaki Ikeda; Yoshinori Ikarashi; Hiro Wakasugi; Mitchell Kronenberg; Toshinori Nakayama; Masaru Taniguchi; Kagemasa Kuribayashi; Lloyd J Old; Hiroshi Shiku
CD4+ CD25+ T cells responding to serologically defined autoantigens suppress antitumor immune responses.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(19):10902-6.
2003: Kunle Odunsi; Achim A Jungbluth; Elisabeth Stockert; Feng Qian; Sacha Gnjatic; Jonathan Tammela; Marilyn Intengan; Amy Beck; Bernadette Keitz; Darren Santiago; Barbara Williamson; Matthew J Scanlan; Gerd Ritter; Yao-Tseng Chen; Deborah Driscoll; Ashwani Sood; Shashikant Lele; Lloyd J Old
NY-ESO-1 and LAGE-1 cancer-testis antigens are potential targets for immunotherapy in epithelial ovarian cancer.
Cancer research 2003;63(18):6076-83.
2003: Egbert Oosterwijk; Chaitanya R Divgi; Adrienne H Brouwers; Otto Boerman; Steven M Larson; Peter F A Mulders; Lloyd J Old
Monoclonal antibody-based therapy for renal cell carcinoma.
The Urologic clinics of North America 2003;30(3):623-31.
2003: Kiki Tahtis; Fook-Thean Lee; Jennifer M Wheatley; Pilar Garin-Chesa; John E Park; Fiona E Smyth; Yuichi Obata; Elisabeth Stockert; Cathrine M Hall; Lloyd J Old; Wolfgang J Rettig; Andrew M Scott
Expression and targeting of human fibroblast activation protein in a human skin/severe combined immunodeficient mouse breast cancer xenograft model.
Molecular cancer therapeutics 2003;2(8):729-37.
2003: Tetsuya Nakada; Yuji Noguchi; Shuichiro Satoh; Toshiro Ono; Takashi Saika; Takushi Kurashige; Sacha Gnjatic; Gerd Ritter; Yao-Tseng Chen; Elisabeth Stockert; Yasutomo Nasu; Tomoyasu Tsushima; Hiromi Kumon; Lloyd J Old; Eiichi Nakayama
NY-ESO-1 mRNA expression and immunogenicity in advanced prostate cancer.
Cancer immunity 2003;3():10.
2003: Sacha Gnjatic; Djordje Atanackovic; Elke Jäger; Mitsutoshi Matsuo; Annamalai Selvakumar; Nasser K Altorki; ROBERT G MAKI; Bo Dupont; Gerd Ritter; Yao-Tseng Chen; Alexander Knuth; Lloyd J Old
Survey of naturally occurring CD4+ T cell responses against NY-ESO-1 in cancer patients: correlation with antibody responses.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(15):8862-7.
2003: Djordje Atanackovic; Mitsutoshi Matsuo; Erika Ritter; Gail Mazzara; Gerd Ritter; Elke Jäger; Alexander Knuth; Lloyd J Old; Sacha Gnjatic
Monitoring CD4+ T cell responses against viral and tumor antigens using T cells as novel target APC.
Journal of immunological methods 2003;278(1-2):57-66.
2003: Axel Mischo; Andreas Wadle; Kristin Wätzig; Dirk Jäger; Elisabeth Stockert; Darren Santiago; Gerd Ritter; Evi Regitz; Elke Jäger; Alex Knuth; Lloyd J Old; Michael Pfreundschuh; Christoph Renner
Recombinant antigen expression on yeast surface (RAYS) for the detection of serological immune responses in cancer patients.
Cancer immunity 2003;3():5.
2003: Andrew M Scott; Greg Wiseman; Sydney Welt; Alex A. Adjei; Fook-Thean Lee; Wendie Hopkins; Chaitanya R Divgi; Lorelei H Hanson; Paul Mitchell; Denise N Gansen; Steven M Larson; James N Ingle; Eric W Hoffman; Paul Tanswell; Gerd Ritter; Leonard S Cohen; Peter Bette; Lisa Arvay; Andree Amelsberg; Dan Vlock; Wolfgang J Rettig; Lloyd J Old
A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(5):1639-47.
2003: Sydney Welt; Gerd Ritter; Clarence Williams; Leonard S Cohen; Achim Jungbluth; Elizabeth A Richards; Lloyd J Old; Nancy Kemeny
Preliminary report of a phase I study of combination chemotherapy and humanized A33 antibody immunotherapy in patients with advanced colorectal cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(4):1347-53.
2003: Sydney Welt; Gerd Ritter; Clarence Williams; Leonard S Cohen; Mary John; Achim Jungbluth; Elizabeth A Richards; Lloyd J Old; Nancy Kemeny
Phase I study of anticolon cancer humanized antibody A33.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(4):1338-46.
2003: P Markus Deckert; C Renner; L S Cohen; Achim Jungbluth; Gerd Ritter; J R Bertino; Lloyd J Old; Sydney Welt
A33scFv-cytosine deaminase: a recombinant protein construct for antibody-directed enzyme-prodrug therapy.
British journal of cancer 2003;88(6):937-9.
2003: Sang-Yull Lee; Yuichi Obata; Masahiro Yoshida; Elisabeth Stockert; Barbara Williamson; Achim A Jungbluth; Yao-Tseng Chen; Lloyd J Old; Matthew J Scanlan
Immunomic analysis of human sarcoma.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(5):2651-6.
2003: Lloyd J Old
Cancer Vaccine Collaborative 2002: opening address.
Cancer immunity 2003;3 Suppl 1():1.
2003: Sacha Gnjatic; Djordje Atanackovic; Mitsutoshi Matsuo; Elke Jäger; Sang-Yull Lee; Danila Valmori; Yao-Tseng Chen; Gerd Ritter; Alexander Knuth; Lloyd J Old
Cross-presentation of HLA class I epitopes from exogenous NY-ESO-1 polypeptides by nonprofessional APCs.
Journal of immunology (Baltimore, Md. : 1950) 2003;170(3):1191-6.
2003: Achim A Jungbluth; Elisabeth Stockert; H-J Su Huang; Vincent P Collins; Keren Coplan; Kristin Iversen; Denise Kolb; Terrance J Johns; Andrew M Scott; William J Gullick; Gerd Ritter; Leonard Cohen; Matthew J Scanlan; Webster K Cavenee; Lloyd J Old; Webster K Cavanee
A monoclonal antibody recognizing human cancers with amplification/overexpression of the human epidermal growth factor receptor.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(2):639-44.
2003: Egbert Oosterwijk; Adrienne H Brouwers; Otto Boerman; Steven M Larson; Lloyd J Old; Peter F A Mulders; Chaitanya R Divgi
Monoclonal antibody therapy of kidney cancer.
Cancer treatment and research 2003;116():199-212.
2002: Valérie Dutoit; Robert N Taub; Kyriakos P Papadopoulos; Susan Talbot; Mary-Louise Keohan; Michelle Brehm; Sacha Gnjatic; Paul E Harris; Brygida Bisikirska; Philippe Guillaume; Jean-Charles Cerottini; Charles Hesdorffer; Lloyd J Old; Danila Valmori
Multiepitope CD8(+) T cell response to a NY-ESO-1 peptide vaccine results in imprecise tumor targeting.
The Journal of clinical investigation 2002;110(12):1813-22.
2002: Gavin P Dunn; Allen Bruce; Hiroaki Ikeda; Lloyd J Old; Robert D Schreiber
Cancer immunoediting: from immunosurveillance to tumor escape.
Nature immunology 2002;3(11):991-8.
2002: Ali O Güre; Isaac J Wei; Lloyd J Old; Yao-Tseng Chen
The SSX gene family: characterization of 9 complete genes.
International journal of cancer. Journal international du cancer 2002;101(5):448-53.
2002: Zhanqi Liu; Fook-Thean Lee; Nobuo Hanai; Fiona E Smyth; Antony W Burgess; Lloyd J Old; Andrew M Scott
Cytokine enhancement of in vitro antibody-dependent cellular cytotoxicity mediated by chimeric anti-GD3 monoclonal antibody KM871.
Cancer immunity 2002;2():13.
2002: Ekaterina P Koroleva; Maria A Lagarkova; Andrey A Mesheryakov; Matthew J Scanlan; Lloyd J Old; Sergei A Nedospasov; Dmitry V Kuprash
Serological identification of antigens associated with renal cell carcinoma.
Russian journal of immunology : RJI : official journal of Russian Society of Immunology 2002;7(3):229-38.
2002: Matthew J Scanlan; Ali O Gure; Achim A Jungbluth; Lloyd J Old; Yao-Tseng Chen
Cancer/testis antigens: an expanding family of targets for cancer immunotherapy.
Immunological reviews 2002;188():22-32.
2002: Elke Jäger; Julia Karbach; Sacha Gnjatic; Dirk Jäger; Markus J Maeurer; Akin Atmaca; Michael Arand; Jonathan Skipper; Elisabeth Stockert; Yao-Tseng Chen; Lloyd J Old; Alexander Knuth
Identification of a naturally processed NY-ESO-1 peptide recognized by CD8+ T cells in the context of HLA-B51.
Cancer immunity 2002;2():12.
2002: Birgit Alpen; Ali O Güre; Matthew J Scanlan; Lloyd J Old; Yao-Tseng Chen
A new member of the NY-ESO-1 gene family is ubiquitously expressed in somatic tissues and evolutionarily conserved.
Gene 2002;297(1-2):141-9.
2002: Sacha Gnjatic; Elke Jäger; Weisan Chen; Nasser K Altorki; Mitsutoshi Matsuo; Sang-Yull Lee; Qiyuan Chen; Yasuhiro Nagata; Djordje Atanackovic; Yao-Tseng Chen; Gerd Ritter; Jonathan Cebon; Alexander Knuth; Lloyd J Old
CD8(+) T cell responses against a dominant cryptic HLA-A2 epitope after NY-ESO-1 peptide immunization of cancer patients.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(18):11813-8.
2002: Dirk Jäger; Elisabeth Stockert; Julia Karbach; Kristina Herrlinger; Akin Atmaca; Michael Arand; Yao-Tseng Chen; Sacha Gnjatic; Lloyd J Old; Alexander Knuth; Elke Jäger
Urine antibody against human cancer antigen NY-ESO-1.
Cancer immunity 2002;2():10.
2002: Yasuhiro Nagata; Satoru Ono; Mitsutoshi Matsuo; Sacha Gnjatic; Danila Valmori; Gerd Ritter; Wendy Garrett; Lloyd J Old; Ira Mellman
Differential presentation of a soluble exogenous tumor antigen, NY-ESO-1, by distinct human dendritic cell populations.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(16):10629-34.
2002: Matthew J Scanlan; Sydney Welt; Claudia M Gordon; Yao-Tseng Chen; Ali O Gure; Elisabeth Stockert; Achim A Jungbluth; Gerd Ritter; Dirk Jäger; Elke Jäger; Alexander Knuth; Lloyd J Old
Cancer-related serological recognition of human colon cancer: identification of potential diagnostic and immunotherapeutic targets.
Cancer research 2002;62(14):4041-7.
2002: Dirk Jäger; Marc Unkelbach; Claudia Frei; Florian Bert; Matthew J Scanlan; Elke Jäger; Lloyd J Old; Yao-Tseng Chen; Alexander Knuth
Identification of tumor-restricted antigens NY-BR-1, SCP-1, and a new cancer/testis-like antigen NW-BR-3 by serological screening of a testicular library with breast cancer serum.
Cancer immunity 2002;2():5.
2002: Achim A Jungbluth; Yao-Tseng Chen; Klaus J Busam; Keren Coplan; Denise Kolb; Kristin Iversen; Barbara Williamson; Frank K H van Landeghem; Elisabeth Stockert; Lloyd J Old
CT7 (MAGE-C1) antigen expression in normal and neoplastic tissues.
International journal of cancer. Journal international du cancer 2002;99(6):839-45.
2002: Stefania Forti; Matthew J Scanlan; Annamaria Invernizzi; Fabio Castiglioni; Sandro Pupa; Roberto Agresti; Rosanna Fontanelli; Daniele Morelli; Lloyd J Old; Serenella M Pupa; Sylvie Ménard
Identification of breast cancer-restricted antigens by antibody screening of SKBR3 cDNA library using a preselected patient's serum.
Breast cancer research and treatment 2002;73(3):245-56.
2002: Matthew J Scanlan; Claudia M Gordon; Barbara Williamson; Sang-Yull Lee; Yao-Tseng Chen; Elisabeth Stockert; Achim Jungbluth; Gerd Ritter; Dirk Jäger; Elke Jäger; Alexander Knuth; Lloyd J Old
Identification of cancer/testis genes by database mining and mRNA expression analysis.
International journal of cancer. Journal international du cancer 2002;98(4):485-92.
2002: Hiroaki Ikeda; Lloyd J Old; Robert D Schreiber
The roles of IFN gamma in protection against tumor development and cancer immunoediting.
Cytokine & growth factor reviews 2002;13(2):95-109.
2002: Terrance G Johns; Elisabeth Stockert; Gerd Ritter; Achim A Jungbluth; H-J Su Huang; Webster K Cavenee; Fiona E Smyth; Cathrine M Hall; Nadine Watson; Edouard C Nice; William J Gullick; Lloyd J Old; Antony W Burgess; Andrew M Scott
Novel monoclonal antibody specific for the de2-7 epidermal growth factor receptor (EGFR) that also recognizes the EGFR expressed in cells containing amplification of the EGFR gene.
International journal of cancer. Journal international du cancer 2002;98(3):398-408.
2002: Cristina R Antonescu; Klaus J Busam; Kristin Iversen; Denise Kolb; Keren Coplan; Giulio C Spagnoli; Marc Ladanyi; Lloyd J Old; Achim A Jungbluth
MAGE antigen expression in monophasic and biphasic synovial sarcoma.
Human pathology 2002;33(2):225-9.
2001: Hiroyoshi Nishikawa; Koji Tanida; Hiroaki Ikeda; Miho Sakakura; Yoshihiro Miyahara; Takumi Aota; K Mukai; Masatoshi Watanabe; Kagemasa Kuribayashi; Lloyd J Old; Hiroshi Shiku
Role of SEREX-defined immunogenic wild-type cellular molecules in the development of tumor-specific immunity.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(25):14571-6.
2001: Achim A Jungbluth; Cristina R Antonescu; Klaus J Busam; Kristin Iversen; Denise Kolb; Keren Coplan; Yao-Tseng Chen; Elisabeth Stockert; Marc Ladanyi; Lloyd J Old
Monophasic and biphasic synovial sarcomas abundantly express cancer/testis antigen NY-ESO-1 but not MAGE-A1 or CT7.
International journal of cancer. Journal international du cancer 2001;94(2):252-6.
2001: Andrew M Scott; Fook-Thean Lee; Wendie Hopkins; Jonathan Cebon; J M Wheatley; Zhanqi Liu; Fiona E Smyth; Carmel Murone; Sue Sturrock; Duncan MacGregor; Nobuo Hanai; K Inoue; M Yamasaki; Martin W Brechbiel; Ian D Davis; Roger Murphy; Anthony Hannah; M Lim-Joon; T Chan; Geoffrey Chong; Gerd Ritter; Eric W Hoffman; Antony W Burgess; Lloyd J Old
Specific targeting, biodistribution, and lack of immunogenicity of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma: results of a phase I trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(19):3976-87.
2001: Gerd Ritter; Leonard S Cohen; Clarence Williams; E C Richards; Lloyd J Old; Sydney Welt
Serological analysis of human anti-human antibody responses in colon cancer patients treated with repeated doses of humanized monoclonal antibody A33.
Cancer research 2001;61(18):6851-9.
2001: Rodney B Luwor; Terrance G Johns; Carmel Murone; H-J Su Huang; Webster K Cavenee; Gerd Ritter; Lloyd J Old; Antony W Burgess; Andrew M Scott
Monoclonal antibody 806 inhibits the growth of tumor xenografts expressing either the de2-7 or amplified epidermal growth factor receptor (EGFR) but not wild-type EGFR.
Cancer research 2001;61(14):5355-61.
2001: Kazuhiko Mishima; Terrance G Johns; Rodney B Luwor; Andrew M Scott; Elisabeth Stockert; Achim A Jungbluth; XD Ji; P Suvarna; J R Voland; Lloyd J Old; H-J Su Huang; Webster K Cavenee
Growth suppression of intracranial xenografted glioblastomas overexpressing mutant epidermal growth factor receptors by systemic administration of monoclonal antibody (mAb) 806, a novel monoclonal antibody directed to the receptor.
Cancer research 2001;61(14):5349-54.
2001: Takushi Kurashige; Yuji Noguchi; Takashi Saika; Toshiro Ono; Y Nagata; Achim Jungbluth; Gerd Ritter; Yao-Tseng Chen; Elisabeth Stockert; Tomoyasu Tsushima; Hiromi Kumon; Lloyd J Old; Eiichi Nakayama
Ny-ESO-1 expression and immunogenicity associated with transitional cell carcinoma: correlation with tumor grade.
Cancer research 2001;61(12):4671-4.
2001: Achim A Jungbluth; Yao-Tseng Chen; Elisabeth Stockert; Klaus J Busam; Denise Kolb; Kristin Iversen; Keren Coplan; Barbara Williamson; N Altorki; Lloyd J Old
Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues.
International journal of cancer. Journal international du cancer 2001;92(6):856-60.
2001: Fook-Thean Lee; Angela Rigopoulos; Cathrine Hall; K Clarke; Stephen H Cody; Fiona E Smyth; Zhanqi Liu; Martin W Brechbiel; Nobuo Hanai; Edouard C Nice; Bruno Catimel; Antony W Burgess; Sydney Welt; Gerd Ritter; Lloyd J Old; Andrew M Scott
Specific localization, gamma camera imaging, and intracellular trafficking of radiolabelled chimeric anti-G(D3) ganglioside monoclonal antibody KM871 in SK-MEL-28 melanoma xenografts.
Cancer research 2001;61(11):4474-82.
2001: Fook-Thean Lee; Cathrine Hall; Angela Rigopoulos; J Zweit; Kunthi Pathmaraj; Graeme J O'Keefe; Fiona E Smyth; Sydney Welt; Lloyd J Old; Andrew M Scott
Immuno-PET of human colon xenograft- bearing BALB/c nude mice using 124I-CDR-grafted humanized A33 monoclonal antibody.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2001;42(5):764-9.
2001: Vijay Shankaran; Hiroaki Ikeda; Allen Bruce; J Michael White; P E Swanson; Lloyd J Old; Robert D Schreiber
IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity.
Nature 2001;410(6832):1107-11.
2001: Kiki Tahtis; Fook-Thean Lee; Fiona E Smyth; Barbara E Power; C Renner; Martin W Brechbiel; Lloyd J Old; Peter J Hudson; Andrew M Scott
Biodistribution properties of (111)indium-labeled C-functionalized trans-cyclohexyl diethylenetriaminepentaacetic acid humanized 3S193 diabody and F(ab')(2) constructs in a breast carcinoma xenograft model.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(4):1061-72.
2001: Matthew J Scanlan; Ivan T Gout; Claudia M Gordon; Barbara Williamson; Elisabeth Stockert; Ali O Gure; Dirk Jäger; Yao-Tseng Chen; A Mackay; M J O'Hare; Lloyd J Old
Humoral immunity to human breast cancer: antigen definition and quantitative analysis of mRNA expression.
Cancer immunity 2001;1():4.
2001: Lloyd J Old
Cancer/testis (CT) antigens - a new link between gametogenesis and cancer.
Cancer immunity 2001;1():1.
2001: Toshiro Ono; Takushi Kurashige; N Harada; Yuji Noguchi; Takashi Saika; N Niikawa; M Aoe; S Nakamura; T Higashi; A Hiraki; Hisashi Wada; Hiromi Kumon; Lloyd J Old; Eiichi Nakayama
Identification of proacrosin binding protein sp32 precursor as a human cancer/testis antigen.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(6):3282-7.
2001: Dirk Jäger; Elisabeth Stockert; Ali O Güre; Matthew J Scanlan; Julia Karbach; Elke Jäger; Alexander Knuth; Lloyd J Old; Yao-Tseng Chen
Identification of a tissue-specific putative transcription factor in breast tissue by serological screening of a breast cancer library.
Cancer research 2001;61(5):2055-61.
2001: Achim A Jungbluth; R King; David E Fisher; Kristin Iversen; Keren Coplan; Denise Kolb; Barbara Williamson; Yao-Tseng Chen; Elisabeth Stockert; Lloyd J Old; Klaus J Busam
Immunohistochemical and reverse transcription-polymerase chain reaction expression analysis of tyrosinase and microphthalmia-associated transcription factor in angiomyolipomas.
Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry 2001;9(1):29-34.
2001: Paul Tanswell; Pilar Garin-Chesa; Wolfgang J Rettig; Sydney Welt; Chaitanya R Divgi; E S Casper; R D Finn; Steven M Larson; Lloyd J Old; A M Scott
Population pharmacokinetics of antifibroblast activation protein monoclonal antibody F19 in cancer patients.
British journal of clinical pharmacology 2001;51(2):177-80.
2000: Toshiro Ono; Shuichiro Sato; N Kimura; Motoyuki Tanaka; A Shibuya; Lloyd J Old; Eiichi Nakayama
Serological analysis of BALB/C methylcholanthrene sarcoma Meth A by SEREX: identification of a cancer/testis antigen.
International journal of cancer. Journal international du cancer 2000;88(6):845-51.
2000: Elke Jäger; Sacha Gnjatic; Y Nagata; Elisabeth Stockert; Dirk Jäger; Julia Karbach; Antje Neumann; J Rieckenberg; Yao-Tseng Chen; Gerd Ritter; Eric Hoffman; Michael Arand; Lloyd J Old; Alexander Knuth
Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(22):12198-203.
2000: Sacha Gnjatic; Yasuhiro Nagata; Elke Jager; Elisabeth Stockert; Srinivas Shankara; B L Roberts; G P Mazzara; Sang-Yull Lee; P Rod Dunbar; Bo Dupont; V Cerundolo; Gerd Ritter; Yao-Tseng Chen; Alexander Knuth; Lloyd J Old
Strategy for monitoring T cell responses to NY-ESO-1 in patients with any HLA class I allele.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(20):10917-22.
2000: K Clarke; Fook-Thean Lee; Martin W Brechbiel; Fiona E Smyth; Lloyd J Old; Andrew M Scott
Therapeutic efficacy of anti-Lewis(y) humanized 3S193 radioimmunotherapy in a breast cancer model: enhanced activity when combined with taxol chemotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(9):3621-8.
2000: K Clarke; Fook-Thean Lee; Martin W Brechbiel; Fiona E Smyth; Lloyd J Old; Andrew M Scott
In vivo biodistribution of a humanized anti-Lewis Y monoclonal antibody (hu3S193) in MCF-7 xenografted BALB/c nude mice.
Cancer research 2000;60(17):4804-11.
2000: H L Hanson; David L Donermeyer; Hiroaki Ikeda; J Michael White; Vijay Shankaran; Lloyd J Old; H Shiku; Robert D Schreiber; Paul M Allen
Eradication of established tumors by CD8+ T cell adoptive immunotherapy.
Immunity 2000;13(2):265-76.
2000: Achim A Jungbluth; Elisabeth Stockert; Yao-Tseng Chen; Denise Kolb; Kristin Iversen; Keren Coplan; Barbara Williamson; N Altorki; Klaus J Busam; Lloyd J Old
Monoclonal antibody MA454 reveals a heterogeneous expression pattern of MAGE-1 antigen in formalin-fixed paraffin embedded lung tumours.
British journal of cancer 2000;83(4):493-7.
2000: P Markus Deckert; Achim Jungbluth; N Montalto; M A Clark; Ronald D Finn; Clarence Williams; E C Richards; Katherine S Panageas; Lloyd J Old; Sydney Welt
Pharmacokinetics and microdistribution of polyethylene glycol-modified humanized A33 antibody targeting colon cancer xenografts.
International journal of cancer. Journal international du cancer 2000;87(3):382-90.
2000: Ji-Li Chen; P Rod Dunbar; Uzi Gileadi; Elke Jäger; Sacha Gnjatic; Y Nagata; Elisabeth Stockert; Dennis Panicali; Y T Chen; A Knuth; Lloyd J Old; Vincenzo Cerundolo
Identification of NY-ESO-1 peptide analogues capable of improved stimulation of tumor-reactive CTL.
Journal of immunology (Baltimore, Md. : 1950) 2000;165(2):948-55.
2000: Dirk Jäger; Elisabeth Stockert; Elke Jäger; Ali O Güre; Matthew J Scanlan; Alexander Knuth; Lloyd J Old; Yao-Tseng Chen
Serological cloning of a melanocyte rab guanosine 5'-triphosphate-binding protein and a chromosome condensation protein from a melanoma complementary DNA library.
Cancer research 2000;60(13):3584-91.
2000: Andrew M Scott; DM Geleick; M Rubira; K Clarke; Edouard C Nice; Fiona E Smyth; Elisabeth Stockert; E C Richards; F J Carr; W J Harris; Kathryn Armour; J Rood; A Kypridis; V Kronina; Roger Murphy; Fook-Thean Lee; Zhanqi Liu; K Kitamura; Gerd Ritter; K Laughton; Eric Hoffman; Antony W Burgess; Lloyd J Old
Construction, production, and characterization of humanized anti-Lewis Y monoclonal antibody 3S193 for targeted immunotherapy of solid tumors.
Cancer research 2000;60(12):3254-61.
2000: Christoph Rader; G Ritter; S Nathan; M Elia; Ivan T Gout; Achim A Jungbluth; L S Cohen; Sydney Welt; Lloyd J Old; Carlos F Barbas
The rabbit antibody repertoire as a novel source for the generation of therapeutic human antibodies.
The Journal of biological chemistry 2000;275(18):13668-76.
2000: Elke Jäger; Y Nagata; Sacha Gnjatic; H Wada; Elisabeth Stockert; Julia Karbach; P Rod Dunbar; S Y Lee; Achim Jungbluth; Dirk Jäger; Michael Arand; Gerd Ritter; V Cerundolo; Bo Dupont; Yao-Tseng Chen; Lloyd J Old; Alexander Knuth
Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(9):4760-5.
2000: Ali O Güre; Elisabeth Stockert; Matthew J Scanlan; Roger Keresztes; Dirk Jäger; Nasser K Altorki; Lloyd J Old; Yao-Tseng Chen
Serological identification of embryonic neural proteins as highly immunogenic tumor antigens in small cell lung cancer.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(8):4198-203.
2000: Klaus J Busam; Kristin Iversen; Marianne Berwick; Giulio C Spagnoli; Lloyd J Old; Achim A Jungbluth
Immunoreactivity with the anti-MAGE antibody 57B in malignant melanoma: frequency of expression and correlation with prognostic parameters.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2000;13(4):459-65.
2000: Matthew J Scanlan; Nasser K Altorki; Ali O Gure; Barbara Williamson; Achim Jungbluth; Y T Chen; Lloyd J Old
Expression of cancer-testis antigens in lung cancer: definition of bromodomain testis-specific gene (BRDT) as a new CT gene, CT9.
Cancer letters 2000;150(2):155-64.
2000: Ali O Güre; Elisabeth Stockert; Karen C Arden; Antonia D Boyer; Carrie Viars; Matthew J Scanlan; Lloyd J Old; Yao-Tseng Chen
CT10: a new cancer-testis (CT) antigen homologous to CT7 and the MAGE family, identified by representational-difference analysis.
International journal of cancer. Journal international du cancer 2000;85(5):726-32.
2000: Elke Jäger; D Jäger; Julia Karbach; Y T Chen; G Ritter; Y Nagata; Sacha Gnjatic; Elisabeth Stockert; Michael Arand; Lloyd J Old; Alexander Knuth
Identification of NY-ESO-1 epitopes presented by human histocompatibility antigen (HLA)-DRB4*0101-0103 and recognized by CD4(+) T lymphocytes of patients with NY-ESO-1-expressing melanoma.
The Journal of experimental medicine 2000;191(4):625-30.
2000: Achim A Jungbluth; Klaus J Busam; Denise Kolb; Kristin Iversen; Keren Coplan; Yao-Tseng Chen; Giulio C Spagnoli; Lloyd J Old
Expression of MAGE-antigens in normal tissues and cancer.
International journal of cancer. Journal international du cancer 2000;85(4):460-5.
2000: Y Obata; T Takahashi; J Sakamoto; H Tamaki; S Tominaga; N Hamajima; Y T Chen; Lloyd J Old
SEREX analysis of gastric cancer antigens.
Cancer chemotherapy and pharmacology 2000;46 Suppl():S37-42.
2000: Achim A Jungbluth; Kristin Iversen; Keren Coplan; Denise Kolb; Elisabeth Stockert; Yao-Tseng Chen; Lloyd J Old; Klaus J Busam
T311--an anti-tyrosinase monoclonal antibody for the detection of melanocytic lesions in paraffin embedded tissues.
Pathology, research and practice 2000;196(4):235-42.
1999: John E Park; MC Lenter; R N Zimmermann; Pilar Garin-Chesa; Lloyd J Old; Wolfgang J Rettig
Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts.
The Journal of biological chemistry 1999;274(51):36505-12.
1999: Dirk Jäger; Elisabeth Stockert; Matthew J Scanlan; Ali O Güre; Elke Jäger; Alexander Knuth; Lloyd J Old; Yao-Tseng Chen
Cancer-testis antigens and ING1 tumor suppressor gene product are breast cancer antigens: characterization of tissue-specific ING1 transcripts and a homologue gene.
Cancer research 1999;59(24):6197-204.
1999: Matthew J Scanlan; JD Gordan; Barbara Williamson; Elisabeth Stockert; Neil H Bander; Victor Jongeneel; Ali O Gure; Dirk Jäger; Elke Jäger; Alexander Knuth; Yao-Tseng Chen; Lloyd J Old
Antigens recognized by autologous antibody in patients with renal-cell carcinoma.
International journal of cancer. Journal international du cancer 1999;83(4):456-64.
1999: Elke Jäger; Elisabeth Stockert; Z Zidianakis; Yao-Tseng Chen; Julia Karbach; Dirk Jäger; Michael Arand; Gerd Ritter; Lloyd J Old; Alexander Knuth
Humoral immune responses of cancer patients against "Cancer-Testis" antigen NY-ESO-1: correlation with clinical events.
International journal of cancer. Journal international du cancer 1999;84(5):506-10.
1999: Achim A Jungbluth; Kristin Iversen; Keren Coplan; Barbara Williamson; Yao-Tseng Chen; Elisabeth Stockert; Lloyd J Old; Klaus J Busam
Expression of melanocyte-associated markers gp-100 and Melan-A/MART-1 in angiomyolipomas. An immunohistochemical and rt-PCR analysis.
Virchows Archiv : an international journal of pathology 1999;434(5):429-35.
1999: Matthew J Scanlan; Barbara Williamson; Achim Jungbluth; Elisabeth Stockert; Karen C Arden; Carrie Viars; Ali O Gure; JD Gordan; Yao-Tseng Chen; Lloyd J Old
Isoforms of the human PDZ-73 protein exhibit differential tissue expression.
Biochimica et biophysica acta 1999;1445(1):39-52.
1999: T S Doi; M W Marino; Toshitada Takahashi; T Yoshida; T Sakakura; Lloyd J Old; Y Obata
Absence of tumor necrosis factor rescues RelA-deficient mice from embryonic lethality.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(6):2994-9.
1999: Y T Chen; Lloyd J Old
Cancer-testis antigens: targets for cancer immunotherapy.
The cancer journal from Scientific American 1999;5(1):16-7.
1998: Y Noguchi; H Wada; MW Marino; Lloyd J Old
Regulation of IFN-gamma production in granulocyte-macrophage colony-stimulating factor-deficient mice.
European journal of immunology 1998;28(12):3980-8.
1998: Chaitanya R Divgi; Neil H Bander; Andrew M Scott; Joseph A O'Donoghue; George Sgouros; Sydney Welt; Ronald D Finn; F Morrissey; P Capitelli; J M Williams; Devie Deland; A Nakhre; Egbert Oosterwijk; S Gulec; MC Graham; Steven M Larson; Lloyd J Old
Phase I/II radioimmunotherapy trial with iodine-131-labeled monoclonal antibody G250 in metastatic renal cell carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(11):2729-39.
1998: Ugur Sahin; Ozlem Türeci; Y T Chen; G Seitz; Carlos Villena-Heinsen; Lloyd J Old; M Pfreundschuh
Expression of multiple cancer/testis (CT) antigens in breast cancer and melanoma: basis for polyvalent CT vaccine strategies.
International journal of cancer. Journal international du cancer 1998;78(3):387-9.
1998: Scott J Rodig; D Kaplan; Vijay Shankaran; Lloyd J Old; Robert D Schreiber
Signaling and signaling dysfunction through the interferon gamma receptor.
European cytokine network 1998;9(3 Suppl):49-53.
1998: Alfred M Cohen; Pilar Garin-Chesa; M Hanson; K Weyhrauch; Nancy Kemeny; Yuman Fong; Philip B Paty; Sydney Welt; Lloyd J Old
In vitro detection of occult bone marrow metastases in patients with colorectal cancer hepatic metastases.
Diseases of the colon and rectum 1998;41(9):1112-5.
1998: Bruno Catimel; Andrew M Scott; Fook-Thean Lee; Nobuo Hanai; Gerd Ritter; Sydney Welt; Lloyd J Old; Antony W Burgess; Edouard C Nice
Direct immobilization of gangliosides onto gold-carboxymethyldextran sensor surfaces by hydrophobic interaction: applications to antibody characterization.
Glycobiology 1998;8(9):927-38.
1998: Klaus J Busam; Yao-Tseng Chen; Lloyd J Old; Elisabeth Stockert; Kristin Iversen; Keren Coplan; Juan Rosai; R L Barnhill; Achim A Jungbluth
Expression of melan-A (MART1) in benign melanocytic nevi and primary cutaneous malignant melanoma.
The American journal of surgical pathology 1998;22(8):976-82.
1998: Ozlem Türeci; Yao-Tseng Chen; Ugur Sahin; Ali O Güre; Carsten Zwick; C Villena; S Tsang; Gerhard Seitz; Lloyd J Old; Michael Pfreundschuh
Expression of SSX genes in human tumors.
International journal of cancer. Journal international du cancer 1998;77(1):19-23.
1998: D H Kaplan; Vijay Shankaran; A S Dighe; E Stockert; M Aguet; Lloyd J Old; Robert D Schreiber
Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(13):7556-61.
1998: Yao-Tseng Chen; Ali O Güre; S Tsang; Elisabeth Stockert; Elke Jäger; Alexander Knuth; Lloyd J Old
Identification of multiple cancer/testis antigens by allogeneic antibody screening of a melanoma cell line library.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(12):6919-23.
1998: Matthew J Scanlan; Yao-Tseng Chen; Barbara Williamson; Ali O Gure; Elisabeth Stockert; JD Gordan; Ozlem Türeci; Ugur Sahin; Michael Pfreundschuh; Lloyd J Old
Characterization of human colon cancer antigens recognized by autologous antibodies.
International journal of cancer. Journal international du cancer 1998;76(5):652-8.
1998: Achim A Jungbluth; Klaus J Busam; William L Gerald; Elisabeth Stockert; Keren Coplan; Kristin Iversen; D P MacGregor; Lloyd J Old; Yao-Tseng Chen
A103: An anti-melan-a monoclonal antibody for the detection of malignant melanoma in paraffin-embedded tissues.
The American journal of surgical pathology 1998;22(5):595-602.
1998: Elisabeth Stockert; Elke Jäger; Yao-Tseng Chen; Matthew J Scanlan; Ivan T Gout; Julia Karbach; Michael Arand; Alexander Knuth; Lloyd J Old
A survey of the humoral immune response of cancer patients to a panel of human tumor antigens.
The Journal of experimental medicine 1998;187(8):1349-54.
1998: Lloyd J Old; Yao-Tseng Chen
New paths in human cancer serology.
The Journal of experimental medicine 1998;187(8):1163-7.
1998: Robert L Moritz; G Ritter; Bruno Catimel; L S Cohen; Sydney Welt; Lloyd J Old; Antony W Burgess; Edouard C Nice; R J Simpson
Micro-sequencing strategies for the human A33 antigen, a novel surface glycoprotein of human gastrointestinal epithelium.
Journal of chromatography. A 1998;798(1-2):91-101.
1998: A Loh; George Sgouros; Joseph A O'Donoghue; Devie Deland; Dev R Puri; P Capitelli; John L Humm; Steven M Larson; Lloyd J Old; Chaitanya R Divgi
Pharmacokinetic model of iodine-131-G250 antibody in renal cell carcinoma patients.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1998;39(3):484-9.
1998: Ali O Güre; Nasser K Altorki; Elisabeth Stockert; Matthew J Scanlan; Lloyd J Old; Yao-Tseng Chen
Human lung cancer antigens recognized by autologous antibodies: definition of a novel cDNA derived from the tumor suppressor gene locus on chromosome 3p21.3.
Cancer research 1998;58(5):1034-41.
1998: Elke Jäger; Yao-Tseng Chen; J W Drijfhout; Julia Karbach; Mark Ringhoffer; Dirk Jäger; Michael Arand; H Wada; Y Noguchi; Elisabeth Stockert; Lloyd J Old; Alexander Knuth
Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes.
The Journal of experimental medicine 1998;187(2):265-70.
1998: EC Barendswaard; Andrew M Scott; Chaitanya R Divgi; Clarence Williams; K Coplan; E Riedel; Tzy-Jyun Yao; Otto A Gansow; Ronald D Finn; Steven M Larson; Lloyd J Old; Sydney Welt
Rapid and specific targeting of monoclonal antibody A33 to a colon cancer xenograft in nude mice.
International journal of oncology 1998;12(1):45-53.
1998: J Liu; MW Marino; G Wong; Dianne Grail; A Dunn; J Bettadapura; AJ Slavin; Lloyd J Old; Claude C A Bernard
TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination.
Nature medicine 1998;4(1):78-83.
1998: Klaus J Busam; Kristin Iversen; Keren Coplan; Lloyd J Old; Elisabeth Stockert; Yao-Tseng Chen; D McGregor; Achim Jungbluth
Immunoreactivity for A103, an antibody to melan-A (Mart-1), in adrenocortical and other steroid tumors.
The American journal of surgical pathology 1998;22(1):57-63.
1997: H Wada; Y Noguchi; MW Marino; A R Dunn; Lloyd J Old
T cell functions in granulocyte/macrophage colony-stimulating factor deficient mice.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(23):12557-61.
1997: Ali O Gure; Ozlem Türeci; Ugur Sahin; S Tsang; Matthew J Scanlan; Elke Jäger; Alexander Knuth; Michael Pfreundschuh; Lloyd J Old; Yao-Tseng Chen
SSX: a multigene family with several members transcribed in normal testis and human cancer.
International journal of cancer. Journal international du cancer 1997;72(6):965-71.
1997: Keith B Elkon; C C Liu; J G Gall; JM Trevejo; MW Marino; K A Abrahamsen; X Song; J L Zhou; Lloyd J Old; RG Crystal; Erik Falck-Pedersen
Tumor necrosis factor alpha plays a central role in immune-mediated clearance of adenoviral vectors.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(18):9814-9.
1997: Gerd Ritter; L S Cohen; Edouard Nice; Bruno Catimel; A W Burgess; R L Moritz; H Ji; J K Heath; S J White; Sydney Welt; Lloyd J Old; R J Simpson
Characterization of posttranslational modifications of human A33 antigen, a novel palmitoylated surface glycoprotein of human gastrointestinal epithelium.
Biochemical and biophysical research communications 1997;236(3):682-6.
1997: Bruno Catimel; Maureen Nerrie; F T Lee; Andrew M Scott; G Ritter; Sydney Welt; Lloyd J Old; Antony W Burgess; Edouard C Nice
Kinetic analysis of the interaction between the monoclonal antibody A33 and its colonic epithelial antigen by the use of an optical biosensor. A comparison of immobilisation strategies.
Journal of chromatography. A 1997;776(1):15-30.
1997: MW Marino; A Dunn; Dianne Grail; M Inglese; Y Noguchi; E Richards; Achim Jungbluth; H Wada; M Moore; Barbara Williamson; S Basu; Lloyd J Old
Characterization of tumor necrosis factor-deficient mice.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(15):8093-8.
1997: Hiroaki Ikeda; Nobuo Ohta; K Furukawa; H Miyazaki; Lijie Wang; Kagemasa Kuribayashi; Lloyd J Old; Hiroshi Shiku
Mutated mitogen-activated protein kinase: a tumor rejection antigen of mouse sarcoma.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(12):6375-9.
1997: Jorg Tschmelitsch; EC Barendswaard; Clarence Williams; Tzy-Jyun Yao; Alfred M Cohen; Lloyd J Old; Sydney Welt
Enhanced antitumor activity of combination radioimmunotherapy (131I-labeled monoclonal antibody A33) with chemotherapy (fluorouracil).
Cancer research 1997;57(11):2181-6.
1997: J Niedermeyer; M J Scanlan; Pilar Garin-Chesa; C Daiber; H H Fiebig; Lloyd J Old; Wolfgang J Rettig; Andreas Schnapp
Mouse fibroblast activation protein: molecular cloning, alternative splicing and expression in the reactive stroma of epithelial cancers.
International journal of cancer. Journal international du cancer 1997;71(3):383-9.
1997: Yao-Tseng Chen; Matthew J Scanlan; Ugur Sahin; Ozlem Türeci; Ali O Gure; S Tsang; Barbara Williamson; Elisabeth Stockert; Michael Pfreundschuh; Lloyd J Old
A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(5):1914-8.
1997: Hong Ji; Robert L Moritz; Gavin E Reid; Gerd Ritter; Bruno Catimel; Edouard C Nice; Joan K Heath; Sara J White; Sydney Welt; Lloyd J Old; Antony W Burgess; Richard J Simpson
Electrophoretic analysis of the novel antigen for the gastrointestinal-specific monoclonal antibody, A33.
Electrophoresis 1997;18(3-4):614-21.
1997: Joan K Heath; Sara J White; Cameron N Johnstone; Bruno Catimel; Richard J Simpson; Robert L Moritz; G F Tu; H Ji; RH Whitehead; L C Groenen; Andrew M Scott; Gerd Ritter; L Cohen; Sydney Welt; Lloyd J Old; Edouard C Nice; Antony W Burgess
The human A33 antigen is a transmembrane glycoprotein and a novel member of the immunoglobulin superfamily.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(2):469-74.
1997: Yao-Tseng Chen; Antonia D Boyer; Carrie Viars; S Tsang; Lloyd J Old; Karen C Arden
Genomic cloning and localization of CTAG, a gene encoding an autoimmunogenic cancer-testis antigen NY-ESO-1, to human chromosome Xq28.
Cytogenetics and cell genetics 1997;79(3-4):237-40.
1996: Yoshikazu Noguchi; A Jungbluth; E C Richards; Lloyd J Old
Effect of interleukin 12 on tumor induction by 3-methylcholanthrene.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(21):11798-801.
1996: Bruno Catimel; Gerd Ritter; Sydney Welt; Lloyd J Old; L Cohen; M A Nerrie; Sara J White; Joan K Heath; B Demediuk; T Domagala; F T Lee; A M Scott; G F Tu; Hong Ji; Robert L Moritz; Richard J Simpson; Antony W Burgess; Edouard C Nice
Purification and characterization of a novel restricted antigen expressed by normal and transformed human colonic epithelium.
The Journal of biological chemistry 1996;271(41):25664-70.
1996: Lloyd J Old
Immunotherapy for cancer.
Scientific American 1996;275(3):136-43.
1996: P Antoniw; A P Farnsworth; A Turner; A M Haines; A Mountain; J Mackintosh; D Shochat; John L Humm; Sydney Welt; Lloyd J Old; G T Yarranton; D J King
Radioimmunotherapy of colorectal carcinoma xenografts in nude mice with yttrium-90 A33 IgG and Tri-Fab (TFM).
British journal of cancer 1996;74(4):513-24.
1996: Yao-Tseng Chen; Elisabeth Stockert; A Jungbluth; S Tsang; Keren Coplan; Matthew J Scanlan; Lloyd J Old
Serological analysis of Melan-A(MART-1), a melanocyte-specific protein homogeneously expressed in human melanomas.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(12):5915-9.
1996: F Daghighian; EC Barendswaard; Sydney Welt; John L Humm; A Scott; M C Willingham; E McGuffie; Lloyd J Old; Steven M Larson
Enhancement of radiation dose to the nucleus by vesicular internalization of iodine-125-labeled A33 monoclonal antibody.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(6):1052-7.
1996: Sydney Welt; A M Scott; Chaitanya R Divgi; Nancy Kemeny; Ronald D Finn; F Daghighian; Jean St Germain; E C Richards; Steven M Larson; Lloyd J Old
Phase I/II study of iodine 125-labeled monoclonal antibody A33 in patients with advanced colon cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(6):1787-97.
1996: G Ritter; S R Fortunato; L Cohen; Y Noguchi; EM Bernard; Elisabeth Stockert; Lloyd J Old
Induction of antibodies reactive with GM2 ganglioside after immunization with lipopolysaccharides from Camplyobacter jejuni.
International journal of cancer. Journal international du cancer 1996;66(2):184-90.
1995: G Ritter; E Ritter-Boosfeld; R Adluri; M Calves; S Ren; Robert K Yu; H F Oettgen; Lloyd J Old; Philip O Livingston
Analysis of the antibody response to immunization with purified O-acetyl GD3 gangliosides in patients with malignant melanoma.
International journal of cancer. Journal international du cancer 1995;62(6):668-72.
1995: Yao-Tseng Chen; Elisabeth Stockert; S Tsang; Keren Coplan; Lloyd J Old
Immunophenotyping of melanomas for tyrosinase: implications for vaccine development.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(18):8125-9.
1995: P C Brenner; Wolfgang J Rettig; M P Sanz-Moncasi; Victor E Reuter; Armen G Aprikian; Lloyd J Old; W R Fair; Pilar Garin-Chesa
TAG-72 expression in primary, metastatic and hormonally treated prostate cancer as defined by monoclonal antibody CC49.
The Journal of urology 1995;153(5):1575-9.
1995: K Kitamura; Philip O Livingston; S R Fortunato; Elisabeth Stockert; F Helling; G Ritter; H F Oettgen; Lloyd J Old
Serological response patterns of melanoma patients immunized with a GM2 ganglioside conjugate vaccine.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(7):2805-9.
1995: Yoshikazu Noguchi; E C Richards; Yao-Tseng Chen; Lloyd J Old
Influence of interleukin 12 on p53 peptide vaccination against established Meth A sarcoma.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(6):2219-23.
1995: S Mathew; Matthew J Scanlan; B K Mohan Raj; Vundavalli Murty; Pilar Garin-Chesa; Lloyd J Old; Wolfgang J Rettig; Raju S K Chaganti
The gene for fibroblast activation protein alpha (FAP), a putative cell surface-bound serine protease expressed in cancer stroma and wound healing, maps to chromosome band 2q23.
Genomics 1995;25(1):335-7.
1994: K Kitamura; Elisabeth Stockert; Pilar Garin-Chesa; Sydney Welt; K O Lloyd; Kathryn Armour; T P Wallace; william harris; F J Carr; Lloyd J Old
Specificity analysis of blood group Lewis-y (Le(y)) antibodies generatedagainst synthetic and natural Le(y) determinants.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(26):12957-61.
1994: M P Sanz-Moncasi; Pilar Garin-Chesa; Elisabeth Stockert; E A Jaffe; Lloyd J Old; Wolfgang J Rettig
Identification of a high molecular weight endothelial cell surface glycoprotein, endoGlyx-1, in normal and tumor blood vessels.
Laboratory investigation; a journal of technical methods and pathology 1994;71(3):366-73.
1994: A S Dighe; E Richards; Lloyd J Old; Robert D Schreiber
Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFN gamma receptors.
Immunity 1994;1(6):447-56.
1994: Wolfgang J Rettig; S L Su; S R Fortunato; Matthew J Scanlan; B K Raj; Pilar Garin-Chesa; John Healey; Lloyd J Old
Fibroblast activation protein: purification, epitope mapping and induction by growth factors.
International journal of cancer. Journal international du cancer 1994;58(3):385-92.
1994: Matthew J Scanlan; B K Raj; Benjamin F Calvo; Pilar Garin-Chesa; M P Sanz-Moncasi; John Healey; Lloyd J Old; Wolfgang J Rettig
Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(12):5657-61.
1994: Sydney Welt; Chaitanya R Divgi; A M Scott; Pilar Garin-Chesa; Ronald D Finn; M Graham; E A Carswell; A Cohen; Steven M Larson; Lloyd J Old
Antibody targeting in metastatic colon cancer: a phase I study of monoclonal antibody F19 against a cell-surface protein of reactive tumor stromal fibroblasts.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(6):1193-203.
1994: L Xu; Y T Chen; A G Huvos; I M Zlotolow; Wolfgang J Rettig; Lloyd J Old; Pilar Garin-Chesa
Overexpression of p53 protein in squamous cell carcinomas of head and neck without apparent gene mutations.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 1994;3(2):83-92.
1994: Yoshikazu Noguchi; Yao-Tseng Chen; Lloyd J Old
A mouse mutant p53 product recognized by CD4+ and CD8+ T cells.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(8):3171-5.
1994: P C Caron; Joseph G Jurcic; A M Scott; Ronald D Finn; Chaitanya R Divgi; MC Graham; I M Jureidini; George Sgouros; D Tyson; Lloyd J Old
A phase 1B trial of humanized monoclonal antibody M195 (anti-CD33) in myeloid leukemia: specific targeting without immunogenicity.
Blood 1994;83(7):1760-8.
1994: A Morita; T Takahashi; E Stockert; E Nakayama; T Tsuji; Y Matsudaira; Lloyd J Old; Y Obata
TL antigen as a transplantation antigen recognized by TL-restricted cytotoxic T cells.
The Journal of experimental medicine 1994;179(3):777-84.
1994: Yao-Tseng Chen; Elisabeth Stockert; Y Chen; Pilar Garin-Chesa; Wolfgang J Rettig; Pierre van der Bruggen; T Boon; Lloyd J Old
Identification of the MAGE-1 gene product by monoclonal and polyclonal antibodies.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(3):1004-8.
1993: M S Czuczman; David J Straus; Chaitanya R Divgi; M Graham; Pilar Garin-Chesa; Ronald Finn; J Myers; Lloyd J Old; Steven M Larson; David A Scheinberg
Phase I dose-escalation trial of iodine 131-labeled monoclonal antibody OKB7 in patients with non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(10):2021-9.
1993: Wolfgang J Rettig; Pilar Garin-Chesa; John Healey; S L Su; H L Ozer; M Schwab; Anthony P Albino; Lloyd J Old
Regulation and heteromeric structure of the fibroblast activation protein in normal and transformed cells of mesenchymal and neuroectodermal origin.
Cancer research 1993;53(14):3327-35.
1993: Pilar Garin-Chesa; I Campbell; P E Saigo; J L Lewis; Lloyd J Old; Wolfgang J Rettig
Trophoblast and ovarian cancer antigen LK26. Sensitivity and specificity in immunopathology and molecular identification as a folate-binding protein.
The American journal of pathology 1993;142(2):557-67.
1993: M A Schwartz; D R Lovett; Arlene Redner; Ronald D Finn; MC Graham; Chaitanya R Divgi; L Dantis; T S Gee; M Andreeff; Lloyd J Old
Dose-escalation trial of M195 labeled with iodine 131 for cytoreduction and marrow ablation in relapsed or refractory myeloid leukemias.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(2):294-303.
1992: Wolfgang J Rettig; Pilar Garin-Chesa; John Healey; S L Su; E A Jaffe; Lloyd J Old
Identification of endosialin, a cell surface glycoprotein of vascular endothelial cells in human cancer.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(22):10832-6.
1992: Kevin P O'Boyle; R Zamore; S Adluri; A Cohen; Nancy Kemeny; Sydney Welt; Kenneth O Lloyd; H F Oettgen; Lloyd J Old; Philip O Livingston
Immunization of colorectal cancer patients with modified ovine submaxillary gland mucin and adjuvants induces IgM and IgG antibodies to sialylated Tn.
Cancer research 1992;52(20):5663-7.
1992: Lloyd J Old
Tumor immunology: the first century.
Current opinion in immunology 1992;4(5):603-7.
1992: Catia Traversari; Pierre van der Bruggen; Benoît J Van den Eynde; P Hainaut; C Lemoine; N Ohta; Lloyd J Old; Thierry Boon
Transfection and expression of a gene coding for a human melanoma antigen recognized by autologous cytolytic T lymphocytes.
Immunogenetics 1992;35(3):145-52.
1991: A Kalisiak; J G Minniti; Egbert Oosterwijk; Lloyd J Old; David A Scheinberg
Neutral glycosphingolipid expression in B-cell neoplasms.
International journal of cancer. Journal international du cancer 1991;49(6):837-45.
1991: Richard J Cote; Paul Peter Rosen; M L Lesser; Lloyd J Old; M P Osborne
Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(10):1749-56.
1991: Egbert Oosterwijk; A Kalisiak; J C Wakka; David A Scheinberg; Lloyd J Old
Monoclonal antibodies against Gal alpha 1-4Gal beta 1-4Glc (Pk, CD77) produced with a synthetic glycoconjugate as immunogen: reactivity with carbohydrates, with fresh frozen human tissues and hematopoietic tumors.
International journal of cancer. Journal international du cancer 1991;48(6):848-54.
1991: G Ritter; E Boosfeld; R Adluri; M Calves; H F Oettgen; Lloyd J Old; Philip O Livingston
Antibody response to immunization with ganglioside GD3 and GD3 congeners (lactones, amide and gangliosidol) in patients with malignant melanoma.
International journal of cancer. Journal international du cancer 1991;48(3):379-85.
1991: Michael P Osborne; G Y Wong; S Asina; Lloyd J Old; Richard J Cote; Paul Peter Rosen
Sensitivity of immunocytochemical detection of breast cancer cells in human bone marrow.
Cancer research 1991;51(10):2706-9.
1991: A Kalisiak; Egbert Oosterwijk; J G Minniti; Lloyd J Old; David A Scheinberg
A monoclonal antibody for terminal beta-galactose. Use in analysis of glycosphingolipids.
Glycoconjugate journal 1991;8(1):55-62.
1991: Marcello Siniscalco; I Oberlé; P Melis; B Alhadeff; J Murray; G Filippi; T Mattioni; Y T Chen; Henry Furneaux; Lloyd J Old
Physical and genetic mapping of the CDR gene with particular reference to its position with respect to the FRAXA site.
American journal of medical genetics 1991;38(2-3):357-62.
1990: G Ritter; E Boosfeld; M J Calves; H F Oettgen; Lloyd J Old; Philip O Livingston
Antibody response to immunization with purified GD3 ganglioside and GD3 derivatives (lactones, amide and gangliosidol) in the mouse.
Immunobiology 1990;182(1):32-43.
1990: Pilar Garin-Chesa; Lloyd J Old; Wolfgang J Rettig
Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(18):7235-9.
1990: T Ebert; Neil H Bander; CL Finstad; R D Ramsawak; Lloyd J Old
Establishment and characterization of human renal cancer and normal kidney cell lines.
Cancer research 1990;50(17):5531-6.
1990: ROBERT G MAKI; Lloyd J Old; Pramod K Srivastava
Human homologue of murine tumor rejection antigen gp96: 5'-regulatory and coding regions and relationship to stress-induced proteins.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(15):5658-62.
1990: David A Scheinberg; David J Straus; Samuel D J Yeh; Chaitanya R Divgi; Pilar Garin-Chesa; M Graham; K Pentlow; Daniel G Coit; H F Oettgen; Lloyd J Old
A phase I toxicity, pharmacology, and dosimetry trial of monoclonal antibody OKB7 in patients with non-Hodgkin's lymphoma: effects of tumor burden and antigen expression.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(5):792-803.
1990: H Yamaguchi; K Furukawa; S R Fortunato; Philip O Livingston; Kenneth O Lloyd; H F Oettgen; Lloyd J Old
Human monoclonal antibody with dual GM2/GD2 specificity derived from an immunized melanoma patient.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(9):3333-7.
1990: Yao-Tseng Chen; Wolfgang J Rettig; A K Yenamandra; C A Kozak; Raju S K Chaganti; Jerome B Posner; Lloyd J Old
Cerebellar degeneration-related antigen: a highly conserved neuroectodermal marker mapped to chromosomes X in human and mouse.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(8):3077-81.
1990: G Ritter; E Boosfeld; E Markstein; Robert K Yu; S L Ren; W B Stallcup; H F Oettgen; Lloyd J Old; Philip O Livingston
Biochemical and serological characteristics of natural 9-O-acetyl GD3 from human melanoma and bovine buttermilk and chemically O-acetylated GD3.
Cancer research 1990;50(5):1403-10.
1989: Philip O Livingston; G Ritter; P Srivastava; M Padavan; M J Calves; H F Oettgen; Lloyd J Old
Characterization of IgG and IgM antibodies induced in melanoma patients by immunization with purified GM2 ganglioside.
Cancer research 1989;49(24 Pt 1):7045-50.
1989: M Xu; Francisco X Real; Sydney Welt; M H Schüssler; H F Oettgen; Lloyd J Old
Expression of TAG-72 in normal colon, transitional mucosa, and colon cancer.
International journal of cancer. Journal international du cancer 1989;44(6):985-9.
1989: Neil H Bander; CL Finstad; Carlos Cordon-Cardo; R D Ramsawak; E D Vaughan; W F Whitmore; H F Oettgen; M R Melamed; Lloyd J Old
Analysis of a mouse monoclonal antibody that reacts with a specific region of the human proximal tubule and subsets renal cell carcinomas.
Cancer research 1989;49(23):6774-80.
1989: N Hamasima; T Takahashi; O Taguchi; Y Nishizuka; E Stockert; Lloyd J Old; Y Obata
Expression of TL, H-2, and chimeric H-2/TL genes in transgenic mice: abnormal thymic differentiation and T-cell lymphomas in a TL transgenic strain.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(20):7995-9.
1989: Kenneth O Lloyd; Lloyd J Old
Human monoclonal antibodies to glycolipids and other carbohydrate antigens: dissection of the humoral immune response in cancer patients.
Cancer research 1989;49(13):3445-51.
1989: David A Scheinberg; M Tanimoto; S McKenzie; Annabel Strife; Lloyd J Old; Bayard Clarkson
Monoclonal antibody M195: a diagnostic marker for acute myelogenous leukemia.
Leukemia 1989;3(6):440-5.
1989: M Tanimoto; David A Scheinberg; C Cordon-Cardo; D Huie; Bayard Clarkson; Lloyd J Old
Restricted expression of an early myeloid and monocytic cell surface antigen defined by monoclonal antibody M195.
Leukemia 1989;3(5):339-48.
1989: Michael P Osborne; S Asina; G Y Wong; Lloyd J Old; Richard J Cote
Immunofluorescent monoclonal antibody detection of breast cancer in bone marrow: sensitivity in a model system.
Cancer research 1989;49(9):2510-3.
1989: Henry Furneaux; E J Dropcho; D Barbut; Yao-Tseng Chen; Marc K Rosenblum; Lloyd J Old; Jerome B Posner
Characterization of a cDNA encoding a 34-kDa Purkinje neuron protein recognized by sera from patients with paraneoplastic cerebellar degeneration.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(8):2873-7.
1989: P K Srivastava; Lloyd J Old
Identification of a human homologue of the murine tumor rejection antigen GP96.
Cancer research 1989;49(6):1341-3.
1989: D Schadendorf; H Yamaguchi; Lloyd J Old; P K Srivastava
A novel heteromorphic human cell surface alloantigen, gp60, defined by a human monoclonal antibody.
Journal of immunology (Baltimore, Md. : 1950) 1989;142(5):1621-5.
1989: Pilar Garin-Chesa; H R Beresford; A Carrato-Mena; H F Oettgen; Lloyd J Old; M R Melamed; Wolfgang J Rettig
Cell surface molecules of human melanoma. Immunohistochemical analysis of the gp57, GD3, and mel-CSPG antigenic systems.
The American journal of pathology 1989;134(2):295-303.
1989: K S Furukawa; K Furukawa; F X Real; Lloyd J Old; K O Lloyd
A unique antigenic epitope of human melanoma is carried on the common melanoma glycoprotein gp95/p97.
The Journal of experimental medicine 1989;169(2):585-90.
1989: Mark T. Jennings; V D Jennings; L L Asadourian; Salah A Ebrahim; C E Klein; Lloyd J Old
Antigenic phenotypes of cultured malignant astrocytomas: identification of lineage-consistent, lineage-independent and putative tumor-restricted antigenic expression.
Journal of the neurological sciences 1989;89(1):79-92.
1989: Mark T. Jennings; V D Jennings; L L Asadourian; Marc K Rosenblum; A P Albino; J G Cairncross; Lloyd J Old
Five novel cell surface antigens of CNS neoplasms.
Journal of the neurological sciences 1989;89(1):63-78.
1989: K Furukawa; H Yamaguchi; H F Oettgen; Lloyd J Old; Kenneth O Lloyd
Two human monoclonal antibodies reacting with the major gangliosides of human melanomas and comparison with corresponding mouse monoclonal antibodies.
Cancer research 1989;49(1):191-6.
1989: W J Rettig; Lloyd J Old
Immunogenetics of human cell surface differentiation.
Annual review of immunology 1989;7():481-511.
1988: K Furukawa; H Yamaguchi; H F Oettgen; Lloyd J Old; Kenneth O Lloyd
Analysis of the expression of N-glycolylneuraminic acid-containing gangliosides in cells and tissues using two human monoclonal antibodies.
The Journal of biological chemistry 1988;263(34):18507-12.
1988: Michel Bazinet; Richard J Cote; Carlos Cordon-Cardo; Andrzej Myc; W R Fair; Lloyd J Old
Immunohistochemical characterization of two monoclonal antibodies, P25.48 and P25.91, which define a new prostate-specific antigen.
Cancer research 1988;48(23):6938-42.
1988: S Vadhan-Raj; Carlos Cordon-Cardo; E Carswell; D Mintzer; L Dantis; C Duteau; M A Templeton; H F Oettgen; Lloyd J Old; Alan N Houghton
Phase I trial of a mouse monoclonal antibody against GD3 ganglioside in patients with melanoma: induction of inflammatory responses at tumor sites.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1988;6(10):1636-48.
1988: B Y Rubin; S L Anderson; R M Lunn; N K Richardson; G R Hellermann; L J Smith; Lloyd J Old
Tumor necrosis factor and IFN induce a common set of proteins.
Journal of immunology (Baltimore, Md. : 1950) 1988;141(4):1180-4.
1988: Sydney Welt; Beatrice W T Yin; K Furukawa; K A Karlsson; Lloyd J Old; Kenneth O Lloyd
Analysis of a mouse monoclonal antibody detecting the H type 1 blood group determinant.
Carbohydrate research 1988;178():333-6.
1988: Carlos Cordon-Cardo; Victor E Reuter; Kenneth O Lloyd; Joel Sheinfeld; W R Fair; Lloyd J Old; M R Melamed
Blood group-related antigens in human urothelium: enhanced expression of precursor, LeX, and LeY determinants in urothelial carcinoma.
Cancer research 1988;48(14):4113-20.
1988: D S Schrump; K Furukawa; H Yamaguchi; Kenneth O Lloyd; Lloyd J Old
Recognition of galactosylgloboside by monoclonal antibodies derived from patients with primary lung cancer.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(12):4441-5.
1988: Francisco X Real; K S Furukawa; M J Mattes; S A Gusik; Carlos Cordon-Cardo; H F Oettgen; Lloyd J Old; Kenneth O Lloyd
Class 1 (unique) tumor antigens of human melanoma: identification of unique and common epitopes on a 90-kDa glycoprotein.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(11):3965-9.
1988: Y Obata; E Stockert; Y T Chen; T Takahashi; Lloyd J Old
Influence of 5' flanking sequences on TL and H-2 expression in transfected L cells.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(10):3541-5.
1988: Richard J Cote; Paul Peter Rosen; T B Hakes; M Sedira; Michel Bazinet; D W Kinne; Lloyd J Old; Michael P Osborne
Monoclonal antibodies detect occult breast carcinoma metastases in the bone marrow of patients with early stage disease.
The American journal of surgical pathology 1988;12(5):333-40.
1988: C E Klein; H L Ozer; F Traganos; J Atzpodien; H F Oettgen; Lloyd J Old
A transformation-associated 130-kD cell surface glycoprotein is growth controlled in normal human cells.
The Journal of experimental medicine 1988;167(5):1684-96.
1988: Wolfgang J Rettig; K H Grzeschik; A K Yenamandra; E Garcia; Lloyd J Old
Definition of selectable cell surface markers for human chromosomes and chromosome segments in rodent-human hybrids.
Somatic cell and molecular genetics 1988;14(3):223-31.
1988: Lloyd J Old
Tumor necrosis factor.
Scientific American 1988;258(5):59-60, 69-75.
1988: Wolfgang J Rettig; Pilar Garin-Chesa; H R Beresford; H F Oettgen; M R Melamed; Lloyd J Old
Cell-surface glycoproteins of human sarcomas: differential expression in normal and malignant tissues and cultured cells.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(9):3110-4.
1988: T M Thomson; Francisco X Real; S Murakami; Carlos Cordon-Cardo; Lloyd J Old; Alan N Houghton
Differentiation antigens of melanocytes and melanoma: analysis of melanosome and cell surface markers of human pigmented cells with monoclonal antibodies.
The Journal of investigative dermatology 1988;90(4):459-66.
1988: P G Chesa; Wolfgang J Rettig; T M Thomson; Lloyd J Old; M R Melamed
Immunohistochemical analysis of nerve growth factor receptor expression in normal and malignant human tissues.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 1988;36(4):383-9.
1988: P K Srivastava; Lloyd J Old
Individually distinct transplantation antigens of chemically induced mouse tumors.
Immunology today 1988;9(3):78-83.
1988: T M Thomson; Wolfgang J Rettig; P G Chesa; S H Green; A C Mena; Lloyd J Old
Expression of human nerve growth factor receptor on cells derived from all three germ layers.
Experimental cell research 1988;174(2):533-9.
1988: Wolfgang J Rettig; P G Chesa; H R Beresford; M R Melamed; Lloyd J Old
Definition of an extracellular matrix protein in rostral portions of the human central nervous system.
Brain research 1988;438(1-2):315-22.
1988: P K Srivastava; C A Kozak; Lloyd J Old
Chromosomal assignment of the gene encoding the mouse tumor rejection antigen gp96.
Immunogenetics 1988;28(3):205-7.
1987: Lloyd J Old
Tumour necrosis factor. Another chapter in the long history of endotoxin.
Nature 1987;330(6149):602-3.
1987: M J Mattes; K Look; K Furukawa; V K Pierce; Lloyd J Old; J L Lewis; Kenneth O Lloyd
Mouse monoclonal antibodies to human epithelial differentiation antigens expressed on the surface of ovarian carcinoma ascites cells.
Cancer research 1987;47(24 Pt 1):6741-50.
1987: M J Mattes; Francisco X Real; K Furukawa; Lloyd J Old; Kenneth O Lloyd
Class 1 (unique) tumor antigens of human melanoma: partial purification and characterization of the FD antigen and analysis of a mouse polyclonal antiserum.
Cancer research 1987;47(24 Pt 1):6614-9.
1987: R R Kantor; M J Mattes; Kenneth O Lloyd; Lloyd J Old; A P Albino
Biochemical analysis of two cell surface glycoprotein complexes, very common antigen 1 and very common antigen 2. Relationship to very late activation T cell antigens.
The Journal of biological chemistry 1987;262(31):15158-65.
1987: R R Kantor; Neil H Bander; CL Finstad; L H Graf; Kenneth O Lloyd; Lloyd J Old; A P Albino
DNA-mediated gene transfer of a human cell surface 170-kilodalton glycoprotein. Evidence for association with an endogenous murine protein.
The Journal of biological chemistry 1987;262(31):15166-71.
1987: C E Klein; Carlos Cordon-Cardo; R Soehnchen; Richard J Cote; H F Oettgen; M Eisinger; Lloyd J Old
Changes in cell surface glycoprotein expression during differentiation of human keratinocytes.
The Journal of investigative dermatology 1987;89(5):500-6.
1987: Sydney Welt; E A Carswell; Carl-Wilhelm Vogel; H F Oettgen; Lloyd J Old
Immune and nonimmune effector functions of IgG3 mouse monoclonal antibody R24 detecting the disialoganglioside GD3 on the surface of melanoma cells.
Clinical immunology and immunopathology 1987;45(2):214-29.
1987: K Welte; G Miller; Paul B Chapman; H Yuasa; E Natoli; J E Kunicka; Carlos Cordon-Cardo; C Buhrer; Lloyd J Old; Alan N Houghton
Stimulation of T lymphocyte proliferation by monoclonal antibodies against GD3 ganglioside.
Journal of immunology (Baltimore, Md. : 1950) 1987;139(6):1763-71.
1987: N C Dracopoli; B Alhadeff; Alan N Houghton; Lloyd J Old
Loss of heterozygosity at autosomal and X-linked loci during tumor progression in a patient with melanoma.
Cancer research 1987;47(15):3995-4000.
1987: E J Dropcho; Y T Chen; Jerome B Posner; Lloyd J Old
Cloning of a brain protein identified by autoantibodies from a patient with paraneoplastic cerebellar degeneration.
Proceedings of the National Academy of Sciences of the United States of America 1987;84(13):4552-6.
1987: Wolfgang J Rettig; H Nishimura; A K Yenamandra; T Seki; Fumiko Obata; H R Beresford; Lloyd J Old; J Silver
Differential expression of the human Thy-1 gene in rodent-human somatic cell hybrids [corrected].
Journal of immunology (Baltimore, Md. : 1950) 1987;138(12):4484-9.
1987: S Welt; M J Mattes; R Grando; T M Thomson; R W Leonard; Pat Zanzonico; R E Bigler; S Yeh; H F Oettgen; Lloyd J Old
Monoclonal antibody to an intracellular antigen images human melanoma transplants in nu/nu mice.
Proceedings of the National Academy of Sciences of the United States of America 1987;84(12):4200-4.
1987: P K Srivastava; Y T Chen; Lloyd J Old
5'-structural analysis of genes encoding polymorphic antigens of chemically induced tumors.
Proceedings of the National Academy of Sciences of the United States of America 1987;84(11):3807-11.
1987: P G Chesa; Wolfgang J Rettig; M R Melamed; Lloyd J Old; H L Niman
Expression of p21ras in normal and malignant human tissues: lack of association with proliferation and malignancy.
Proceedings of the National Academy of Sciences of the United States of America 1987;84(10):3234-8.
1987: Philip O Livingston; E J Natoli; M J Calves; Elisabeth Stockert; H F Oettgen; Lloyd J Old
Vaccines containing purified GM2 ganglioside elicit GM2 antibodies in melanoma patients.
Proceedings of the National Academy of Sciences of the United States of America 1987;84(9):2911-5.
1987: H Yamaguchi; K Furukawa; S R Fortunato; Philip O Livingston; Kenneth O Lloyd; H F Oettgen; Lloyd J Old
Cell-surface antigens of melanoma recognized by human monoclonal antibodies.
Proceedings of the National Academy of Sciences of the United States of America 1987;84(8):2416-20.
1987: Lloyd J Old
Tumour necrosis factor. Polypeptide mediator network.
Nature 1987;326(6111):330-1.
1987: Zbigniew Darzynkiewicz; S P Carter; Lloyd J Old
Effect of recombinant tumor necrosis factor on HL-60 cells: cell-cycle specificity and synergism with actinomycin D.
Journal of cellular physiology 1987;130(3):328-35.
1987: Alan N Houghton; F X Real; L J Davis; C Cordon-Cardo; Lloyd J Old
Phenotypic heterogeneity of melanoma. Relation to the differentiation program of melanoma cells.
The Journal of experimental medicine 1987;165(3):812-29.
1987: Wolfgang J Rettig; B A Spengler; P G Chesa; Lloyd J Old; J L Biedler
Coordinate changes in neuronal phenotype and surface antigen expression in human neuroblastoma cell variants.
Cancer research 1987;47(5):1383-9.
1987: J David Brook; H R Beresford; D J Shaw; Lloyd J Old; Wolfgang J Rettig
Localisation on human chromosome 19 of three genes for cell surface antigens defined by monoclonal antibodies.
Cytogenetics and cell genetics 1987;45(3-4):156-62.
1987: Y T Chen; Y Obata; E Stockert; T Takahashi; Lloyd J Old
Tla-region genes and their products.
Immunologic research 1987;6(1-2):30-45.
1987: N E Tolkoff-Rubin; R E Thompson; D J Piper; W P Hansen; Neil H Bander; C Cordon-Cardo; C J Finstad; L H Klotz; Lloyd J Old; Robert Rubin
Diagnosis of renal proximal tubular injury by urinary immunoassay for a proximal tubular antigen, the adenosine deaminase binding protein.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1987;2(3):143-8.
1987: H F Oettgen; Lloyd J Old
Tumor necrosis factor.
Important advances in oncology 1987;():105-30.
1986: Wolfgang J Rettig; P G Chesa; H R Beresford; H J Feickert; Mark T. Jennings; J Cohen; H F Oettgen; Lloyd J Old
Differential expression of cell surface antigens and glial fibrillary acidic protein in human astrocytoma subsets.
Cancer research 1986;46(12 Pt 1):6406-12.
1986: W J Rettig; Vundavalli Murty; M J Mattes; Raju S K Chaganti; Lloyd J Old
Extracellular matrix-modulated expression of human cell surface glycoproteins A42 and J143. Intrinsic and extrinsic signals determine antigenic phenotype.
The Journal of experimental medicine 1986;164(5):1581-99.
1986: A P Albino; Alan N Houghton; M Eisinger; J S Lee; R R Kantor; A I Oliff; Lloyd J Old
Class II histocompatibility antigen expression in human melanocytes transformed by Harvey murine sarcoma virus (Ha-MSV) and Kirsten MSV retroviruses.
The Journal of experimental medicine 1986;164(5):1710-22.
1986: Y Fradet; C Cordon-Cardo; W F Whitmore; M R Melamed; Lloyd J Old
Cell surface antigens of human bladder tumors: definition of tumor subsets by monoclonal antibodies and correlation with growth characteristics.
Cancer research 1986;46(10):5183-8.
1986: B Y Rubin; S L Anderson; S A Sullivan; B D Williamson; E A Carswell; Lloyd J Old
Nonhematopoietic cells selected for resistance to tumor necrosis factor produce tumor necrosis factor.
The Journal of experimental medicine 1986;164(4):1350-5.
1986: C Cordon-Cardo; K O Lloyd; CL Finstad; M E McGroarty; Victor E Reuter; Neil H Bander; Lloyd J Old; M R Melamed
Immunoanatomic distribution of blood group antigens in the human urinary tract. Influence of secretor status.
Laboratory investigation; a journal of technical methods and pathology 1986;55(4):444-54.
1986: Wolfgang J Rettig; T M Thomson; B A Spengler; J L Biedler; Lloyd J Old
Assignment of human nerve growth factor receptor gene to chromosome 17 and regulation of receptor expression in somatic cell hybrids.
Somatic cell and molecular genetics 1986;12(5):441-7.
1986: F X Real; Wolfgang J Rettig; P G Chesa; M R Melamed; Lloyd J Old; J Mendelsohn
Expression of epidermal growth factor receptor in human cultured cells and tissues: relationship to cell lineage and stage of differentiation.
Cancer research 1986;46(9):4726-31.
1986: E J Natoli; Philip O Livingston; clifford stuart pukel; K O Lloyd; H Wiegandt; J Szalay; H F Oettgen; Lloyd J Old
A murine monoclonal antibody detecting N-acetyl- and N-glycolyl-GM2: characterization of cell surface reactivity.
Cancer research 1986;46(8):4116-20.
1986: K Haranaka; E A Carswell; B D Williamson; J S Prendergast; N Satomi; Lloyd J Old
Purification, characterization, and antitumor activity of nonrecombinant mouse tumor necrosis factor.
Proceedings of the National Academy of Sciences of the United States of America 1986;83(11):3949-53.
1986: C Cordon-Cardo; K O Lloyd; J Sakamoto; M E McGroarty; Lloyd J Old; M R Melamed
Immunohistologic expression of blood-group antigens in normal human gastrointestinal tract and colonic carcinoma.
International journal of cancer. Journal international du cancer 1986;37(5):667-76.
1986: Richard J Cote; D M Morrissey; Alan N Houghton; T M Thomson; M E Daly; H F Oettgen; Lloyd J Old
Specificity analysis of human monoclonal antibodies reactive with cell surface and intracellular antigens.
Proceedings of the National Academy of Sciences of the United States of America 1986;83(9):2959-63.
1986: P K Srivastava; A B DeLeo; Lloyd J Old
Tumor rejection antigens of chemically induced sarcomas of inbred mice.
Proceedings of the National Academy of Sciences of the United States of America 1986;83(10):3407-11.
1986: M Panneerselvam; S Welt; Lloyd J Old; Carl-Wilhelm Vogel
A molecular mechanism of complement resistance of human melanoma cells.
Journal of immunology (Baltimore, Md. : 1950) 1986;136(7):2534-41.
1986: W J Rettig; F X Real; B A Spengler; J L Biedler; Lloyd J Old
Human melanoma proteoglycan: expression in hybrids controlled by intrinsic and extrinsic signals.
Science (New York, N.Y.) 1986;231(4743):1281-4.
1986: J Sakamoto; K Furukawa; C Cordon-Cardo; B W Yin; W J Rettig; H F Oettgen; Lloyd J Old; K O Lloyd
Expression of Lewisa, Lewisb, X, and Y blood group antigens in human colonic tumors and normal tissue and in human tumor-derived cell lines.
Cancer research 1986;46(3):1553-61.
1986: N C Dracopoli; W J Rettig; G K Whitfield; G J Darlington; B A Spengler; J L Biedler; Lloyd J Old; I A Kourides
Assignment of the gene for the beta subunit of thyroid-stimulating hormone to the short arm of human chromosome 1.
Proceedings of the National Academy of Sciences of the United States of America 1986;83(6):1822-6.
1986: H Morishita; H Shiku; K Horibe; Y Obata; E Stockert; H F Oettgen; Lloyd J Old; K Yamada
Cell surface antigens of murine leukemias induced by radiation leukemia virus. Recognition of individually distinct cell surface antigens by cytotoxic T cells on leukemias expressing crossreactive transplantation antigens.
The Journal of experimental medicine 1986;163(2):452-7.
1986: W J Rettig; N C Dracopoli; B A Spengler; J H Kersey; J L Biedler; Lloyd J Old
Cell-surface antigens determined by human chromosomes 1 and 12: comparative serological and somatic cell genetic analysis of eight antigenic systems.
Somatic cell and molecular genetics 1986;12(1):33-40.
1986: Zbigniew Darzynkiewicz; L Staiano-Coico; J E Kunicka; A B DeLeo; Lloyd J Old
p53 content in relation to cell growth and proliferation in murine L1210 leukemia and normal lymphocytes.
Leukemia research 1986;10(12):1383-9.
1985: Lloyd J Old
Tumor necrosis factor (TNF).
Science (New York, N.Y.) 1985;230(4726):630-2.
1985: Philip O Livingston; K Kaelin; C M Pinsky; H F Oettgen; Lloyd J Old
The serologic response of patients with stage II melanoma to allogeneic melanoma cell vaccines.
Cancer 1985;56(9):2194-200.
1985: M J Mattes; K Look; J L Lewis; Lloyd J Old; K O Lloyd
Three mouse monoclonal antibodies to human differentiation antigens: reactivity with two mucin-like antigens and with connective tissue fibers.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 1985;33(11):1095-102.
1985: Wolfgang J Rettig; N C Dracopoli; P G Chesa; B A Spengler; H R Beresford; P Davies; J L Biedler; Lloyd J Old
Role of human chromosome 11 in determining surface antigenic phenotype of normal and malignant cells. Somatic cell genetic analysis of eight antigens, including putative human Thy-1.
The Journal of experimental medicine 1985;162(5):1603-19.
1985: J L Huffman; Y Fradet; C Cordon-Cardo; Harry W Herr; C M Pinsky; H F Oettgen; Lloyd J Old; W F Whitmore; M R Melamed
Effect of intravesical Bacillus Calmette-Guérin on detection of a urothelial differentiation antigen in exfoliated cells of carcinoma in situ of the human urinary bladder.
Cancer research 1985;45(10):5201-4.
1985: Wolfgang J Rettig; P G Chesa; Mark T. Jennings; B A Spengler; M R Melamed; H F Oettgen; J L Biedler; Lloyd J Old
Cell surface antigen of human neuroblastomas is related to nuclear antigen of normal cells.
Proceedings of the National Academy of Sciences of the United States of America 1985;82(20):6894-8.
1985: B Y Rubin; S L Anderson; S A Sullivan; B D Williamson; E A Carswell; Lloyd J Old
Purification and characterization of a human tumor necrosis factor from the LuKII cell line.
Proceedings of the National Academy of Sciences of the United States of America 1985;82(19):6637-41.
1985: Y T Chen; Y Obata; E Stockert; Lloyd J Old
Thymus-leukemia (TL) antigens of the mouse. Analysis of TL mRNA and TL cDNA TL+ and TL- strains.
The Journal of experimental medicine 1985;162(4):1134-48.
1985: M Eisinger; O Marko; S Ogata; Lloyd J Old
Growth regulation of human melanocytes: mitogenic factors in extracts of melanoma, astrocytoma, and fibroblast cell lines.
Science (New York, N.Y.) 1985;229(4717):984-6.
1985: F X Real; Alan N Houghton; A P Albino; C Cordon-Cardo; M R Melamed; H F Oettgen; Lloyd J Old
Surface antigens of melanomas and melanocytes defined by mouse monoclonal antibodies: specificity analysis and comparison of antigen expression in cultured cells and tissues.
Cancer research 1985;45(9):4401-11.
1985: B Y Rubin; S L Anderson; S A Sullivan; B D Williamson; E A Carswell; Lloyd J Old
High affinity binding of 125I-labeled human tumor necrosis factor (LuKII) to specific cell surface receptors.
The Journal of experimental medicine 1985;162(3):1099-104.
1985: Philip O Livingston; M Jones; A B Deleo; H F Oettgen; Lloyd J Old
The serologic response to Meth A sarcoma vaccines after cyclophosphamide treatment is additionally increased by various adjuvants.
Journal of immunology (Baltimore, Md. : 1950) 1985;135(2):1505-9.
1985: T M Thomson; M J Mattes; L Roux; Lloyd J Old; K O Lloyd
Pigmentation-associated glycoprotein of human melanomas and melanocytes: definition with a mouse monoclonal antibody.
The Journal of investigative dermatology 1985;85(2):169-74.
1985: Y Obata; Y T Chen; E Stockert; Lloyd J Old
Structural analysis of TL genes of the mouse.
Proceedings of the National Academy of Sciences of the United States of America 1985;82(16):5475-9.
1985: CL Finstad; C Cordon-Cardo; Neil H Bander; W F Whitmore; M R Melamed; Lloyd J Old
Specificity analysis of mouse monoclonal antibodies defining cell surface antigens of human renal cancer.
Proceedings of the National Academy of Sciences of the United States of America 1985;82(9):2955-9.
1985: W J Rettig; C Cordon-Cardo; J P Koulos; J L Lewis; H F Oettgen; Lloyd J Old
Cell surface antigens of human trophoblast and choriocarcinoma defined by monoclonal antibodies.
International journal of cancer. Journal international du cancer 1985;35(4):469-75.
1985: A P Albino; L H Graf; R R Kantor; W McLean; S Silagi; Lloyd J Old
DNA-mediated transfer of human melanoma cell surface glycoprotein gp130: identification of transfectants by erythrocyte rosetting.
Molecular and cellular biology 1985;5(4):692-7.
1985: Neil H Bander; C Cordon-Cardo; CL Finstad; W F Whitmore; E D Vaughan; H F Oettgen; M Melamed; Lloyd J Old
Immunohistologic dissection of the human kidney using monoclonal antibodies.
The Journal of urology 1985;133(3):502-5.
1985: N C Dracopoli; Alan N Houghton; Lloyd J Old
Loss of polymorphic restriction fragments in malignant melanoma: implications for tumor heterogeneity.
Proceedings of the National Academy of Sciences of the United States of America 1985;82(5):1470-4.
1985: Philip O Livingston; A P Albino; T J Chung; F X Real; Alan N Houghton; H F Oettgen; Lloyd J Old
Serological response of melanoma patients to vaccines prepared from VSV lysates of autologous and allogeneic cultured melanoma cells.
Cancer 1985;55(4):713-20.
1985: Alan N Houghton; D Mintzer; Carlos Cordon-Cardo; S Welt; B Fliegel; S Vadhan; E Carswell; M R Melamed; H F Oettgen; Lloyd J Old
Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: a phase I trial in patients with malignant melanoma.
Proceedings of the National Academy of Sciences of the United States of America 1985;82(4):1242-6.
1985: W J Rettig; C Cordon-Cardo; J S Ng; H F Oettgen; Lloyd J Old; K O Lloyd
High-molecular-weight glycoproteins of human teratocarcinoma defined by monoclonal antibodies to carbohydrate determinants.
Cancer research 1985;45(2):815-21.
1985: N C Dracopoli; W J Rettig; A P Albino; D Esposito; N Archidiacono; M Rocchi; Marcello Siniscalco; Lloyd J Old
Genes controlling gp25/30 cell-surface molecules map to chromosomes X and Y and escape X-inactivation.
American journal of human genetics 1985;37(1):199-207.
1985: V Srinivas; E Orihuela; K O Lloyd; Lloyd J Old; W F Whitmore
Estimation of ABO(H) isoantigen expression in bladder tumors.
The Journal of urology 1985;133(1):25-8.
1985: C Cordon-Cardo; M J Mattes; M R Melamed; J L Lewis; Lloyd J Old; K O Lloyd
Immunopathologic analysis of a panel of mouse monoclonal antibodies reacting with human ovarian carcinomas and other human tumors.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 1985;4(2):121-30.
1985: M A Palladino; G E Ranges; H F Oettgen; Lloyd J Old
Functional relationships of Lyt-2 and Lyt-3 expression and T-cell cytotoxicity: a new model system.
Advances in experimental medicine and biology 1985;184():355-64.
1984: F Graus; C Cordon-Cardo; Alan N Houghton; M R Melamed; Lloyd J Old
Distribution of the ganglioside GD3 in the human nervous system detected by R24 mouse monoclonal antibody.
Brain research 1984;324(1):190-4.
1984: R J Andy; C L Finstad; Lloyd J Old; K O Lloyd; R Kornfeld
The antigen identified by a mouse monoclonal antibody raised against human renal cancer cells is the adenosine deaminase binding protein.
The Journal of biological chemistry 1984;259(20):12844-9.
1984: W J Rettig; N C Dracopoli; T A Goetzger; B A Spengler; J L Biedler; H F Oettgen; Lloyd J Old
Somatic cell genetic analysis of human cell surface antigens: chromosomal assignments and regulation of expression in rodent-human hybrid cells.
Proceedings of the National Academy of Sciences of the United States of America 1984;81(20):6437-41.
1984: C Cordon-Cardo; N H Bander; Y Fradet; CL Finstad; W F Whitmore; K O Lloyd; H F Oettgen; M R Melamed; Lloyd J Old
Immunoanatomic dissection of the human urinary tract by monoclonal antibodies.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 1984;32(10):1035-40.
1984: F X Real; M J Mattes; Alan N Houghton; H F Oettgen; K O Lloyd; Lloyd J Old
Class 1 (unique) tumor antigens of human melanoma. Identification of a 90,000 dalton cell surface glycoprotein by autologous antibody.
The Journal of experimental medicine 1984;160(4):1219-33.
1984: N C Dracopoli; W J Rettig; T A Goetzger; Alan N Houghton; B A Spengler; H F Oettgen; J L Biedler; Lloyd J Old
Three human cell surface antigen systems determined by genes on chromosome 12.
Somatic cell and molecular genetics 1984;10(5):475-81.
1984: Alan N Houghton; T M Thomson; D Gross; H F Oettgen; Lloyd J Old
Surface antigens of melanoma and melanocytes. Specificity of induction of Ia antigens by human gamma-interferon.
The Journal of experimental medicine 1984;160(1):255-69.
1984: A Knuth; B Danowski; H F Oettgen; Lloyd J Old
T-cell-mediated cytotoxicity against autologous malignant melanoma: analysis with interleukin 2-dependent T-cell cultures.
Proceedings of the National Academy of Sciences of the United States of America 1984;81(11):3511-5.
1984: Richard J Cote; D M Morrissey; H F Oettgen; Lloyd J Old
Analysis of human monoclonal antibodies derived from lymphocytes of patients with cancer.
Federation proceedings 1984;43(9):2465-9.
1984: W J Rettig; N C Dracopoli; T A Goetzger; B A Spengler; J L Biedler; H F Oettgen; Lloyd J Old
Two cell-surface markers for human chromosome 1 in interspecies hybrids.
Somatic cell and molecular genetics 1984;10(3):297-305.
1984: A P Albino; R Le Strange; A I Oliff; Mark E Furth; Lloyd J Old
Transforming ras genes from human melanoma: a manifestation of tumour heterogeneity?
Nature 1984;308(5954):69-72.
1984: Zbigniew Darzynkiewicz; B Williamson; E A Carswell; Lloyd J Old
Cell cycle-specific effects of tumor necrosis factor.
Cancer research 1984;44(1):83-90.
1984: M J Mattes; C Cordon-Cardo; J L Lewis; Lloyd J Old; K O Lloyd
Cell surface antigens of human ovarian and endometrial carcinoma defined by mouse monoclonal antibodies.
Proceedings of the National Academy of Sciences of the United States of America 1984;81(2):568-72.
1984: Y Fradet; C Cordon-Cardo; T Thomson; M E Daly; W F Whitmore; K O Lloyd; M R Melamed; Lloyd J Old
Cell surface antigens of human bladder cancer defined by mouse monoclonal antibodies.
Proceedings of the National Academy of Sciences of the United States of America 1984;81(1):224-8.
1983: M J Mattes; T M Thomson; Lloyd J Old; K O Lloyd
A pigmentation-associated, differentiation antigen of human melanoma defined by a precipitating antibody in human serum.
International journal of cancer. Journal international du cancer 1983;32(6):717-21.
1983: D W Shen; F X Real; A B DeLeo; Lloyd J Old; P A Marks; R A Rifkind
Protein p53 and inducer-mediated erythroleukemia cell commitment to terminal cell division.
Proceedings of the National Academy of Sciences of the United States of America 1983;80(19):5919-22.
1983: B D Williamson; E A Carswell; B Y Rubin; J S Prendergast; Lloyd J Old
Human tumor necrosis factor produced by human B-cell lines: synergistic cytotoxic interaction with human interferon.
Proceedings of the National Academy of Sciences of the United States of America 1983;80(17):5397-401.
1983: A P Albino; K O Lloyd; H Ikeda; Lloyd J Old
Biochemical analysis of a 130,000 molecular weight glycoprotein on human melanoma cells.
Journal of immunology (Baltimore, Md. : 1950) 1983;131(3):1595-9.
1983: A Knuth; K O Lloyd; M Lipkin; H F Oettgen; Lloyd J Old
Natural antibodies in human sera directed against blood-group-related determinants expressed on colon cancer cells.
International journal of cancer. Journal international du cancer 1983;32(2):199-204.
1983: Alan N Houghton; Hannah Brooks; Richard J Cote; M C Taormina; H F Oettgen; Lloyd J Old
Detection of cell surface and intracellular antigens by human monoclonal antibodies. Hybrid cell lines derived from lymphocytes of patients with malignant melanoma.
The Journal of experimental medicine 1983;158(1):53-65.
1983: Philip O Livingston; H Takeyama; M S Pollack; Alan N Houghton; A Albino; C M Pinsky; H F Oettgen; Lloyd J Old
Serological responses of melanoma patients to vaccines derived from allogeneic cultured melanoma cells.
International journal of cancer. Journal international du cancer 1983;31(5):567-75.
1983: Richard J Cote; D M Morrissey; Alan N Houghton; E J Beattie; H F Oettgen; Lloyd J Old
Generation of human monoclonal antibodies reactive with cellular antigens.
Proceedings of the National Academy of Sciences of the United States of America 1983;80(7):2026-30.
1983: Patrick M Flood; A B DeLeo; Lloyd J Old; R K Gershon
Relation of cell surface antigens on methylcholanthrene-induced fibrosarcomas to immunoglobulin heavy chain complex variable region-linked T cell interaction molecules.
Proceedings of the National Academy of Sciences of the United States of America 1983;80(6):1683-7.
1983: K Yokoyama; E Stockert; L R Pease; Y Obata; Lloyd J Old; Stanley G Nathenson
Polymorphism and diversity in the Tla gene system.
Immunogenetics 1983;18(5):445-51.
1983: Patrick M Flood; A B Deleo; Lloyd J Old; R K Gershon
Similarities between transplantation antigens on methylcholanthrene-induced sarcomas and T-cell regulatory molecules.
Annals of the New York Academy of Sciences 1983;418():206-19.
1983: Patrick M Flood; A B DeLeo; Lloyd J Old; R K Gershon
Inhibition of the induction of contrasuppression by antisera against tumor-associated surface antigens on methylcholanthrene-induced sarcomas.
Haematology and blood transfusion 1983;28():486-8.
1983: M J Mattes; J G Cairncross; Lloyd J Old; K O Lloyd
Monoclonal antibodies to three widely distributed human cell surface antigens.
Hybridoma 1983;2(3):253-64.
1982: T Watanabe; clifford stuart pukel; H Takeyama; K O Lloyd; H Shiku; L T Li; Luiz Travassos; H F Oettgen; Lloyd J Old
Human melanoma antigen AH is an autoantigenic ganglioside related to GD2.
The Journal of experimental medicine 1982;156(6):1884-9.
1982: Alan N Houghton; M Eisinger; A P Albino; J G Cairncross; Lloyd J Old
Surface antigens of melanocytes and melanomas. Markers of melanocyte differentiation and melanoma subsets.
The Journal of experimental medicine 1982;156(6):1755-66.
1982: Philip O Livingston; T Watanabe; H Shiku; Alan N Houghton; A Albino; T Takahashi; L A Resnick; R Michitsch; C M Pinsky; H F Oettgen; Lloyd J Old
Serological response of melanoma patients receiving melanoma cell vaccines. I. Autologous cultured melanoma cells.
International journal of cancer. Journal international du cancer 1982;30(4):413-22.
1982: B Anger; R Bockman; M Andreeff; R Erlandson; Suresh C Jhanwar; T Kameya; P Saigo; W Wright; E J Beattie; H F Oettgen; Lloyd J Old
Characterization of two newly established human cell lines from patients with large-cell anaplastic lung carcinoma.
Cancer 1982;50(8):1518-29.
1982: W E Mercer; D Nelson; A B DeLeo; Lloyd J Old; R Baserga
Microinjection of monoclonal antibody to protein p53 inhibits serum-induced DNA synthesis in 3T3 cells.
Proceedings of the National Academy of Sciences of the United States of America 1982;79(20):6309-12.
1982: J G Cairncross; M J Mattes; H R Beresford; A P Albino; Alan N Houghton; K O Lloyd; Lloyd J Old
Cell surface antigens of human astrocytoma defined by mouse monoclonal antibodies: identification of astrocytoma subsets.
Proceedings of the National Academy of Sciences of the United States of America 1982;79(18):5641-5.
1982: Albert B DeLeo; K S Chang; N A Wivel; E Appella; Lloyd J Old; L W Law
possible role of a retrovirus in the expression of tumor-specific antigens of the Meth A sarcoma.
International journal of cancer. Journal international du cancer 1982;29(6):687-93.
1982: clifford stuart pukel; K O Lloyd; Luiz Travassos; W G Dippold; H F Oettgen; Lloyd J Old
GD3, a prominent ganglioside of human melanoma. Detection and characterisation by mouse monoclonal antibody.
The Journal of experimental medicine 1982;155(4):1133-47.
1982: G Jay; M A Palladino; G Khoury; Lloyd J Old
Mouse Lyt-2 antigen: evidence for two heterodimers with a common subunit.
Proceedings of the National Academy of Sciences of the United States of America 1982;79(8):2654-7.
1982: B R Anger; K O Lloyd; H F Oettgen; Lloyd J Old
Mouse monoclonal IgM antibody against human lung cancer line SK-LC-3 with specificity for H(O) blood group antigen.
Hybridoma 1982;1(2):139-47.
1982: Lloyd J Old
Cancer immunology: the search for specificity.
National Cancer Institute monograph 1982;60():193-209.
1982: K Yokoyama; E Stockert; Lloyd J Old; Stanley G Nathenson
Structural evidence that the small subunit found associated with the TL antigen is beta 2-microglobulin.
Immunogenetics 1982;15(6):543-9.
1981: A P Albino; K O Lloyd; Alan N Houghton; H F Oettgen; Lloyd J Old
Heterogeneity in surface antigen and glycoprotein expression of cell lines derived from different melanoma metastases of the same patient. Implications for the study of tumor antigens.
The Journal of experimental medicine 1981;154(6):1764-78.
1981: G C DuBois; E Appella; L W Law; Albert B DeLeo; Lloyd J Old
The soluble antigens of BALB/c sarcoma Meth-A: a relationship between a serologically defined tumor-specific surface antigen (TSSA) and the tumor-associated transplantation antigen (TATA).
Transplantation proceedings 1981;13(4):1765-73.
1981: K Yokoyama; E Stockert; Lloyd J Old; Stanley G Nathenson
Structural comparisons of TL antigens derived from normal and leukemia cells of Tl+ and TL- strains and relationship to genetically linked H-2 major histocompatibility complex products.
Proceedings of the National Academy of Sciences of the United States of America 1981;78(11):7078-82.
1981: D D Pravtcheva; A B DeLeo; F H Ruddle; Lloyd J Old
Chromosome assignment of the tumor-specific antigen of a 3-methylcholanthrene-induced mouse sarcoma.
The Journal of experimental medicine 1981;154(3):964-77.
1981: Y Obata; Elisabeth Stockert; A B DeLeo; P V O'Donnell; H W Snyder; Lloyd J Old
A cell surface antigen of the mouse related to xenotropic MuLv defined by naturally occurring antibody and monoclonal antibody. Relation to Gix G(rada1), G(aksl2) systems of MuLV-related antigens.
The Journal of experimental medicine 1981;154(3):659-75.
1981: R Ueda; S Ogata; D M Morrissey; C L Finstad; J Szkudlarek; W F Whitmore; H F Oettgen; K O Lloyd; Lloyd J Old
Cell surface antigens of human renal cancer defined by mouse monoclonal antibodies: identification of tissue-specific kidney glycoproteins.
Proceedings of the National Academy of Sciences of the United States of America 1981;78(8):5122-6.
1981: E Gregory MacEwen; A K Patnaik; A A Hayes; R J Wilkins; W D Hardy; R L Kassel; Lloyd J Old
Temporary plasma-induced remission of lymphoblastic leukemia in a dog.
American journal of veterinary research 1981;42(8):1450-2.
1981: P V O'Donnell; Elisabeth Stockert; Y Obata; Lloyd J Old
Leukemogenic properties of AKR dualtropic (MCF) viruses: amplification of murine leukemia virus-related antigens on thymocytes and acceleration of leukemia development in AKR mice.
Virology 1981;112(2):548-63.
1981: G Jay; G Khoury; A B DeLeo; W G Dippold; Lloyd J Old
p53 transformation-related protein: detection of an associated phosphotransferase activity.
Proceedings of the National Academy of Sciences of the United States of America 1981;78(5):2932-6.
1981: W G Dippold; G Jay; A B DeLeo; G Khoury; Lloyd J Old
p53 transformation-related protein: detection by monoclonal antibody in mouse and human cells.
Proceedings of the National Academy of Sciences of the United States of America 1981;78(3):1695-9.
1981: Lloyd J Old
Cancer immunology: the search for specificity--G. H. A. Clowes Memorial lecture.
Cancer research 1981;41(2):361-75.
1980: G C DuBois; E Appella; L W Law; Albert B DeLeo; Lloyd J Old
Immunogenic properties of soluble cytosol fractions on Meth A sarcoma cells.
Cancer research 1980;40(11):4204-8.
1980: W G Dippold; K O Lloyd; L T Li; H Ikeda; H F Oettgen; Lloyd J Old
Cell surface antigens of human malignant melanoma: definition of six antigenic systems with mouse monoclonal antibodies.
Proceedings of the National Academy of Sciences of the United States of America 1980;77(10):6114-8.
1980: Alan N Houghton; M C Taormina; H Ikeda; T Watanabe; H F Oettgen; Lloyd J Old
Serological survey of normal humans for natural antibody to cell surface antigens of melanoma.
Proceedings of the National Academy of Sciences of the United States of America 1980;77(7):4260-4.
1980: Elisabeth Stockert; P V O'Donnell; Y Obata; Lloyd J Old
Inhibition of AKR leukemogenesis by SMX-1, a dualtropic murine leukemia virus.
Proceedings of the National Academy of Sciences of the United States of America 1980;77(6):3720-4.
1980: E Nakayama; W Dippold; H Shiku; H F Oettgen; Lloyd J Old
Alloantigen-induced T-cell proliferation: Lyt phenotype of responding cells and blocking of proliferation by Lyt antisera.
Proceedings of the National Academy of Sciences of the United States of America 1980;77(5):2890-4.
1980: H F Oettgen; Lloyd J Old
Immunotherapy of colon cancer: prospects for developing immunogenic vaccines based on autologous serological typing.
Cancer 1980;45(5 Suppl):1218-22.
1980: Albert B DeLeo; G Jay; E Appella; G C DuBois; L W Law; Lloyd J Old
Cell surface antigens of chemically induced sarcomas of inbred mice.
Transplantation proceedings 1980;12(1):65-9.
1980: H F Oettgen; E A Carswell; R L Kassel; N Fiore; B Williamson; M K Hoffmann; K Haranaka; Lloyd J Old
Endotoxin-induced tumor necrosis factor.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1980;75():207-12.
1980: M Pfreundschuh; H Shiku; T Takahashi; R Ueda; J Ransohoff; H F Oettgen; Lloyd J Old
Tumor-specific antigens.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1980;75():1-9.
1980: G Jay; Albert B DeLeo; E Appella; G C Dubois; L W Law; G Khoury; Lloyd J Old
A common transformation-related protein in murine sarcomas and leukemias.
Cold Spring Harbor symposia on quantitative biology 1980;44 Pt 1,():659-64.
1980: P V O'Donnell; Elisabeth Stockert; Y Obata; A B DeLeo; Lloyd J Old
Murine-leukemia-virus-related cell-surface antigens as serological markers of AKR ecotropic, xenotropic, and dualtropic viruses.
Cold Spring Harbor symposia on quantitative biology 1980;44 Pt 2,():1255-64.
1979: R Ueda; H Shiku; M Pfreundschuh; T Takahashi; L T Li; W F Whitmore; H F Oettgen; Lloyd J Old
Cell surface antigens of human renal cancer defined by autologous typing.
The Journal of experimental medicine 1979;150(3):564-79.
1979: K O Lloyd; Luiz Travassos; T Takahashi; Lloyd J Old
Cell surface glycoproteins of human tumor cell lines: unusual characteristics of malignant melanoma.
Journal of the National Cancer Institute 1979;63(3):623-34.
1979: Philip O Livingston; H Shiku; M A Bean; C M Pinsky; H F Oettgen; Lloyd J Old
Cell-mediated cytotoxicity for cultured autologous melanoma cells.
International journal of cancer. Journal international du cancer 1979;24(1):34-44.
1979: E Nakayama; H Shiku; T Takahashi; H F Oettgen; Lloyd J Old
Definition of a unique cell surface antigen of mouse leukemia RL male 1 by cell-mediated cytotoxicity.
Proceedings of the National Academy of Sciences of the United States of America 1979;76(7):3486-90.
1979: Thomas Carey; K O Lloyd; T Takahashi; Luiz Travassos; Lloyd J Old
AU cell-surface antigen of human malignant melanoma: solubilization and partial characterization.
Proceedings of the National Academy of Sciences of the United States of America 1979;76(6):2898-902.
1979: A B DeLeo; G Jay; E Appella; G C Dubois; L W Law; Lloyd J Old
Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouse.
Proceedings of the National Academy of Sciences of the United States of America 1979;76(5):2420-4.
1979: E Nakayama; H Shiku; E Stockert; H F Oettgen; Lloyd J Old
Cytotoxic T cells: Lyt phenotype and blocking of killing activity by Lyt antisera.
Proceedings of the National Academy of Sciences of the United States of America 1979;76(4):1977-81.
1979: E Stockert; A B DeLeo; P V O'Donnell; Y Obata; Lloyd J Old
G(AKSL2): a new cell surface antigen of the mouse related to the dualtropic mink cell focus-inducing class of murine leukemia virus detected by naturally occurring antibody.
The Journal of experimental medicine 1979;149(1):200-15.
1978: R J Winchester; C Y Wang; A Gibofsky; H G Kunkel; K O Lloyd; Lloyd J Old
Expression of Ia-like antigens on cultured human malignant melanoma cell lines.
Proceedings of the National Academy of Sciences of the United States of America 1978;75(12):6235-9.
1978: M Pfreundschuh; H Shiku; T Takahashi; R Ueda; J Ransohoff; H F Oettgen; Lloyd J Old
Serological analysis of cell surface antigens of malignant human brain tumors.
Proceedings of the National Academy of Sciences of the United States of America 1978;75(10):5122-6.
1978: R Risser; E Stockert; Lloyd J Old
Abelson antigen: a viral tumor antigen that is also a differentiation antigen of BALB/c mice.
Proceedings of the National Academy of Sciences of the United States of America 1978;75(8):3918-22.
1978: N Imamura; T Takahashi; K O Lloyd; J L Lewis; Lloyd J Old
Analysis of human ovarian tumor antigens using heterologous antisera: detection of new antigenic systems.
International journal of cancer. Journal international du cancer 1978;21(5):570-7.
1978: M K Hoffmann; H F Oettgen; Lloyd J Old; Robert S Mittler; Ulrich Hammerling
Induction and immunological properties of tumor necrosis factor.
Journal of the Reticuloendothelial Society 1978;23(4):307-19.
1978: Y Obata; E Stockert; P V O'Donnell; S Okubo; H W Snyder; Lloyd J Old
G(RADA1): a new cell surface antigen of mouse leukemia defined by naturally occurring antibody and its relationship to murine leukemia virus.
The Journal of experimental medicine 1978;147(4):1089-105.
1978: E A Boyse; Lloyd J Old
The immunogenetics of differentiation in the mouse.
Harvey lectures 1978;71():23-53.
1978: M I Bernhard; Lloyd J Old; T Takahashi; N H Sarkar; W C Lawrence
Definition of an antigen shared by herpesviruses and oncornaviruses.
IARC scientific publications 1978;(24 Pt 1):215-24.
1977: S Green; A Dobrjansky; M A Chiasson; E Carswell; Morton K Schwartz; Lloyd J Old
Corynebacterium parvum as the priming agent in the production of tumor necrosis factor in the mouse.
Journal of the National Cancer Institute 1977;59(5):1519-22.
1977: T J Garrett; T Takahashi; Bayard Clarkson; Lloyd J Old
Detection of antibody to autologous human leukemia cells by immune adherence assays.
Proceedings of the National Academy of Sciences of the United States of America 1977;74(10):4587-90.
1977: A B DeLeo; H Shiku; T Takahashi; M John; Lloyd J Old
Cell surface antigens of chemically induced sarcomas of the mouse. I. Murine leukemia virus-related antigens and alloantigens on cultured fibroblasts and sarcoma cells: description of a unique antigen on BALB/c Meth A sarcoma.
The Journal of experimental medicine 1977;146(3):720-34.
1977: E Stockert; Lloyd J Old
Preleukemic expression of TL antigens in x-irradiated C57BL/6 mice.
The Journal of experimental medicine 1977;146(1):271-6.
1977: R L Kassel; Lloyd J Old; N K Day; W D Hardy
Plasma-mediated leukemia cell destruction: concentration and purification of the antileukemia factor.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1977;155(2):230-3.
1977: Lloyd J Old
Cancer immunology.
Scientific American 1977;236(5):62-70, 72-3, 76, 79.
1977: M K Hoffmann; H F Oettgen; Lloyd J Old; A F Chin; Ulrich Hammerling
Endotoxin-induced serum factor controlling differentiation of bone-marrow-derived lymphocytes.
Proceedings of the National Academy of Sciences of the United States of America 1977;74(3):1200-3.
1977: H Shiku; T Takahashi; L A Resnick; H F Oettgen; Lloyd J Old
Cell surface antigens of human malignant melanoma. III. Recognition of autoantibodies with unusual characteristics.
The Journal of experimental medicine 1977;145(3):784-9.
1977: J W Hartley; N K Wolford; Lloyd J Old; W P Rowe
A new class of murine leukemia virus associated with development of spontaneous lymphomas.
Proceedings of the National Academy of Sciences of the United States of America 1977;74(2):789-92.
1977: Lloyd J Old; R A Good
Cellular engineering.
Clinical bulletin 1977;7(1):33-9.
1977: Lloyd J Old; E Stockert
Immunogenetics of cell surface antigens of mouse leukemia.
Annual review of genetics 1977;11():127-60.
1976: K Kawashima; H Ikeda; J W Hartley; E Stockert; W P Rowe; Lloyd J Old
Changes in expression of murine leukemia virus antigens and production of xenotropic virus in the late preleukemic period in AKR mice.
Proceedings of the National Academy of Sciences of the United States of America 1976;73(12):4680-4.
1976: H Shiku; T Takahashi; M A Bean; Lloyd J Old; H F Oettgen
Ly phenotype of cytotoxic T cells for syngeneic tumor.
The Journal of experimental medicine 1976;144(4):1116-20.
1976: M K Hoffmann; S Green; Lloyd J Old; H F Oettgen
Serum containing endotoxin-induced tumour necrosis factor substitutes for helper T cells.
Nature 1976;263(5576):416-7.
1976: Thomas Carey; T Takahashi; L A Resnick; H F Oettgen; Lloyd J Old
Cell surface antigens of human malignant melanoma: mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells.
Proceedings of the National Academy of Sciences of the United States of America 1976;73(9):3278-82.
1976: K Kawashima; H Ikeda; E Stockert; T Takahashi; Lloyd J Old
Age-related changes in cell surface antigens of preleukemic AKR thymocytes.
The Journal of experimental medicine 1976;144(1):193-208.
1976: Joseph Roberts; F A Schmid; Lloyd J Old; E Stockert
A comparative study of the antitumor effectiveness of E. coli and Erwinia asparaginases.
Cancer biochemistry biophysics 1976;1(4):175-8.
1976: H Shiku; T Takahashi; M A Bean; U Hämmerling; H F Oettgen; Lloyd J Old
Surface phenotype of nonadherent peritoneal cells effecting cell-mediated cytotoxicity in vitro for allogeneic and syngeneic murine sarcoma cells.
Israel journal of medical sciences 1976;12(4-5):425-34.
1976: S Green; A Dobrjansky; E A Carswell; R L Kassel; Lloyd J Old; N Fiore; Morton K Schwartz
Partial purification of a serum factor that causes necrosis of tumors.
Proceedings of the National Academy of Sciences of the United States of America 1976;73(2):381-5.
1976: Lloyd J Old
Tumor necrosis factor.
Clinical bulletin 1976;6(3):118-20.
1975: L Helson; S Green; E Carswell; Lloyd J Old
Effect of tumour necrosis factor on cultured human melanoma cells.
Nature 1975;258(5537):731-2.
1975: M A Bean; B R Bloom; R B Herberman; Lloyd J Old; H F Oettgen; G Klein; W D Terry
Cell-mediated cytotoxicity for bladder carcinoma: evaluation of a workshop.
Cancer research 1975;35(10):2902-13.
1975: W D Hardy; P W Hess; E G MacEwen; A A Hayes; R L Kassel; N K Day; Lloyd J Old
Treatment of feline lymphosarcoma with feline blood constituents.
Bibliotheca haematologica 1975;(43):518-21.
1975: E A Carswell; Lloyd J Old; R L Kassel; S Green; N Fiore; B Williamson
An endotoxin-induced serum factor that causes necrosis of tumors.
Proceedings of the National Academy of Sciences of the United States of America 1975;72(9):3666-70.
1975: R Dofuku; J L Biedler; B A Spengler; Lloyd J Old
Trisomy of chromosome 15 in spontaneous leukemia of AKR mice.
Proceedings of the National Academy of Sciences of the United States of America 1975;72(4):1515-7.
1975: H Shiku; M A Bean; Lloyd J Old; H F Oettgen
Cytotoxic reactions of murine lymphoid cells studied with a tritiated proline microcytotoxicity test.
Journal of the National Cancer Institute 1975;54(2):415-25.
1975: Lloyd J Old; E W Hahn; Jae Ho Kim
Hyperthermia in cancer research.
Clinical bulletin 1975;5(4):165-7.
1975: Lloyd J Old; I H Krakoff
Combination chemotherapy.
Clinical bulletin 1975;5(3):120-3.
1975: H Shiku; P Kisielow; M A Bean; T Takahashi; E A Boyse; H F Oettgen; Lloyd J Old
Expression of T-cell differentiation antigens on effector cells in cell-mediated cytotoxicity in vitro. Evidence for functional heterogeneity related to the surface phenotype of T cells.
The Journal of experimental medicine 1975;141(1):227-41.
1974: S B Day; Lloyd J Old; R A Good
Communication of scientific information at a cancer research institute.
Federation proceedings 1974;33(6):1699-1701.
1974: H F Oettgen; Lloyd J Old; J H Farrow; F T Valentine; H S Lawrence; L Thomas
Effects of dialyzable transfer factor in patients with breast cancer.
Proceedings of the National Academy of Sciences of the United States of America 1974;71(6):2319-23.
1973: M A Mandel; T Takahashi; Lloyd J Old
Studies of thoracic duct lymphocytes of mice. 3. Cell surface antigen characteristics.
Journal of immunology (Baltimore, Md. : 1950) 1973;111(5):1474-8.
1973: R L Kassel; Lloyd J Old; E A Carswell; N C Fiore; W D Hardy
Serum-mediated leukemia cell destruction in AKR mice.
The Journal of experimental medicine 1973;138(4):925-38.
1973: H Sato; E A Boyse; T Aoki; C Iritani; Lloyd J Old
Leukemia-associated transplantation antigens related to murine leukemia virus. The X.1 system: immune response controlled by a locus linked to H-2.
The Journal of experimental medicine 1973;138(3):593-606.
1973: E A Boyse; E A Carswell; M P Scheid; Lloyd J Old
Tolerance of Sk-incompatible skin grafts.
Nature 1973;244(5416):441-2.
1973: W D Hardy; Lloyd J Old; P W Hess; M Essex; S Cotter
Horizontal transmission of feline leukaemia virus.
Nature 1973;244(5414):266-9.
1973: T Muramatsu; Stanley G Nathenson; E A Boyse; Lloyd J Old
Some biochemical properties of thymus leukemia antigens solubilized from cell membranes by papain digestion.
The Journal of experimental medicine 1973;137(5):1256-62.
1973: H Ikeda; E Stockert; W P Rowe; E A Boyse; F Lilly; H Sato; S Jacobs; Lloyd J Old
Relation of chromosome 4 (linkage group 8) to murine leukemia virus-associated antigens of AKR mice.
The Journal of experimental medicine 1973;137(4):1103-7.
1973: K Komuro; E A Boyse; Lloyd J Old
Production of TL antibody by mice immunized with TL- cell populations. A possible assay for thymic hormone.
The Journal of experimental medicine 1973;137(2):533-6.
1973: Lloyd J Old; E A Boyse
Current enigmas in cancer research.
Harvey lectures 1973;67():273-315.
1972: E Stockert; H Sato; K Itakura; E A Boyse; Lloyd J Old; J J Hutton
Location of the second gene required for expression of the leukemia-associated mouse antigens G IX .
Science (New York, N.Y.) 1972;178(4063):862-3.
1972: R Rogers; T C Merigan; W D Hardy; Lloyd J Old; R Kassel
Cat interferon inhibits feline leukaemia virus infection in cell culture.
Nature: New biology 1972;237(78):270-1.
1972: E M Edynak; Lloyd J Old; M Vrana; M P Lardis
A fetal antigen associated with human neoplasia.
The New England journal of medicine 1972;286(22):1178-83.
1972: M Scheid; E A Boyse; E A Carswell; Lloyd J Old
Serologically demonstrable alloantigens of mouse epidermal cells.
The Journal of experimental medicine 1972;135(4):938-55.
1972: E A Boyse; L Flaherty; E Stockert; Lloyd J Old
Histoincompatibility attributable to genes near H-2 that are not revealed by hemagglutination or cytotoxicity tests.
Transplantation 1972;13(4):431-2.
1972: K Itakura; J J Hutton; E A Boyse; Lloyd J Old
Genetic linkage relationships of loci specifying differentiation alloantigens in the mouse.
Transplantation 1972;13(3):239-43.
1971: T Takahashi; Lloyd J Old; C J Hsu; E A Boyse
A new differentiation antigen of plasma cells.
European journal of immunology 1971;1(6):478-82.
1971: E A Boyse; Lloyd J Old; M Scheid
Selective gene action in the specification of cell surface structure.
The American journal of pathology 1971;65(2):439-50.
1971: S Chang; E Stockert; E A Boyse; U Hämmerling; Lloyd J Old
Spontaneous release of cytotoxic alloantibody from viable cells sensitized in excess antibody.
Immunology 1971;21(5):829-38.
1971: R C Nowinski; N H Sarkar; Lloyd J Old; D H Moore; D I Scheer; J Hilgers
Characteristics of the structural components of the mouse mammary tumor virus. II. Viral proteins and antigens.
Virology 1971;46(1):21-38.
1971: T Takahashi; Lloyd J Old; K R McIntire; E A Boyse
Immunoglobulin and other surface antigens of cells of the immune system.
The Journal of experimental medicine 1971;134(4):815-32.
1971: T Aoki; H A Wood; Lloyd J Old; E A Boyse; E De Harven; M P Lardis; C W Stackpole
Another visual marker of antibody for electron microscopy.
Virology 1971;45(3):858-62.
1971: E A Boyse; Lloyd J Old; C A Iritani
The technique of obtaining thymocytes from living mice.
Transplantation 1971;12(1):93-5.
1971: E A Boyse; Lloyd J Old
A comment on the genetic data relating to expression of TL antigens.
Transplantation 1971;11(6):561-2.
1971: E Stockert; Lloyd J Old; E A Boyse
The G-IX system. A cell surface allo-antigen associated with murine leukemia virus; implications regarding chromosomal integration of the viral genome.
The Journal of experimental medicine 1971;133(6):1334-55.
1971: H F Oettgen; Lloyd J Old; E A Boyse
Human tumor immunology.
The Medical clinics of North America 1971;55(3):761-85.
1971: C W Stackpole; T Aoki; E A Boyse; Lloyd J Old; J Lumley-Frank; E De Harven
Cell surface antigens: serial sectioning of single cells as an approach to topographical analysis.
Science (New York, N.Y.) 1971;172(3982):472-4.
1971: R C Nowinski; Lloyd J Old; P V O'Donnell; F K Sanders
Serological identification of hamster oncornaviruses.
Nature: New biology 1971;230(17):282-4.
1971: K Itakura; J J Hutton; E A Boyse; Lloyd J Old
Linkage groups of the theta and Ly-A loci.
Nature: New biology 1971;230(12):126.
1971: G Giraldo; E Beth; Y Hirshaut; T Aoki; Lloyd J Old; E A Boyse; H C Chopra
Human sarcomas in culture. Foci of altered cells and a common antigen; induction of foci and antigen in human fibroblast cultures by filtrates.
The Journal of experimental medicine 1971;133(3):454-78.
1971: M A Mandel; T Takahashi; Lloyd J Old
Cell surface antigens of normal and neoplastic lymphoid cells.
Surgical forum 1971;22():479-80.
1970: R C Nowinski; Lloyd J Old; N H Sarkar; D H Moore
Common properties of the oncogenic RNA viruses (oncornaviruses).
Virology 1970;42(4):1152-7.
1970: E A Boyse; E M Lance; E A Carswell; S Cooper; Lloyd J Old
Rejection of skin allografts by radiation chimaeras: selective gene action in the specification of cell surface structure.
Nature 1970;227(5261):901-3.
1970: E A Carswell; H J Wanebo; Lloyd J Old; E A Boyse
Immunogenic properties of reticulum cell sarcomas of SJL/J mice.
Journal of the National Cancer Institute 1970;44(6):1281-8.
1970: T Takahashi; Lloyd J Old; E A Boyse
Surface alloantigens of plasma cells.
The Journal of experimental medicine 1970;131(6):1325-41.
1970: G Geering; T Aoki; Lloyd J Old
Shared viral antigen of mammalian leukaemia viruses.
Nature 1970;226(5242):265-6.
1970: E A Boyse; E Stockert; C A Iritani; Lloyd J Old
Implications of TL phenotype changes in an H-2-loss variant of a transplanted H-2b-H-2a leukemia.
Proceedings of the National Academy of Sciences of the United States of America 1970;65(4):933-8.
1970: G Klein; G Geering; Lloyd J Old; G Henle; W Henle; P Clifford
Comparison of the anti-EBV titer and the EBV-associated membrane reactive and precipitating antibody levels in the sera of Burkitt lymphoma and nasopharyngeal carcinoma patients and controls.
International journal of cancer. Journal international du cancer 1970;5(2):185-94.
1970: T Aoki; E A Boyse; Lloyd J Old; E De Harven; U Hämmerling; H A Wood
G (Gross) and H-2 cell-surface antigens: location on Gross leukemia cells by electron microscopy with visually labeled antibody.
Proceedings of the National Academy of Sciences of the United States of America 1970;65(3):569-76.
1970: W D Hardy; Lloyd J Old
L-asparaginase in the treatment of neoplastic diseases of the dog, cat and cow.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1970;33():131-9.
1970: P S Sarma; J F Baskar; R J Huebner; Lloyd J Old; W D Hardy
Feline leukemia virus: detection of group-specific viral antigen and infectious virus by a complement-fixation test.
Bibliotheca haematologica 1970;(36):368-78.
1970: W D Hardy; G Geering; Lloyd J Old; E de Harven; R S Brodey; S K McDonough
Serological studies of the feline leukemia virus.
Bibliotheca haematologica 1970;(36):343-54.
1969: U Hämmerling; N Shigeno; Lloyd J Old; E A Boyse
Labelling of mouse alloantibody with tritiated dl-alanine.
Immunology 1969;17(6):999-1006.
1969: B R Bloom; B Bennett; H F Oettgen; E P McLean; Lloyd J Old
Demonstration of delayed hypersensitivity to soluble antigens of chemically induced tumors by inhibition of macrophage migration.
Proceedings of the National Academy of Sciences of the United States of America 1969;64(4):1176-80.
1969: W D Hardy; G Geering; Lloyd J Old; E DE Harven; R S Brody; S McDonough
Feline leukemia virus: occurrence of viral antigen in the tissues of cats with lymphosarcoma and other diseases.
Science (New York, N.Y.) 1969;166(3908):1019-21.
1969: T Aoki; U Hämmerling; E De Harven; E A Boyse; Lloyd J Old
Antigenic structure of cell surfaces. An immunoferritin study of the occurrence and topography of H-2' theta, and TL alloantigens on mouse cells.
The Journal of experimental medicine 1969;130(5):979-1001.
1969: U Hämmerling; T Aoki; H A Wood; Lloyd J Old; E A Boyse; E de Harvin
New visual markers of antibody for electron microscopy.
Nature 1969;223(5211):1158-9.
1969: G Klein; P Clifford; G Henle; W Henle; G Geering; Lloyd J Old
EBV-associated serological patterns in a Burkitt lymphoma patient during regression and recurrence.
International journal of cancer. Journal international du cancer 1969;4(4):416-21.
1969: D A Davies; B J Alkins; E A Boyse; Lloyd J Old; E Stockert
Soluble TL and H-2 antigens prepared from a TL positive leukaemia of a TL negative mouse strain.
Immunology 1969;16(5):669-76.
1969: A Gregoriades; Lloyd J Old
Isolation and some characteristics of a group-specific antigen of the murine leukemia viruses.
Virology 1969;37(2):189-202.
1968: U Hämmerling; T Aoki; E de Harven; E A Boyse; Lloyd J Old
Use of hybrid antibody with anti-gamma-G and anti-ferritin specificities in locating cell surface antigens by electron microscopy.
The Journal of experimental medicine 1968;128(6):1461-73.
1968: G Geering; W D Hardy; Lloyd J Old; E de Harven; R S Brodey
Shared group-specific antigen of murine and feline leukemia viruses.
Virology 1968;36(4):678-80.
1968: P E Came; G Geering; Lloyd J Old; E A Boyse
A serological study of polyhedral cytoplasmic viruses isolated from amphibia.
Virology 1968;36(3):392-400.
1968: H F Oettgen; Lloyd J Old; E P McLean; E A Carswell
Delayed hypersensitivity and transplantation immunity elicited by soluble antigens of chemically induced tumours in inbred guinea-pigs.
Nature 1968;220(5164):295-7.
1968: H F Oettgen; T Aoki; Lloyd J Old; E A Boyse; E de Harven; G M Mills
Suspension culture of a pigment-producing cell line derived from a human malignant melanoma.
Journal of the National Cancer Institute 1968;41(4):827-43.
1968: Lloyd J Old; C Iritani; E Stockert; E A Boyse; H A Campbell
Increased anti-leukaemia activity of E. coli asparaginase in mice infected with L.D.H.-elevating virus.
Lancet 1968;2(7569):684-5.
1968: N Shigeno; U Hämmerling; C Arpels; E A Boyse; Lloyd J Old
Preparation of lymphocyte-specific antibody from anti-lymphocyte serum.
Lancet 1968;2(7563):320-3.
1968: Lloyd J Old; E A Boyse
Prospects for immunotherapy of human cancer.
Annals of internal medicine 1968;69(2):393-7.
1968: Lloyd J Old; E A Boyse; H A Campbell
L-asparagine and leukemia.
Scientific American 1968;219(2):34-40.
1968: Lloyd J Old; E A Boyse; G Geering; H F Oettgen
Serologic approaches to the study of cancer in animals and in man.
Cancer research 1968;28(7):1288-99.
1968: E A Boyse; Lloyd J Old; E Stockert; N Shigeno
Genetic origin of tumor antigens.
Cancer research 1968;28(7):1280-7.
1968: E A Boyse; E Stockert; Lloyd J Old
Isoantigens of the H-2 and Tla loci of the mouse: interactions affecting their representation on thymocytes.
The Journal of experimental medicine 1968;128(1):85-95.
1968: E A Boyse; Lloyd J Old; E Stockert
An approach to the mapping of antigens on the cell surface.
Proceedings of the National Academy of Sciences of the United States of America 1968;60(3):886-93.
1968: T Aoki; E A Boyse; Lloyd J Old
Wild-type Gross leukemia virus. I. Soluble antigen (GSA) in the plasma and tissues of infected mice.
Journal of the National Cancer Institute 1968;41(1):89-96.
1968: E A Boyse; Lloyd J Old
Loss of skin allograft tolerance by chimeras.
Transplantation 1968;6(4):619.
1968: T Aoki; E A Boyse; Lloyd J Old
Wild-type Gross leukemia virus. II. Influence of immunogenetic factors on natural transmission and on the consequences of infection.
Journal of the National Cancer Institute 1968;41(1):97-101.
1968: T Aoki; E A Boyse; Lloyd J Old
Wild-type Gross leukemia virus. 3. Serological tests as indicators of leukemia risk.
Journal of the National Cancer Institute 1968;41(1):103-10.
1968: M E Lamm; E A Boyse; Lloyd J Old; B Lisowska-Bernstein; E Stockert
Modulation of TL (thymus-leukemia) antigens by Fab-fragments of TL antibody.
Journal of immunology (Baltimore, Md. : 1950) 1968;101(1):99-103.
1968: J H Kim; E A Boyse; Lloyd J Old; H A Campbell
Inhibition of HeLa cell cultures by preparations of Escherichia coli L-asparaginase.
Biochimica et biophysica acta 1968;158(3):476-9.
1968: E A Boyse; M Miyazawa; T Aoki; Lloyd J Old
Ly-A and Ly-B: two systems of lymphocyte isoantigens in the mouse.
Proceedings of the Royal Society of London. Series B, Containing papers of a Biological character. Royal Society (Great Britain) 1968;170(19):175-93.
1968: B Horowitz; B K Madras; A Meister; Lloyd J Old; E A Boyes; E Stockert
Asparagine synthetase activity of mouse leukemias.
Science (New York, N.Y.) 1968;160(3827):533-5.
1968: R C Nowinski; Lloyd J Old; E A Boyse; E de Harven; G Geering
Group-specific viral antigens in the milk and tissues of mice naturally infected with mammary tumor virus or Gross leukemia virus.
Virology 1968;34(4):617-29.
1968: Lloyd J Old; E Stockert; E A Boyse; Jae Ho Kim
Antigenic modulation. Loss of TL antigen from cells exposed to TL antibody. Study of the phenomenon in vitro.
The Journal of experimental medicine 1968;127(3):523-39.
1968: R C Nowinski; E A Boyse; Lloyd J Old; E A Carswell
Influence of mammary tumor virus infection on the acceptance or rejection of transplanted ML+ leukemias.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1968;127(1):20-5.
1967: H F Oettgen; Lloyd J Old; E A Boyse; H A Campbell; F S Philips; Bayard Clarkson; L Tallal; R D Leeper; Morton K Schwartz; J H Kim
Inhibition of leukemias in man by L-asparaginase.
Cancer research 1967;27(12):2619-31.
1967: H F Oettgen; T Aoki; G Geering; E A Boyse; Lloyd J Old
Definition of an antigenic system associated with Burkitt's lymphoma.
Cancer research 1967;27(12):2532-4.
1967: E A Boyse; E Stockert; Lloyd J Old
Modification of the antigenic structure of the cell membrane by thymus-leukemia (TL) antibody.
Proceedings of the National Academy of Sciences of the United States of America 1967;58(3):954-7.
1967: J D Wakefield; G J Thorbecke; Lloyd J Old; E A Boyse
Production of immunoglobulins and their subunits by human tissue culture cell lines.
Journal of immunology (Baltimore, Md. : 1950) 1967;99(2):308-19.
1967: Lloyd J Old; E A Boyse; H A Campbell; R S Brodey; J Fidler; J D Teller
Treatment of lymphosarcoma in the dog with L-asparaginase.
Cancer 1967;20(7):1066-70.
1967: D A Davies; E A Boyse; Lloyd J Old; E Stockert
Mouse isoantigens: separation of soluble TL (thymus-leukemia) antigen from soluble H-2 histocompatibility antigen by column chromatography.
The Journal of experimental medicine 1967;125(4):549-58.
1967: H A Campbell; L T Mashburn; E A Boyse; Lloyd J Old
Two L-asparaginases from Escherichia coli B. Their separation, purification, and antitumor activity.
Biochemistry 1967;6(3):721-30.
1967: L T Mashburn; E A Boyse; H A Campbell; Lloyd J Old
A comparison of concurrent and delayed tests for antitumor activity of L-asparaginase.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1967;124(2):568-71.
1967: Lloyd J Old; E Stockert; E A Boyse; G Geering
A study of passive immunization against a transplanted G+ leukemia with specific antiserum.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1967;124(1):63-8.
1967: E A Boyse; Lloyd J Old; H A Campbell; L T Mashburn
Suppression of murine leukemias by L-asparaginase. Incidence of sensitivity among leukemias of various types: comparative inhibitory activities of guinea pig serum L-asparaginase and Escherichia coli L-asparaginase.
The Journal of experimental medicine 1967;125(1):17-31.
1967: R C Nowinski; Lloyd J Old; D H Moore; G Geering; E A Boyse
A soluble antigen of the mammary tumor virus.
Virology 1967;31(1):1-14.
1966: Lloyd J Old; E A Boyse; H F Oettgen; E D Harven; G Geering; B Williamson; P Clifford
Precipitating antibody in human serum to an antigen present in cultured burkitt's lymphoma cells.
Proceedings of the National Academy of Sciences of the United States of America 1966;56(6):1699-704.
1966: H J Wanebo; W M Gallmeier; E A Boyse; Lloyd J Old
Paraproteinemia and reticulum cell sarcoma in an inbred mouse strain.
Science (New York, N.Y.) 1966;154(3751):901-3.
1966: T Aoki; Lloyd J Old; E A Boyse
[Leukemia-specific antigens in mice--its relation to viral antigens].
Saishin igaku. Modern medicine 1966;21(10):2343-51.
1966: G Geering; Lloyd J Old; E A Boyse
Antigens of leukemias induced by naturally occurring murine leukemia virus: their relation to the antigens of gross virus and other murine leukemia viruses.
The Journal of experimental medicine 1966;124(4):753-72.
1966: T Aoki; Lloyd J Old; E A Boyse
Serological analysis of leukemia antigens of the mouse.
National Cancer Institute monograph 1966;22():449-57.
1966: T Aoki; E A Boyse; Lloyd J Old
Occurrence of natural antibody to the G (gross) leukemia antigen in mice.
Cancer research 1966;26(7):1415-9.
1966: Lloyd J Old; E A Boyse
Specific antigens of tumors and leukemias of experimental animals.
The Medical clinics of North America 1966;50(3):901-12.
1965: Lloyd J Old; E A Boyse
Antigens of tumors and leukemias induced by viruses.
Federation proceedings 1965;24(5):1009-17.
1965: Lloyd J Old; E A Boyse; E Stockert
The G (Gross) leukemia antigen.
Cancer research 1965;25(6):813-9.
1965: M Schlesinger; E A Boyse; Lloyd J Old
Thymus cells of radiation-chimeras: TL phenotype, sensitivity to guinea-pig serum, and origin from donor cells.
Nature 1965;206(989):1119-21.
1964: F LILLY; E A BOYSE; Lloyd J Old
GENETIC BASIS OF SUSCEPTIBILITY TO VIRAL LEUKAEMOGENESIS.
Lancet 1964;2(7371):1207-9.
1964: B STUECK; Lloyd J Old; E A BOYSE
OCCURRENCE OF SOLUBLE ANTIGEN IN THE PLASMA OF MICE WITH VIRUS-INDUCED LEUKEMIA.
Proceedings of the National Academy of Sciences of the United States of America 1964;52():950-8.
1964: I CHOUROULINKOV; Lloyd J Old; E A BOYSE
[FACTORS WHICH PLAY A ROLE IN THE PRODUCTION OF ISOANTIBODIES IN MICE. SEX, THE COURSE OF IMMUNIZATION, SPLENECTOMY, AND SURGICAL SHOCK].
Journal of the Reticuloendothelial Society 1964;173():315-32.
1964: B STUECK; E A BOYSE; Lloyd J Old; E A CARSWELL
ML: A NEW ANTIGEN FOUND IN LEUKAEMIAS AND MAMMARY TUMOURS OF THE MOUSE.
Nature 1964;203():1033-4.
1964: B STUECK; Lloyd J Old; E A BOYSE
ANTIGENIC CONVERSION OF ESTABLISHED LEUKEMIAS BY AN UNRELATED LEUKAEMOGENIC VIRUS.
Nature 1964;202():1016-8.
1964: B BENNETT; Lloyd J Old; E A BOYSE
THE PHAGOCYTOSIS OF TUMOR CELLS IN VITRO.
Transplantation 1964;2():183-202.
1964: E A BOYSE; Lloyd J Old; S LUELL
GENETIC DETERMINATION OF THE TL (THYMUSLEUKAEMIA) ANTIGEN IN THE MOUSE.
Nature 1964;201():779.
1964: Lloyd J Old; E A BOYSE; E STOCKERT
TYPING OF MOUSE LEUKAEMIAS BY SEROLOGICAL METHODS.
Nature 1964;201():777-9.
1964: E A BOYSE; Lloyd J Old; I CHOUROULINKOV
CYTOTOXIC TEST FOR DEMONSTRATION OF MOUSE ANTIBODY.
Methods in medical research 1964;10():39-47.
1964: Lloyd J Old; E A BOYSE
IMMUNOLOGY OF EXPERIMENTAL TUMORS.
Annual review of medicine 1964;15():167-86.
1963: Lloyd J Old; E A BOYSE
ANTIGENIC PROPERTIES OF EXPERIMENTAL LEUKEMIAS. I. SEROLOGICAL STUDIES IN VITRO WITH SPONTANEOUS AND RADIATION-INDUCED LEUKEMIAS.
Journal of the National Cancer Institute 1963;31():977-95.
1963: Lloyd J Old; E A BOYSE; F LILLY
FORMATION OF CYTOXIC ANTIBODY AGAINST LEUKEMIAS INDUCED BY FRIEND VIRUS.
Cancer research 1963;23():1063-8.
1963: Lloyd J Old; franccesca villella; E CARSWELL
Contact reactivity to carcinogenic polycyclic hydrocarbons.
Nature 1963;198():1215-6.
1963: E A BOYSE; Lloyd J Old; E STOCKERT
Inhibitory effect of guinea pig serum on a number of new leukaemias in mice.
Nature 1963;198():800.
1963: Lloyd J Old; E A BOYSE; H A CAMPBELL; G M DARIA
Leukaemia-inhibiting properties and L-asparaginase activity of sera from certain South American rodents.
Nature 1963;198():801.
1963: B BENNETT; Lloyd J Old; E A BOYSE
Opsonization of cells by isoantibody in vitro.
Nature 1963;198():10-2.
1962: I CHOUROULINKOV; E A BOYSE; Lloyd J Old
Cytotoxic activity of isoantibody on sarcoma I.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1962;111():263-5.
1962: E A BOYSE; Lloyd J Old; E STOCKERT
Some further data on cytotoxic isoantibodies in the mouse.
Annals of the New York Academy of Sciences 1962;99():574-87.
1962: Lloyd J Old; D A CLARKE; B BENACERRAF; E STOCKERT
Effect of prior splenectomy on the growth of sarcoma 180 in normal and Bacillus Calmette-Guerin infected mice.
Experientia 1962;18():335-6.
1962: E A BOYSE; Lloyd J Old; E STOCKERT
Immunological enhancement of a leukaemia.
Nature 1962;194():1142-4.
1962: E A BOYSE; Lloyd J Old; G THOMAS
A report on some observations with a simplified cytotoxic test.
Transplantation bulletin 1962;29():63-7.
1962: E L WAY; J TAYLOR; Lloyd J Old; R GEORGE
Corticotrophic studies with aspirin.
The Journal of endocrinology 1962;24():7-16.
1962: H BALNER; Lloyd J Old; D A CLARKE
Accelerated rejection of male skin isografts by female C57BL mice infected with Bacillus Calmette-Guerin (B.C.G.).
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1962;109():58-62.
1961: H BALNER; Lloyd J Old; D A CLARKE
Reduction of x-ray lethality in mice by agents affecting the reticuloendothelial system.
Radiation research 1961;15():836-49.
1961: J L BIEDLER; Lloyd J Old; D A CLARKE
Chromosomal lesion associated with carcinogen-induced tumours in mice.
Nature 1961;192():286-8.
1961: Lloyd J Old; franccesca villella; D A CLARKE; E A CARSWELL; E STOCKERT
The role of the reticuloendothelial system in the host reaction to neoplasia.
Cancer research 1961;21():1281-300.
1961: G J THORBECKE; Lloyd J Old; franccesca villella; D A CLARKE
A histochemical study of acid and alkaline phosphatase in mouse livers during various conditions modifying activity of the reticuloendothelial system.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 1961;9():392-9.
1960: Lloyd J Old; franccesca villella; D A CLARKE; M GOLDSMITH
The reticuloendothelial system and the neoplastic process.
Annals of the New York Academy of Sciences 1960;88():264-80.
1959: Lloyd J Old; D A CLARKE; B BENACERRAF
Effect of Bacillus Calmette-Guerin infection on transplanted tumours in the mouse.
Nature 1959;184(Suppl 5)():291-2.